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Abstract 
Embryonic stem (ES) cells are cells derived from the inner cell mass of a 
blastocyst. They are pluripotent and can proliferate indefinitely while maintaining a 
stable diploid karyotype. Upon re-implantation into the mouse blastocyst, the progeny 
of ES cells can contribute to all cell lineages of the adult mouse, including germ cells. 
ES cells are a powerful tool for studying development, as all adult cell types can 
potentially be generated in vitro. 
One of the biggest challenges currently facing ES cell biology is to understand 
the mechanisms involved in the differentiation of ES cells to specific lineages. Pure 
populations of a specific cell lineage cannot be achieved without selection, such as 
fluorescence activated cell sorting (FACS), imn-iunopanning or growing cells in a 
selective environment following genetic manipulation. However, such techniques do 
not address why ES cells do and do not differentiate to particular lineages and cell types. 
To achieve greater understanding of the mechanism of neuronal differentiation 
from ES cells, an ES cell line was generated with eGFP driven by the neuronal specific 
gene mapt (construct obtained from K Tucker and Y Barde). Mapt is expressed 
exclusively in all neurons from the earliest stages of neuronal commitment, we find that 
neural differentiation of this line results in eGFP expressing neurons. Using FAGS, a 
pure population of neurons can be obtained from a heterogeneous population of 
differentiated cells. Neuronal differentiation can be quantified either by fluorescent 
microscopy or flow cytometry. These ES cells have been used to analyse the effect that 
density and the addition of exogenous factors have on neuronal differentiation. 
To better understand the changes that were occurring during differentiation, a 
transcriptome analysis experiment was performed by microarray analysis. Genes already 
known to be important during mammalian neural development were analysed for their 
involvement in ES cell neurogenesis. This comparison revealed a strong correlation 
between events of ES cell differentiation and normal embryonic development. The 
microarray analysis of ES cell neurogenesis also identified genes with an expression 
profile suggestive of a role in ES cell neurogenesis and development of the munne 
nervous system. 
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1 	Introduction 
1.1 	Embryonic stem cells 
Mouse embryonic stem (ES) cells are isolated from the inner cell mass (1CM) of 
the mouse blastocyst (Evans and Kaufman, 1981; Martin, 1981). The mouse blastocyst 
is initially composed of two distinct regions, the 1CM and the trophectoderm, arising 
from the inner and outer cells of the compacted morula respectively. The 
trophectoderm pumps fluid into the blastocyst, forming a fluid filled vesicle, and the 
1CM becomes localised to one end. Two regions within the 1CM then arise; the surface 
layer, in contact with the fluid in the blastocyst, which develops into the primitive 
endoderm and the region not in contact with fluid which becomes the primitive 
ectoderm or epiblast. The primitive endoderm will give rise to the extra-embryonic 
membranes, and the primitive ectoderm will give rise to the embryo proper. The 
trophectoderm gives rise to extra-embryonic structures (Hogan et al., 1994). 
When a blastocyst stage embryo is cultured in mtro in suitable conditions, 
attachment and outgrowth occurs. These cells can be disaggregated and replated (Evans 
and Kaufman, 1981; Martin, 1981), and give rise to colonies, some of which have a 
characteristic undifferentiated morphology. These colonies are the ES cells, and are 
capable of indefinitely proliferating (Robertson, 1987). ES cells have many unique 
properties; they have indefinite proliferative capacity, while maintaining a stable diploid 
karyotype, they can be genetically manipulated, they can contribute fully to foetal 
development when reintroduced to the blastocyst, they can be clonally expanded and 
potentially make all adult cell types in vitro (Smith, 2001; Svendsen and Smith, 1999). 








Figure 1.1 	Schematic representation of blastocyst 
The schematic drawing of the blastocyst represents the regions within the blastocyst which 
initially become specified. The epiblast is the region of the blastocyst that will become the 
embryo proper, and the region which ES cells are believed to represent. 
A feeder layer of mitotically inactivated mouse embryonic fibroblasts was 
initially used for the derivation and maintenance of mouse ES cells (Evans and 
Kaufman, 1981; Martin, 1981). This suggested that the fibroblasts may generate an 
instructive factor(s), maintaining ES cell pluripotency (Smith and Hooper, 1987). One 
such factor produced by the feeder layer is a member of the IL-6 family of cytokines, 
leukaemia inhibitory factor (LIF). Later, LIF in combination with serum was found to 
be sufficient to maintain ES cells in an undifferentiated state (Gearing et al., 1988; Smith 
et al., 1988; Williams et al., 1988). LIF and its related cytokines in the LL-6 family signal 
through the LIF-receptor (LIF-R)/gp130 receptor complex (Gearing et al., 1991; 
Yoshida et al., 1994). During self-renewal, LIF-R/gp130 causes the activation of 
receptor associated JAK kinases and the recruitment of tyrosine phosphorylation and 
dimersiation of STAT3. The STAT3 dimers then translocate to the nucleus and activate 
the targets of self-renewal (Burdon et al., 2002). 
Maintenance of ES cells is also dependent upon the Pit-Oct-Unc (POU) domain 
containing transcription factor oct4 (Scholer et al., 1990a) (also known as pou5fl and oct3 
(Okamoto et al., 1990)). Oct4 is essential for the formation of the epiblast, and mice 
lacking oct4 only generate trophectoderm (Nichols et al., 1998). The precise levels of 
Oct4 are critical in maintaining ES cells, increasing the level of Oct4 causes ES cells to 
differentiate to primitive endoderm and mesoderm, while down-regulating Oct4 induces 
loss of pluripotency and differentiation to trophectoderm (Niwa et al., 2000). 
Surprisingly, mice that are deficient for LIF or the LIF receptor can form an epiblast, 
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suggesting that LIF is not essential for the formation of the epiblast and the 
maintenance of ES cells (Li et at, 1995; Stewart et al., 1992). STAT3 signalling is not 
restricted to ES cells (Hirano et al., 2000), but seems to represent one mechanism by 
which ES cells can be maintained. When 4fr deficient ES cells are grown on a feeder 
layer, although the vast majority of ES cells are lost, a few colonies do remain 
(Chambers et at, 2003). Using an episomal expression screen for factors sufficient to 
maintain ES cell self-renewal in the absence of LIF / STAT3 signalling, a novel 
transcription factor nanog was identified which, when over expressed bypasses STAT3 
signalling and Oct4 expression is maintained (Chambers et al., 2003; Mitsui et at, 2003). 
Recently, fully defined conditions for ES cell derivation and self-renewal have 
been identified; namely the addition of Bone Morphogenic Protein (BMP) 4 along with 
LIF in serum-free medium (Ying et al., 2003a). BMPs are a sub-class of the 
transforming growth factor-B (TGF-B) superfamily and currently more than 20 BMPs 
are known (Mehler et al., 1997). They act locally through cell-cell signalling and over a 
long range as morphogens (Hogan, 1996; Tanabe and Jessdll 1 1996). BMP signalling 
induces cellular survival, apoptosis, proliferation and direct lineage commitment (Mehler 
et at, 1997). BMP induces the phosphorylation of SMADI, which can induce the 
expression of inhibitor of differentiation (Id) genes, and forced expression of Id genes 
removes the need to add BMP4 (Ying et al., 2003a). BMP signalling can have inhibitory 
as well as stimulatory effects on self-renewal, suggesting that there is a very delicate 
balance in ES cells of self-renewal versus differentiation, regulated by a number of 
different pathways (Ying et al., 2003a). The maintenance of ES cells requires the 
balance of multiple pathways simultaneously, and ES cells maintenance requires the 
inhibition of differentiation combined with the promotion of self-renewal. 
ES cells are a powerful tool for studying development, from them, potentially all 
adult cell lineages can be produced in vitro. Upon re-implantation into the mouse 
blastocyst, the progeny of ES cells can contribute to all cell lineages of the adult mouse, 
including germ cells. Furthermore, when making chimeras, ES cells contribute to yolk 
sac mesoderm, allantois and amnion (Beddington and Robertson, 1989; Bradley et at, 
1984). The recent discovery of human ES cells (Reubinoff et at, 2000; Thomson and 
Odorico, 2000) has sparked much interest in both the scientific and popular press 
regarding their potential therapeutic applications. This is principally for their use in cell 
replacement therapy. Although such trials are in their early stages, some tissues may be 
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a potential target for cell replacement therapy, primarily the nervous and haematopoietic 
systems (Daley et al., 2003). 
As with all transplants, there is a risk of rejection from an ES cell derived tissue. 
However, there may be ways around the problems associated with immuno 
histocompatability. ES cell lines could be made which express no Major 
Histocompatability Complex (MHC) class I and class II molecules, the molecules on the 
cell surface that determine whether or not a tissue will be rejected. As the body would 
not recognise the organ as "foreign" then it wouldn't be rejected (Bradley et al., 2002). 
Alternatively one could obtain ES cells by reprogramming a patient's cell to become an 
ES cell through somatic cell nuclear transfer; ES cells could subsequently be derived 
from the cloned blastocysts. This approach has been termed therapeutic cloning 
(Hwang et al., 2004; Kawase et al., 2000; Wakayama et al., 2001). These procedures may 
be technically possible, but difficult and may be unnecessary. ES cell banks are being 
created in the UK and USA (Adam, 2002), these banks will contain various ES cells 
derived from different blastocysts and hence have different genetic backgrounds. To 
cover all the possible variations in MHCs among the population, it has been estimated 
that only 200 different ES cell lines would be needed. Hence, a scenario could be 
envisaged whereby tissues are generated for a stock to treat acute cases, or made to 
order to treat chronic diseases. 
1.2 	Neural induction 
A number of mechanisms have been proposed for neural induction, but the 
models given most attention are the organiser model proposed by Spemann and 
Mangold (Wilson and Edlund, 2001) and Nieuwkoop's "activation-transformation" 
model (Stem, 2001). Spemann and Mangold demonstrated that the amphibian nervous 
system could be induced by signals emanating from a region within the prospective 
mesoderm, the dorsal blastopore lip, known as the organiser (also known as Spemann 
organiser and Hensen's node). Experiments were carries out to identify the molecules 
originating from the organiser in Xenopsis Iaevis, and they were identified as antagonists 
of BMP receptors (Hemmati-Brivanlou et al., 1994; Hemmati-Brivanlou and Melton, 
1992; Hemmati-Brivanlou and Melton, 1994). 
Two classes of receptor for BMPs, type-I and type—IT, modulate their function 
and BMP antagonists generally function by interfering with receptor binding. These 
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antagonists include noggin (Lamb et al., 1993; Smith and Harland, 1992), chordin (Sasai et 
al., 1995; Sasai et al., 1994), cerberus (Bouwmeester et al., 1992), xnr3 (Hansen et aL, 1997; 
Smith et al., 1995) and fo/listatin (Hernmati-Brivanlou et al., 1994). Noggin and Chordin 
bind with high affinity to BMPs and prevent receptor binding (Zimmerman  et al., 1996). 
Cerberus binds  BMPs but with lower affinity (Piccolo et al., 1999). Xnr3 seems to act as 
a receptor antagonist (Hansen et al., 1997), while Follistatin somehow interacts with 
BMP4 and BMP7, but they can still bind to receptors (lemura et al., 1998). 
When the function of the molecules secreted from the organiser were identified 
to be antagonists, and the source of the molecules that they were antagonisrng was the 
mesoderm, it was proposed that there must be a default conversion of cells within the 
tissue that is to a neural fate, hence this was termed the default model. In mice, physical 
ablation of the anterior visceral endoderm (AVE) (Momas and Beddington, 1996), 
generated embryos lacking a forebrain,  which led people to conclude that the AVE was 
the head organiser that was originally proposed by Mangold. Hence, the default model 
is based upon the hypothesis that the only conditions required for neural induction is 
the inhibition of BMPs. 
Although there appears to be a swathe of evidence supporting the default 
model, some experiments are not fully supportive, and can be better reconciled with the 
Nieuwkoop model. Recent studies have demonstrated that the organiser is not 
necessary for neural induction, and neural induction actually occurs before gastrulation, 
prior to the formation of the organizer (Streit et al., 2000; Wilson et al., 2000). 
Experiments have been performed in various species that have a defective organiser. In 
zebrafish embryos that lack Nodal signalling, mesoderm and organiser formation is 
severely impaired, yet neural tissue still forms (Feldman et al., 1998; Zhang et al., 1998). 
When the transcription factor hnJ3-fl is deleted in mice, no morphological node forms, 
but some nervous tissue still develops (Klingensmith et al., 1999). If the default model 
is accurate, then BMP signalling must be blocked for the formation of neural tissue, but 
when the BMP antagonists noggin and chordin are deleted in mice, posterior neural tissue 
still forms, although there are severe defects in the forebrain (Bachiller et al., 2000). 
Experiments in the chick epiblast, demonstrated that the addition of Noggin and 
Chordin is not sufficient to induce neural tissue, but node grafts, even at late stages are 
sufficient (Streit et al., 1998; Wilson et al., 2000). In chick embryos, the onset of BMP 
antagonist expression does not coincide with the acquisition of the neural inducing 
properties of the node, although in Xenopus BMP antagonists are expressed in the 
prospective neural ectoderm before gastrulation. The molecules identified as the 
instructive factors in these studies appear to be Fibroblast Growth Factors (FGFs). 
In Xenopus, FGFs can act as direct neural inducers and blocking FGF signalling 
prevented neuralisation of the ectoderm by chordin RNA (Hongo et al., 1999; Lamb et 
al., 1993). FGF signalling in the epiblast does though lead to down regulation of BMP, 
suggesting that at least some of the effects of FGFs are mediated by inhibition of BMP 
(Wilson et al., 2000). FGF signalling acts through Erki /2, which can phosphorylate 
SMAD1, a BMP target, in the linker region (Pera et al., 2003). This phosphorylation 
inactivates SMADI, another mechanism by which FGFs can inhibit BMP signalling. In 
chick embryos, FGF slowly induces the expression of churchill (ChCh), ChCh then 
activates transcription of the SMAD interacting protein, Sp1, which blocks further 
mesoderm formation (Sheng et al., 2003). When an FGF receptor antagonist SU5402 is 
applied, this down regulation is prevented and epidermal fates are restored. Although 
FGF signalling appears to be extremely important in neural induction, when FGF 
signalling is blocked through the addition of a dominant negative FGF receptor, some 
neural tissue does still form (Amaya et al., 1991; Amaya et al., 1993). 
A further pathway involved in both promoting and inhibiting neural fate is Wnt 
signalling, Wnt signalling can attenuate both FGF and BMP signalling, yet also promote 
BMP signalling pathways during neural induction (Wilson and Edlund, 2001). Wnt 
signalling can repress BMP4, and ectopic Writ prevents BMP4 mRNA expression which 
causes neural induction when injected at early stages into the Xenopus embryo (Baker et 
al., 1999). However, in chick embryos, Writ signalling can down regulate FGF3, causing 
an increase in BMP expression, and ectodermal cell fates are induced (Wilson et al., 
2001). This combinatorial effect of BMPs, FGFs and Writs at different stages makes 
neural induction difficult to delineate. One possible model is that FGFs are sufficient 
for initial neural induction, but this signalling alone is not sufficient to form neural tissue 
(Streit et al., 2000; Wilson et al., 2000), but if BMP signalling is also blocked, FGFs are 
sufficient for neural induction and subsequent neural stabilisation (Sheng et al., 2003). 
This is shown schematically in figure 1.2. 
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Figure 1.2 	Schematic representation of neural induction pathways 
The promotion of neural or epidermal fate is through a combination of promotion and 
inhibition at different times and in different tissues. FGF signalling appears to be the main 
promoter of neural tissue, but it can be inhibited through the action of Wnt and BMP, although 
BMP signalling is inhibited by FGF. 
So if the organiser is not responsible for the induction of the nervous system, 
how does the nervous system become specified? In Nieuwkoop's model of neural 
induction there are two phases; neural induction and neural specification. Sox3 and 
ERNI, markers of the chick nervous system begin to appear before the primitive streak, 
in a broad domain of the epiblast (Streit et al., 2000). In chick embryos, this coincides 
with the spread of the hypoblast layer, suggesting that the hypoblast may be responsible 
for inducing their expression. The hypoblast can transiently induce the expression of 
Sox3 and Otx2 (Foley et al., 2000). However, the hypoblast is only responsible for the 
induction, but not the maintenance of these signals because if it is left in contact for too 
long, the forebrain fails to develop (Foley et al., 2000). The molecular signals emanating 
from the hypoblast remain elusive, although FGF8 can induce the expression of sox3, 
erni and otx2 (Streit et al., 2000; Wilson et al., 2000). However, FGF8 is not sufficient 
for the generation of the nervous system, even in combination with BMP antagonists 
(Streit et al., 2000; Streit and Stem, 1999). Therefore, one could conclude that neural 
induction is a function of the hypoblast in the pre-gastrula embryo, but this then needs 
to be maintained and stabilised by signals emanating from the organiser. 
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1.3 	Neuronal differentiation 
Neuronal differentiation is the conversion of a neural precursor to a neuron. To 
stop being a precursor and start being a neuron, a cell must undergo a number of 
changes. Firstly this is the exit of cell cycle making the cell incapable of further cell 
divisions, be they for self-renewal or differentiation. The neuron must also express 
neuronal specific genes, and not genes of another neural lineage. Finally the cell must 
acquire the characteristics of a neuron, such as the formation of an axon and other 
neuronal specific projections that can interact with other cells. The neuron, once 
specified must then mature, and acquire the characteristics of a mature neuron. It is not 
known how neuronal differentiation and maturation are coupled, but the principal 
interest in this thesis lies in how neurons arise, and not how they mature. 
1.3.1 Symmetric versus asymmetric cell division 
Formation of the nervous system involves many series of cell divisions, when a 
progenitor or stem cell divides it has a number of choices, but each cell division is either 
symmetrical or asymmetrical. Symmetrical division involves the parent cell dividing to 
produce two identical daughter cells, these can be the same or different from the parent 
cell. Asymmetrical division involves formation of two non-identical daughter cells, one 
of which can be identical to the parent cell (Lu et al., 2000). Self-renewal and 
differentiation can both result from symmetric and asymmetric divisions (Chenn and 
McConnell, 1995; Davis and Temple, 1994; Fuchs and Segre, 2000; Johe et al., 1996; 
Morrison et al., 1997; Stemple and Anderson, 1992) and control of these divisions is 
essential to regulating neural stem cells on the ventricular surface during neurogenesis. 
The plane of division of a neural progenitor cell is thought to determine whether 
a cell division is symmetrical or asymmetrical (Lu et al., 2000). A division in the vertical 
plane (perpendicular to the ventricular surface) is thought to generate two identical 
daughter cells, and a division in the horizontal plane (parallel to the ventricular surface) 
is thought to generate two different daughter cells. In vertebrates this has been 
observed by lineage tracing of cells following division in the ventricular zone (Chenn 
and McConnell, 1995). After a vertical cleavage, the two daughter cells remained 
associated with the ventricular zone, but when the division was parallel to the 
ventricular zone, the apical daughter cell remained within the ventricular zone and the 
basal cell migrated away (Chenn and McConnell, 1995). In Drosophila a number of 
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molecules have been shown to be located at only a single pole of the cell during mitosis. 
The plane of division will then affect the inheritance of these molecules by the daughter 
cells (Lu et al., 2000). Many of the mechanisms involved in the localisation of proteins 
during neurogenesis have been identified in Drosophila, and a number of homologues 
of these proteins have also been identified in vertebrates (Lu et al., 2000). 
It is often assumed that a stem cell self-renews by asymmetric division, 
producing a stem cell and a more differentiated cell (Anderson, 2001). However this 
may not be the case and when a population of cells is dividing, 50% of the divisions are 
self-renewing and 50% differentiative (Fuchs and Segre, 2000; Morrison et al., 1997). 
Both peripheral nervous system (PNS) and central nervous system (CNS) stem cells can 
self-renew by symmetric division (Davis and Temple, 1994; Stemple and Anderson, 
1992). Studies of cells derived from the cortex show progenitors can divide 
symmetrically and asymmetrically, but it cannot be ascertained whether the progenitor 
cells produced during asymmetric division are stem cells (Qian et al., 1998; Qian et al., 
2000). These papers also demonstrated that in this context, neurons do not arise 
directly from a stem cell, and require an intermediate precursor (Qian et al., 1998; Qian 
et al., 2000). The potential differentiation pathways are shown in figure 1.3. 
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Figure 1.3 	Neural stem cell division pathways 
All neural stem cells are represented as light blue spheres. The neural stem cell can divide either 
symmetrically (A) or asymmetrically (B and C). Terminal differentiation to a neuron (red 
sphere) could occur through differentiation to a more restricted precursor, then from that cell 
neurons could arise by symmetric division (B) or neurons could arise directly from the stem cell 
by asymmetric division (C), although C does not occur in cells differentiated in vtm from the 
cortex. Adapted from (Anderson, 2001). 
Numb was the first protein demonstrated to be asymmetrically localised during 
neuroblast division in Drosophila (Knoblich et al., 1995; Rhyu et al., 1994; Spana et al., 
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1995; Uemura et al., 1989). Numb is involved in the Notch pathway, and in vertebrates 
it is an intracellular antagonist of Notch (Spana and Doe, 1996; Zhong et al., 1996). 
Notch is involved in lateral inhibition and in the choice of neural stem cell fate (Beatus 
and Lendahl, 1998; Justice and Jan, 2002). Following  the asymmetric division of a 
progenitor cell, a differentiated cell and a progenitor cell arise. The differentiated cell 
expresses the Notch hgand Delta, and through the activation of the Notch pathway, the 
differentiation of the progenitor cell and other progenitor cells are inhibited, i.e. lateral 
inhibition. Although there is some conflicting evidence, it appears that both Notch and 
Numb are asymmetrically distributed on opposite poles of the cell during mitosis 
(Chenn and McConnell, 1995; Wakamatsu et al., 1999; Wakamatsu et al., 2000; Zhong et 
al., 1996). However, there may be both species and cell type differences in the exact 
localisation of the two proteins (Lu et al., 2000). When there is a horizontal division, 
the cell that retains the Notch protein remains in the same region as the parent cell, and 
the cell containing Numb migrates away. This implies that the cell retaining Notch 
remains a progenitor cell and the cell containing Numb differentiates. The differential 
inheritance of proteins following cell division may also result from protein degradation 
(Reese et al., 2000). 
The plane of division in mammalian neural progenitors may be controlled by 
polarity cues localised to the lateral cortex or apical / basal cortex, or there could be a 
single cue which produces vertical cleavage, and when this is absent the plane of 
division is random (Rhyu and Knoblich, 1995). In the ferret ventricular zone, 50% of 
the cleavages are vertical and the rest occur randomly (Chenn et al., 1998). This 
supports the possibility that there a polarity cue supports spindle orientation, and when 
this is absent, or blocked, there is no specific orientation of the mitotic spindle (Lu et al., 
2000). 
1.3.2 Intrinsic regulation of neural stem cells 
Some members of the SOX family of transcription factors have been identified 
as having key roles in neural differentiation (Bylund et al., 2003; Graham et al., 2003; 
Kim et al., 2003). Much of the study into the role of the SOX genes has focussed upon 
the SOX Bi family, composed of SOXI, SOX2 and SOX3 (Bowles et al., 2000; 
Schepers et al., 2002). The SOX BI genes are expressed in neural stem and precursor 
cells, and are downregulated as they exit cell cycle and differentiate (Nishiguchi et al., 
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1998; Pevny et al., 1998; Uwanogho et al., 1995). Their function appears to be the 
maintenance of neural progenitor cells, and the inhibition of differentiation to neurons 
(Bylund et al., 2003; Graham et al., 2003). The inhibition of differentiation may be 
partially mediated by the inhibition of downstream signalling targets of proneural genes 
(Bylund et al., 2003). Studies in chick embryos have shown that .cox2 is expressed only 
in proliferating cells, is down-regulated as they exit mitosis, and is not linked to the 
dorso-ventral position of the cell (Graham et al., 2003). Sox1-3 are expressed in high 
levels in cells with Neurogenin2 (Ngn2), but at low levels in cells with NeuroM (Bylund 
et al., 2003). SOX2 also prevents the differentiation of progenitors to neurons, and 
maintains neural precursors in a proliferative state (Graham et al., 2003), although 
SOX2 is not altering the cell cycle regulatory machinery, but rather through the 
activation of transcription, and 50X2 transcriptional targets must be repressed for 
neuronal differentiation (Bylund et al., 2003). The mechanism of action of SOX genes 
appears to be coupled to their effect on proneural genes. There is negative regulation of 
Ngn2 targets by SOX3 and negative regulation of SOX3 by Ngn2, and the negative 
regulation of Ngn2 is not mediated by Hairy and enhancer of split (Hes5) (Bylund et al., 
2003). The negative regulation by bl-ILH proneural gene targets may be a general 
mechanism for inhibition of SOX genes (Buescher et al., 2002; Kim et al., 2003; 
Overton et aL, 2002). 
SOX proteins interact at a promoter with a POU protein to activate 
transcription (Kamachi et al., 2000). SOX and POU proteins selectively interact with 
each other through their conserved POU and High Mobility Group (HMG) domains 
(Remenyi et al., 2003). Both SOX and POU proteins are expressed in a spatially and 
temporally specific manner during development (Dailey and Basilico, 2001). SOX 
proteins can each interact with several different POU proteins (Kamachi et al., 2000), 
and the same POU proteins can interact with several different SOX proteins (Kamachi 
et al., 2000). Different expression patterns are also likely to be mediated by level of 
activation of the target gene, which can vary depending on the SOX protein due to 
variations between the transactivation domains (Wiebe et al., 2003). A potentially 
important interaction is that of SOX2 and Pax6. SOX2 and Pax6 co-operate to bind 
the promoter of the delta-crjstallin gene in the lens, the binding and subsequent 
promotion of transcription is much less efficient with Pax6 alone than Pax6 and SOX2 
(Kamachi et al., 2001). A direct interaction of Pax6 and the enhancer element for ngn2 
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has recently been shown (Scardigli et al., 2003). The enhancement of ngn2 expression by 
Pax6 was only weak, but this may be because SOX2 was not also present at the 
enhancer. Pax6 is involved in pattering of the CNS, and is expressed in various regions 
during development. Pax6 is a homeobox protein that is involved in the establishment 
of progenitor domains and is expressed in a concentration gradient within the ventral 
neural tube (Wilson and Rubenstein, 2000). Here a progenitor domain is described as a 
group of cells that express a specific combination of transcription factors rather than 
being confined to a specific physical area such as a rhombomere. The expression of 
Pax6, like many other homeodomain proteins is established through promotion of 
expression by BMP signalling and inhibition by SHH signalling, combined with 
repression by other homeodomain proteins to establish specific domains of expression 
(Wilson and Rubenstein, 2000). The regulation of ngn2 by Pax6 provides a potential 
mechanism by which the specification of regional identity can be coupled to neuronal 
differentiation (figure 1.4). 
The acquisition of neuronal fate and furthermore the specification of specific 
classes of neurons can be regulated by proneural genes (Bertrand et al., 2002; Guillemot, 
1999; Ross et al., 2003). Proneural genes are both necessary and sufficient, in the 
correct context, for the generation of the correct neural progenitor and neural lineages 
(Bertrand et al., 2002). Their exact temporal and spatial expression patterns are very 
tightly regulated. The genes are conserved from Drosophila to vertebrates, and have 
maintained a very similar function (Bertrand et al., 2002; Guillemot, 1999; Ross et al., 
2003). Most vertebrate proneural genes are expressed principally in the developing 
nervous system; however they are also involved in adult neurogenesis (F. Guillemot 
personal communication). 
Proneural genes encode basic helix-loop-helix (bHLH) transcription factors 
(Murre et al., 1989). The structural motif of the proneural transcription factors is 
characterised by two ct-helices separated by a loop. The helices mediate dimersiation, 
and the adjacent basic region is required for DNA binding. Like all bHLH transcription 
factors, proneural genes bind DNA in co-operation with a ubiquitously expressed 
bHLH, or E protein (Massari and Murre, 2000). In Drosophila this involves the 
products of the da gene, and in mammals the products of E2A, HEB or E2-2 (Massari 
and Murre, 2000). Proneural genes bind a hexanucleotide region of DNA which 
contains the sequence CANNTG, known as an E-box (Bertrand et al., 2002). Factors 
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that interfere with this dimersiation can act as passive repressors of proneural genes. 
The Drosophila gene emc (extra macro chaetae) and the vertebrate Id (inhibitor of 
dzj/èrentiation) family are I-[LH proteins that lack the basic DNA binding domain, and can 
bind E proteins with high affinity through the formation of heterodimers that cannot 
bind DNA (Bertrand et al., 2002). The vertebrate Hes/Her/Esr proteins and Hairy and 
Enhancer of split (Espi) Drosophila proteins act as classical DNA binding repressors of 
proneural gene transcription (Chen et al., 1997; Davis and Turner, 2001) although they 
also interact with the proneural - E protein interaction (Alifragis et al., 1997; Sasai et al., 
1992). 
Proneural genes may act as a switch, which once activated produce a cascade of 
events leading to neuronal differentiation. When proneural genes are lost, this often 
results in the loss of a particular type of progenitor cell, for example in mash 1 knockouts, 
there are severe defects in the ventral telencephalon and olfactory sensory epithelium 
(Casarosa et al., 1999; Guillemot and Cepko, 1992). In targeted deletions of either ngnl 
or nsn2 single sets of complementary cranial ganglia are lost (Fode et al., 1998; Ma et al., 
1998). Loss of matbi results in the loss of the most dorsal spinal intemeurons (Dl 
interneurons), and an increase in the number of adjacent roof plate cells (Ben-Arie et al., 
1997). The role of Mathi in conferring interneuron identity is confirmed by over 
expression results when Dl interneurons are gained at the expense of other 
interneurons (Bermingham et al., 2001; Gowan et al., 2001). Gain of function analysis 
of the ngn genes have demonstrated that they can have a supernumeracy effect on neural 
progenitors, ectopically activate Notch signalling, drive progenitor cells out of mitosis, 
and promote neuronal differentiation by activating NekroD and atb3 (Bertrand et al., 
2002; Ma et al., 1996; Mizuguchi et al., 2001). 
Proneural genes are inhibited by the Hes family and the Id family of proteins 
(Bertrand et al., 2002; Ross et al., 2003). HesI and HesS can both sustain the 
undifferentiated state of a neural progenitor and suppress the differentiation to neurons 
(Ishibashi et al., 1995; Nakamura et al., 2000; Ohtsuka et al., 2001). Hesi and Hes5 can 
bind to regions of the DNA known as N boxes, which inhibit the expression of 
proneural genes (Chen et al., 1997; Davis and Turner, 2001). Transcriptional repression 
is mediated by the interaction of Hes proteins with the transcriptional co-repressors of 
the Groucho/transcducin-like enhancer of split (Gro/TLE) family (Paroush et al., 
1994). Hes proteins can also modify chromatin through histone deactylation, making 
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DNA inaccessible to transcriptional activation (Nadon and Shoemaker, 2002). In 
addition, Hes factors interact physically with proneural genes, in Drosophila E(spl) 
interacts simultaneously with proneural bHLH proteins and the co-repressor Groucho, 
this recruits Groucho to the targets of proneural genes and inhibits their differentiation 
(Giagtzoglou et al., 2003). Mice with a targeted deletion of the Hesi gene have 
premature production of neurons, and a decrease in the ability of neural stem cells to 
self-renew (Nakamura et al., 2000), and conversely when hesi is overexpressed, 
neurogenesis is blocked and self-renewal of cortical progenitors is enhanced (Ishibashi 
et al., 1994). HesI and Hes5 are both critical components of the Notch pathway 
(Ohtsuka et al., 1999), and targeted deletions of Hesi, Hes5 or Notch produces mice with 
a similar phenotype (de hi Pompa et al., 1997; Ishibashi et al., 1994). 
The second group of repressors, the Id family of proteins can sequester the 
ubiquitous E box proteins, which are required by proneural genes for the activation of 
transcription (Bertrand et al., 2002; Norton, 2000; Ross et al., 2003). Id proteins can 
inhibit the differentiation into neurons and oligodendrocytes but not astrocytes. This is 
likely to be because astrocyte formation is not promoted by proneural bHLH gene, 
which the Id proteins are inhibiting. When Id proteins are overexpressed, they can 
block both neuronal and oligodendrocyte differentiation (Kondo and Raff, 2000; 
Nakashima et al., 2001; Toma et al., 2000; Wang et al., 2001). Id genes have a further 
role in directly promoting cell proliferation. They inhibit the ability of the 
retinoblastoma (Rb) family by interfering with E2F mediated transcription (lavarone et 
al., 1994; Norton, 2000). This then increases the probability that the cell will re-enter 
cell cycle. Regulation of cell cycle exit is critical for the correct patterning of the cortex, 
mice that overexpress a stable form of (3-catenin (a transcriptional regulator of the Wnt 
pathway) have a cortex much larger in size than normal (Chenn and Walsh, 2003). As 
1d2 is promoted by the Wnt/(3-catenin pathway, the effect of 3-catenin may in part 
promote cell cycle progression. Although (3-catenin also regulates other genes involved 
in the cell cycle machinery including cyclin Dl (Fetsu and McCormick, 1999). Mice that 
lack th in the telencephalon also show an increase in the cortical size due to increased 
proliferation of cortical progenitors (Ferguson and Slack, 2001). 
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1.3.3 Intrinsic control of neuronal differentiation 
When proneural genes are not being repressed they start a cascade which leads 
to the formation of neurons or oligodendrocytes, in a context dependent manner. The 
differentiation process is mediated by two waves of proneural genes, initially genes such 
as mashl and ngns promote neurogenesis, and then the NeuroD family promotes 
neuronal progenitors to terminally differentiate (Bertrand et al., 2002; Norton, 2000). 
For example in Xenopus, Ngnrl induces the expression of both Xath3 and NeuroD, and 
ectopic expression of N&nrl can upregulate Xath3 and NeuroD, while Xatb3 and NeuroD 
can cross-activate each other, they cannot induce Ngnrl (T'alikka et al., 2002). The 
proneural differentiation genes such as NeuroD and other NeuroD family members are 
required for the terminal differentiation of neurons. When NernvD is knocked out, the 
mice die from severe diabetes (Naya et al., 1997). The function of NeuroD in the 
pancreas can be restored by expressing NeuivD is under transcriptional regulation of the 
insulin promoter. These mice have severe neurological defects with the failure of 
hippocampal and cerebellar granule neurons to terminally differentiate, resulting in their 
death (Miyata et al., 1999). 
As the expression of any proneural gene is transient, and they are down 
regulated in progenitor cells before cell cycle exit, neuronal differentiation must rely on 
the downstream regulatory genes induced by proneural genes. Proneural genes induce 
the differentiation of specific types of neurons in a context dependent manner. 
Proneural genes appear to require a co-factor to promote the differentiation of specific 
types of neurons, for example Mash I is the main noradrenergic determinant in 
noradrenergic centres of the brain, where it co-operates with the homeodomain protein 
Phox2b to induce the expression of the related homeodomain protein phox2a (Hirsch et 
al., 1998; Lo et al., 1998). Mashl expression also leads to the specification of 
GABAergic neurons (Fode et al., 2000; Parras et al., 2002). In both cases, Mashi 
appears to induce the expression of a homeobox gene, suggesting that cell fate 
determination may be a combinatorial effect of a proneural gene and homeobox gene, 
in cooperation with regionally expressed determinants, modulating specificity (Bertrand 
et al., 2002). This context specific determination is seen more clearly with n,gn2 in the 
vertebrate peripheral nervous system where the ectopic expression of n<gn2 alone is not 
sufficient to induce sensory neurons, as in dissociated chick neural tubes, it is instead 
also reliant on the local concentration of BMP2 (Lo et at, 2002). 
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The competence model of neuronal differentiation has proposed that a 
progenitor expresses a particular pattern of transcription factors in very specific 
domains, which determines which daughter cells can be produced. With each cell 
division the transcription factors that the progenitor cells express change, and hence the 
terminally differentiated daughter cell is different. The addition of extrinsic factors can 
only regulate cell number, and cannot alter the order in which the cells are produced. 
Such a mechanism has been very elegantly demonstrated during the specification of the 
Drosophila nervous system. The order of transcription factor expression is hunchback 
followed by knppeI then pdm and castor (Brody and Odenwald, 2000; Isshiki et al., 2001; 
Pearson and Doe, 2003). Terminally differentiated daughter cells that are produced at 
the time of each transcription factor being expressed maintain the expression of that 
transcription factor. When the early expressed transcription factors are knocked out, 
there is no affect on early born cell fates, but when early expressed transcription factors 
are overexpressed, late cell fates are perturbed. The timing of expression of each 
transcription factor is linked to cell cycle progression, rather than absolute time. 
A general mechanism for neuronal differentiation could be that a proneural gene 
is required with a second co-factor, potentially a temporally and regional specific 
transcription factor, and other regional determinants, to induce the expression of a 
neuronal subtype specific transcription factor, and other more general generic cell cycle 
exit genes. However it is unknown whether proneural genes are required to produce 
every type of neuron. 
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Figure 1.4 	Proposed neuronal differentiation mechanism 
A schematic representation of the mechanisms involved in neuronal differentiation. Green lines 
indicate activation, red lines signify repression. Solid lines are established links; dotted lines are 
less established mechanisms. Following patterning signals, such as SHH and BMPs, the 
progenitor domains are established though the expression of specific homeodomain proteins 
which can cross-regulate each other. Some of the POU domain containing transcription factors, 
such as Pax6 may bind to a SOX protein and promote proneural gene expression. At the same 
time proneural gene expression is being inhibited by Notch, Hesi and 5 and Id proteins. 
Downstream effectors of proneural genes are also being inhibited the SOX/ HD interaction, 
preventing neuronal differentiation. When the proneural gene is upregulated, or the level of 
inhibition is reduced, this suppresses SOX and HD suppression of the proneural targets and 
neuronal differentiation can occur. 
1.3.4 Extrinsic control of self-renewal versus differentiation 
The division of a stem cell can result in differentiation, self-renewal, or both. 
Single exogenous factors can instruct a stem cell to divide in a particular way (Ishibashi 
and McMahon, 2002; Kalyani et al., 1999; Martens et al., 2000; Tropepe et al., 1999; 
Vescovi et aL, 1993), for example the addition of BMP and LIF induces the STAT3 and 
SMAD pathways which leads to glial differentiation (Nakashima et al., 2001), but 
determination of whether these molecules act upon self-renewal or differentiation can 
be elusive (Anderson, 2001). 
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One of the most studied systems for the analysis of exogenous molecules is the 
neurosphere assay. Neurospheres are cellular aggregates formed in mtv following 
dissection and dissociation of the desired region of the embryonic or adult brain 
(Reynolds and Weiss, 1992; Reynolds and Weiss, 1996). The neurosphere forming cells 
appear to be EGF-dependent, but it is not yet understood why this is the case. The 
promotion of neural progenitor cells by a factor is generally determined by the efficiency 
of secondary and tertiary sphere formation, as the sphere forming cell is believed to be a 
neural stem cell (Anderson, 2001). FGF2 is an example of a molecule which can 
promote the proliferation of neural stem cells (Gritti et al., 1996; Kilpatrick and Bartlett, 
1995; Vescovi et al., 1993). However, one of the main disadvantages of the neurosphere 
system is that the properties of the neurosphere appear to change over time, and the 
cells within a neurosphere are not held in a particular state. For example, neurospheres 
derived from developing embryos which are initially responsive to FGF2, and not EGF, 
later gain responsiveness to EGF (Johe et al., 1996; Reynolds et al., 1992; Tropepe et al., 
1999). This gain in responsiveness to EGF follows upregulation of the EGF receptor, 
promoted by FGF2 (Burrows et al., 2000; Lillien and Raphael, 2000), which is 
antagonised by BMP signalling (Lillien and Raphael, 2000). 
The effect of many of these factors appears to be context dependent, and the 
same factor can have a different effect in different scenarios. For example BMPs 
promote neuronal differentiation in cortical ventricular precursors (Li et al., 1998b), but 
in the adult subventricular zone, they inhibit neurogenesis and promote gliogenesis (Lim 
et al., 2000; Mehier et al., 2000). Neurotrophin-3 (NT-3) increases the survival and 
differentiation of cortical progenitor cells, through two independent pathways (Barnabe-
Heider and Miller, 2003), although in sympathetic neurons NT-3 is required for 
neuronal but not precursor survival (Francis et al., 1999). In spinal sensory neurons 
NT-3 produced precocious differentiation of neural progenitors to neurons, depleting 
the precursor pool (Farinas et al., 1996). Brain derived neurotrophic factor (BDNF) can 
increase neuronal differentiation of neural progenitors (Cheng et al., 2003) and may be 
one of the factors responsible for the increase in neurogenesis seen following voluntary 
exercise (Johnson et al., 2003; van Praag et al., 1999). PDGF can bias cortical and 
striatal neural stem cells to a neuronal fate (Johe et al., 1996; Williams et al., 1997). 
However, any neural precursor in vivo is unlikely to receive a single exogenous 
factor, it is more probably that there will be signalling from multiple factors at different 
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concentrations simultaneously, then the cell must process all of these different signals 
and act accordingly (Anderson, 2001). When two factors which have opposing effects 
are added simultaneously in vitro, one factor will often override the second (Anderson, 
2001). So there may be a hierarchy of signalling factors where certain signals will always 
override other signals. This has been studied in neural crest stem cells, although 
different cells from neural stem cells, they are capable of generating neurons and 
astrocytes. When neural crest stem cells are exposed to BMP2 (pro-neural) and 
neuregulin-2 (Nrg-2; a pro-astrocyte signalling molecule) simultaneously, neuronal 
differentiation is promoted and glial differentiation is suppressed (Shah and Anderson, 
1997). Likewise when PDGF (a pro-neuronal signal) and CNTF (a pro-glial signal) are 
added simultaneously, neurons are generated (Park et al., 1999). Neuronal 
differentiation does not necessarily dominate because when BMP2 and Delta-1 (pro-
astrocyte) are applied to neural crest stem cells simultaneously, astrocytes are generated 
(Morrison et al., 2000). 
Such changes in responsiveness to exogenous factors imply that there are 
multiple types of neural stem cells in the developing embryo, or there is one type of 
stem cell which changes over time. The model used in these cases may not be of great 
biological relevance, because neurospheres are essentially an in vitro artefact, and it is 
difficult to analyse the mechanisms of self-renewal and differentiation. The term stem 
cell is not a useful descriptive term for these cells because it does not describe the cells 
accurately and many groups only use the term stem cell to describe cells with different 
properties. I would define a stem cell as a cell that can self-renew and in doing so 
retains its ability to produce the same progeny, in the same proportions over time. 
1.3.5 Programmed cell death 
An often overlooked aspect of neurogenesis is programmed cell death (PCD) 
(Deshmukh and Johnson, 1997). PCD is important for closure of the neural tube 
(Graham et al., 1996; Kuan et al., 2000), and for regulating stem cell numbers (de la 
Rosa and de Pablo, 2000). There is no debate that there is PCD during development of 
the nervous system, but the extent of PCD is unclear, as different methodologies detect 
different levels of cell death (Chun, 2000; Gilmore et al., 2000). The caspase pathway is 
involved in PCD during neural development (Deshmukh and Johnson, 1997; Raff, 
1998). Mice that lack both caspase-3 and caipase-9 die perinataly with ectopic mass 
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formations in various regions of the CNS (Hakem et al., 1998; Kuida et al., 1998; Kuida 
et al., 1996), demonstrating that PCD is essential during normal brain development. 
PCD is important for normal brain development in different regions and in different 
cell types, and when exogenous factors are added in tt,v, their effect may be directly on 
cell death (Sommer and Rao, 2002). However, it is often difficult to identify the exact 
cells that are undergoing PCD, as loss of different cell types can produce the same net 
effect. 
1.4 	Neural and neuronal differentiation of ES cells 
ES cells can potentially differentiate into all adult cell types. Directing 
differentiation towards a precise lineage requires the application of specific protocols to 
obtain cells of specific germ layers and lineages. Through the modification of a variety 
of relatively simple  protocols, many cell types can be generated (Dam et al., 1997; Guan 
et al., 1999; Wiles and Keller, 1991; Ying and Smith, 2003). 
The generation of cells from the neural and neuronal lineage from ES cells has 
been studied by a number of different groups. Current dogma suggests an ES cell 
differentiates through a more restricted neural precursor, that is still capable of self-
renewal, and only able to differentiate into neural cells when remaining in its current 
niche (McKay, 1997; Stavridis and Smith, 2003; Svendsen and Smith, 1999). 
1.4.1 Neural differentiation in embtyoid bodies 
Embryoid bodies (EBs) are multicellular aggregates, formed in suspension 
culture (Doetschman et al., 1985); the structure of the EB resembles an in t'itro 1CM 
(Martin et al., 1977). EBs can generate cells of all three germ layers (Keller, 1995) but 
this differentiation is not controlled or directed and a more homogenous differentiation 
is required to understand lineage commitment. The differentiation of ES cells as EBs 
originates from experiments in embryonic carcinoma (EC) P19 cells. P19 cells can be 
differentiated as cellular aggregates to cells with a neuronal like morphology through the 
addition of retinoic acid Oones-Villeneuve  et aL, 1982; McBurney, 1993). Retinoic acid 
is a morphogen generated by Hensen's node (Hogan et al., 1992), and has posteriorising 
actions on the entire vertebrate axis (Marshall et al., 1992). When retinoic acid is applied 
to differentiating EBs, neural cells are induced (Fraichard et aL, 1995; Strubing et at, 
1995). Following the addition of retinoic acid to the EBs, the aggregates are plated onto 
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an adhesive substrate (Li et al., 1998a). Following plating neurons arise, which have 
been characterised by the expression of a variety of neuronal specific genes. These 
neurons express a range of different neurotransmitters and the neurons are 
electrophysiologically mature. Astrocytes and oligodendrocytes are also generated 
during the differentiation, and can be selectively expanded from retinoic acid treated 
EBs depending upon the subsequent plating conditions (Liu et al., 2000). 
Neural cells can be derived from EBs without the addition of retinoic acid. The 
selective expansion of nestin expressing cells (Lendahl et al., 1990), following attachment 
to an adhesive substrate in serum free media produces selective survival of neural 
progenitor cells, which leads to efficient neuronal differentiation (Okabe et al., 1996). 
This selective differentiation protocol has also been used to generate specific classes of 
neurons from ES cells. Dopaminergic and serotinergic neurons were efficiently 
generated following the addition of Sonic hedgehog (Shh) and FGF-8 to the 
differentiating cells (Lee et al., 2000b). During development, Shh is secreted by the 
notochord and the ventral midbrain, and has ventralising properties (Yamada et al., 
1993), FGF-8 is generated by a ring of cells at the isthmus (the midbrain-hindbrain 
border), providing an instructive patterning signal for the patterning of the midbrain 
(Crossley et al., 1996). Fe is also expressed in the anterior neural ridge, providing an 
instructive cue for the formation of the forebrain (Shimamura and Rubenstein, 1997). 
The differentiation of ES cells to neuronal subtypes in response to the same cues as in 
the embryo suggest that the differentiation of ES cells is due to the cells responding to 
similar cues that occur during the development of the embryo, and ES cells are 
responding to tnorphogens with some degree of plasticity. When ES cells are 
differentiated without the addition of instructive factors other than retinoic acid, 
predominantly GABAergic with some glutamatergic neurons are generated (Bain et al., 
1995; Fraichard et al., 1995; Okabe et al., 1996). It is unclear whether ES cells must be 
instructed to differentiate to other neuronal cell types or whether GABAergic neurons 
are the only neuronal cell types to survive when no other exogenous factors are added. 
1.4.2 Stromal cell mediated neural differentiation 
ES cells can be maintained on a feeder cell layer; this is through the secretion of 
molecules required for ES cell self renewal, or the expression of molecules on the 
surface of the feeder cell layer which interact with receptors on the surface of the ES 
cells. When ES cells are co-cultured with a specific bone-marrow cell derived cell line 
(PA-6), under the correct conditions, dopaminergic neurons are generated (Kawasaki et 
al., 2000). As no other inductive mechanism is required for the differentiation, the PA-6 
cells may be producing instructive factors promoting the differentiation to dopaminergic 
neurons. The uncharacterised factor may partially act through a membrane, suggesting 
that there it may be secreted over a short distance, although if it is a secreted factor, it 
cannot condition the medium. Fibroblasts do not normally exhibit the same promotion 
of dopaminergic neurons, but upon fixation, dopaminergic neurons do develop on 
some of the fibroblast cells. Furthermore, the inducing  effect of the PA-6 cells is 
attenuated by serum or BMP4. This suggests that the inducing  capability of the PA-6 
cells, is blocked by serum or BMP4, or the cells are promoted to differentiate to another 
lineage before the factor(s) can take effect. However, an alternate view is that the PA6 
cells could be permissive for dopaminergic differentiation, and they do not support self-
renewal or alternate cell lineages. 
1.4.3 Defined medium 
ES cells have been differentiated in a series of defined media that have 
subsequently been used to understand the mechanisms of neural induction. 
Differentiating ES cells in defined medium was used to analyse the default model of 
neural induction. When ES cells are differentiated as EBs in defined medium, unless 
members of the transforming growth factor superfamily, such as BMPs and Activin, 
were added to the differentiating cells, the ES cells efficiently converted to neural cells 
(Wiles and Johansson, 1999). A related differentiation strategy also showed that BMP4 
inhibited neural differentiation (Tropepe et al., 2001). In this differentiation, ES cells 
were differentiated in serum-free medium in the presence of LIF. Then at a frequency 
of 0.2%, ES cells gave rise to multicellular aggregates termed neurospheres, which 
express nestin (Tropepe et al., 2001). These cells can be expanded with FGF2, and when 
FGF2 is blocked, the differentiation is inhibited (Tropepe et al., 2001). However, due 
to the low efficiency of the initial differentiation, both LIF and FGF2 could be acting as 
survival factors for the cells, which then convert to neural cells due to the lack of BMP 
signalling. 
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Neither experiment is occurring in what could be termed defined conditions, as 
they are reliant upon the formation of multicellular aggregates, with inevitable secondary 
consequences. 
1.4.4 Monolayer differentiation 
A novel protocol was developed in the Smith lab for the differentiation of ES 
cells to the neural lineage with high efficiency, in completely defined, serum-free culture 
(Ying et al., 2003b). This protocol involves plating ES cells onto gelatinised plastic, then 
differentiating the cells in chemically defined medium (Ying and Smith, 2003; Ying et al., 
2003b). As the differentiation is occurring in an adherent culture, single cells can be 
directly visualised by light microscopy such that individual cells can be tracked during 
the differentiation. 
In the monolayer protocol, ES cells efficiently convert to the neural lineage, 
without the need to add any exogenous factors. Many of the factors in the media are 
only necessary for the survival of the cells, and not the differentiation, and only Apo-
transferrin was found to be essential, other proteins such as insulin and albumin aid the 
initial attachment of the ES cells but are not necessary for the differentiation (Ying et 
al., 2003b). The initial plating of the ES cells is less efficient than in the presence of 
serum, although this can be improved by the transient addition of LIF (Ying and Smith, 
2003). 
The conversion to neural progenitor cells is very efficient and up to 80%  of the 
cells can be converted to neural progenitor cells (Ying et al., 2003b). Neuronal 
differentiation is less efficient, and ways to improve this are addressed in chapter 4. 
This differentiation strategy can also be used to analyse the mechanisms of neural 
induction, and it was found that BMP4 prevents the differentiation to the neural lineage, 
but FGF is required for the neural induction, which cannot be rescued by BMP 
antagonists (Ying et al., 2003b). 
This protocol is an important breakthrough, facilitating differentiation with no 
requirement upon the formation of multicellular aggregates for the differentiation of ES 
cells to the neural lineage. 
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1.4.5 Choosing a differentiation strategy 
The protocol which is used to differentiate ES cells to neurons should depend 
upon the type of experiment being performed. The main criteria when ES cells are 
being differentiated is which population is being analysed, and in what way is the 
differentiation being analysed. Monolayer differentiation has many advantages over the 
other differentiation protocols because it is happening in defined conditions, without 
the need to add exogenous factors, or to aggregate the cells. This makes analysis of 
lineage commitment at a single cell level relatively easy to study because individual cells 
can be studied at all stages of differentiation, this cannot be done in aggregated cultures, 
and is more difficult in co-cultures because ES cells tend to differentiate as attached 
aggregates. Furthermore, when the addition of any factor is being analysed, monolayer 
differentiation provides conditions in which all cells are relatively equally accessible to 
the factors. In aggregates this is not the case, as factors need to diffuse through the 
aggregate to be accessible to all cells, and further, the direct effect of the factors can be 
analysed during monolayer differentiation as there are fewer other cell types or serum 
present, which could be producing an indirect effect. 
1.5 	Lineage selection and mapt 
The technique of lineage selection was first developed as a means to exclude all 
other cell types than neural progenitors during the neural differentiation of ES cells (Li 
et al., 1998a). The introduction of a genetic selection technique allows a specific 
population of cells to be selected from a heterogeneous population of cells based upon 
gene expression (Li et al., 1998a). To derive a pure population of neurons from ES 
cells, a selectable gene/marker, under the control of a neuronal specific gene would be 
necessary. A caveat to this is that a specific cell type cannot be described by the 
expression of a single gene; rather it describes a population. This makes it difficult to 
use a single marker for a specific cell type, but broad cell types can be defined, and 
studied, by looking at one gene. 
The criteria for the gene targeted were that it must be neuronal specific, 
expressed in all neuronal subtypes as soon as a cell becomes a neuron, yet remain 
expressed throughout the lifetime of all neurons. The neuronal specific gene chosen 
was mapt (Binder et al., 1985; Cleveland et al., 1977a; Cleveland et al., 1977b; Kosik et 
al., 1989). Mapt is a microtubule protein, in humans there are at least six isoforms, 
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generated by alternative mRNA splicing, with further complexity added by 
phosphorylation of different isoforms (Goedert et al., 1991). Mapt is predominantly 
localised to axons in the postnatal brain, but found throughout all neurites during 
embryogenesis (Ferreira et al., 1987). It is a component of short cross-bridge structures 
in axons, involved in the establishment of neuronal polarity, axon outgrowth and 
process stability (for review see (Brandt, 1996)). Mapt has been extensively studied due 
to its involvement in Alzheimer's disease (Grundke-Iqbal et al., 1986; Wolozin et al., 
1986). During the disease process, hyperphosphorylated Mapt forms tangles in the 
Alzheimer's brain, known as neurofibrillary tangles (NFl) (Wood et al., 1986). This 
appears to be downstream from the effects of (3-amyloid in Alaheirner's disease. 
However, the precise role of mapt in Alzheimer's disease remains unclear, and both 3-
amyloid and hyperphosphorylated Mapt may be neuroprotective (Smith et al., 2002). 
A further consideration is that the gene targeting is a knock-in strategy, where 
one copy of the gene will be lost, so there must be no heterozygote disadvantage. Two 
different knockouts of mapt have been generated in mice (Dawson et al., 2001; Harada 
et al., 1994), both knockouts have a different phenotypes, but the most relevant is the 
knockout upon which this knock-in strategy will be based (Harada et al., 1994; Tucker et 
al., 2001). The heterozygote mice showed no variation to the wild-type, and the mice 
containing no mapt were viable and fertile, but showed some variations in axonal 
outgrowth timing during development, small-calibre axons having decreased axonal 
stability, and microtubule orgamsation was altered (Harada et al., 1994). Mapt-deficient 
mice showed muscle weakness in the wire-hanging test, hyperactivity in a novel 
environment, and impairment in the contextual fear conditioning (Ikegami et al., 2000). 
The mild phenotype appears to be because there is compensation by other microtubule 
proteins (Liu et al., 1999; Takei et al., 2000). 
Lineage selection can be either drug resistance, or the expression of a 
fluorescent protein, and isolation of the desired population by fluorescent activated cell 
sorting (FACS) (fig. 1.5). Expression of a fluorescent protein was deemed the most 
appropriate method by which to select cells because only threshold levels of drug 
resistance can be used, and the negative population cannot be examined. The negative 
population is also of interest, because the negative cells may yet become neurons, or the 
reason that they have not become neurons could be identified. A fluorescent protein 













Figure 1.5 	Schematic representation of neuronal lineage selection 
ES cells can be differentiated to a predominantly neural population, although mesoderm and 
endoderm can also arise during the differentiation. Neural progenitors are then subsequently 
differentiated to neurons, astrocytes and oligodendrocytes. As only neurons are expressing a 
selectable marker, these can be isolated from the total population. The isolation can be either by 
FACS sorting or resistance to a drug. 
1.6 	Flow cytometry and fluorescent activated cell sorting 
Flow cytometry is the analysis of a single cell suspension presented to a light 
source through hydrodynamic focusing. The resultant scattered light and fluorescence 
are collected and converted to electrical pulses, which are digitized for computer analysis 
(Johnson, 1992). Flow cytometry is routinely used to characterise different populations 
of cells based upon the physical characteristics of the cells and molecular markers. The 
main advantages of flow cytometry are that multiple parameters can be analysed virtually 
simultaneously at the same time, to characterise cells, and upon incorporation of cell 
sorting, essentially pure populations of cell can be generated (De Rosa et al., 2003). Flow 
cytometry in combination with immunocytochemistry is often used to characterise cell 
types within a population of cells. The identification of surface markers can lead to the 
identification and isolation of rare cell types (De Rosa et al., 2003). This ability to 
identify cells based on a broad range of markers has been used by the stem cell field to 
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try to identify and isolate stem cells of various lineages (Manz et al., 2002; Morrison et 
al., 1999; Phillips et al., 2000; Wang et al., 1998). 
Although many sophisticated modifications to the basic principles of flow 
cytometry have been developed, there are essentially three criteria that a cell is analysed 
and sorted on, namely cell size, granularity and fluorescence. Cell size analysis is simply 
measuring the physical size of a cell; the granularity is a function of the complexity of 
the cell., principally on the cell surface. The complexity of the cell surface, due to such 
features as the number of receptors, can aid the discrimination of different cell types. 
The fluorescence of a cell can be divided into a number of categories, either the innate 
fluorescence of the cell (generated through auto-fluorescence or the expression of a 
particular fluorescent reporter gene), or the fluorescence produced by 
immunocytochemis try. Up to 13 parameters can now be analysed simultaneously (De 
Rosa et al., 2001), although this is not necessary in many instances, and requires very 
specialised technology, it illustrates the power of flow cytometry to analyse cells. 
1.7 	Microarrays 
The advent of microarray technology has introduced a new type of investigation 
previously unavailable to biologists; a snapshot of the transcriptome within a population 
of cells at any one time. Such analysis provides a powerful tool to find a vast amount of 
data about a system, and ask questions about gene expression that would previously 
have taken considerably more time and resources. There are many possible experiments 
that can utilise the power of microarrays. Some of these experiments include looking 
for biomarkers, such as markers of disease progression, or frequently mutated genes in 
cancers, compound screening, identifying pathways in specific cell types that are 
activated by a pharmacological agent, and prognosis screening to determine the exact 
disease of individual patients (Butte, 2002). 
A microarray, or DNA chip, is composed of a series of spots on a chip, each 
containing multiple copies of the same cDNA. There are two types of microarrays; 
cDNA (Schena et al., 1995) and oligonucleotide arrays (Lockhart et al., 1996). On a 
cDNA array, each spot contains cDNA obtained from a library, a whole or part of a 
library is then hybridised to one or a series of chips (Schena et al., 1995). An 
oligonucleotide array is an array made from a series of spots that have been specifically 
made to represent an expressed region within the genome, using a series of chemical 
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reactions to make a specific sequence (Lockhart et al-, 1996). The results from these 
two technologies is essentially the same; thousands of measurements gene expression 
per biological sample. The main differences between the two types of chips are cost 
and the number of controls required. Synthetic oligonucleotide arrays can contain 
transcripts that are designed for specific purposes such as detecting splice variants or 
other features, and the hybridisation conditions have been designed such that they are 
the same for each probe. Spotted cDNA arrays can be custom designed so that they 
only contain genes of interest, whether this is to develop a fingerprint of a specific cell 
population or to only analyse uncharacterised sequences (Schulze and Downward, 
2001). 
The arrays used during the experiments described here are synthetic 
oligonucleotide arrays; hence the preparation and analysis of these arrays will be focused 
upon. Once the cells or tissues that are to be hybridised to the microarray have been 
generated, a number of steps must be performed before samples can be hybridised. 
First, total RNA is generated and then ligated into an in vitv expression construct. The 
RNA sequence is then transcribed in the presence of biotinylated bases, resulting in 
their insertion into the cRNA. The resulting cRNA is then fractionated and hybridised 
to the microarrays. Following a series of washes to remove excess probe, the 
microarray is scanned to reveal where the cRNA has hybridised (Lockhart and Winzeler, 
2000; Schulze and Downward, 2001) (fig 1.6). The cRNA will specifically bind only to 
a complementary sequence. Each probe set contains a series of probes that make up a 
slightly different region of a cDNA sequence. The probes may overlap with each other, 
but all of the probes are different. To ensure that the hybridisation has occurred 
specifically, for each of the perfect match probes, there is a mismatch probe. This is a 
probe which has exactly the same sequence except for one base in the middle of the 
transcript which is different. These two probes are known as a probe pair. The 
hybridisation to the mismatched probe is subtracted from the perfect match probe to 




























Figure 1.6 	Schematic representation of synthetic oligonucleotide microarray 
hybridisation 
Following collection of the cell samples to be hybridised to the array, RNA is collected from the 
samples which is cloned into a vector containing a T7 promoter. In the presence of biotinylated 
UTP and CTPs, the insert is expressed, resulting in biotinylated cRNA sequences. These 
sequences are the fragmented and hybridised to chips. Excess samples are removed by washing 
before the level of hybridisation is found by scanning the chip. (After S. Graham) 
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Figure 1.7 	Perfect matches and mismatch probe hybridisation 
Fragmented labelled cRNA should specifically hybridise only to perfect match probes. Any 
hybridisation to the complementary mismatch probe is also analysed, and the extent of 
hybridisation to each sequence is analysed to give an expression level. (After S. Graham) 
In any microarray experiment there will be variations and errors in the sampling 
and analysis. To obtain the most relevant information possible from the arrays, error 
must be reduced to a minimum. Error or bias can be introduced into the experiment at 
52 
different phases and in different ways, so it is important to understand when these can 
occur to minimise all possible errors. The experiment and hence the opportunity for 
error can be divided into three phases; firstly, collecting the biological samples, secondly, 
RNA extraction, labelling and hybridisation and thirdly measuring the fluorescent 
signals (Churchill, 2002). 
The most important issue when collecting biological samples is whether the cells 
or tissue that are being analysed are a true representation of the system being studied. 
In recent years, a number of papers have been published that have tried to identify 
"stem cell genes" (Geschwind et al., 2001; Ivanova et al., 2002; Ramalho-Santos et at., 
2002), but few conclusions can be drawn from the data because it is unclear whether the 
cells being analysed were stem cells. When cells or tissues are collected from the same 
source, random variations between the samples are reduced; this can make the results 
less difficult to interpret, but biological samples obtained from different sources 
increases error (Bartosiewicz et al., 2000) although it can produce results with better 
external validity and broader applicability (Nadon and Shoemaker, 2002). Random 
variation between samples can be counteracted by having at least three replicates, which 
also provides good sensitivity to changes in expression levels (Lee et al., 2000a). 
Multiple replicates allow samples to be analysed for error on a probe by probe basis 
(Nadon and Shoemaker, 2002). However if small sample sizes are used, there is poor 
outlier detection and low sensitivity to statistical tests (Nadon and Shoemaker, 2002). 
Following generation of the biological sample, the cells or tissue must be taken 
through a series of reactions before they can be hybridised to the microarrays (fig 1.6). 
The generation and subsequent labelling of cRNA can be variable, but with good quality 
control (QC), this can be controlled and only samples of high quality will be hybridised 
to the arrays. During the hybridisation, there are a number of possible errors that can 
be introduced into the results, although many of the sources of bias or error can in 
theory be identified and removed (Nadon and Shoemaker, 2002). Many of the errors 
are due to how the chips are spotted and then subsequently how the fluorescent images 
are captured. One common problem is due the chips being dirty; this can result in spots 
on the chips that obscure the degree of hybridisation at a particular site. The 
hybridisation may also occur more efficiently at some sites than other, essentially 
generating dark and bright patched on the chips. The probes within these patches 
cannot then be directly compared. Effective QC can reduce the probability that such 
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chips will be generated, and if they are the chips can be rejected and repeated (S. 
Blakemore personal communication). Background fluorescence caused by general non-
specific binding can arise, although this can be compensated for during the analysis of 
the arrays. 
The data generated during the experiment was analysed using Rosetta Resolver. 
This is an error-modelling approach to analyse data. First the intensity value for each 
probe set is determined by finding the mean value of the perfect match minus the 
mismatch intensity score, after disregarding all values that lay more than three standard 
deviations outside the mean. No corrections are made if the mismatch value is greater 
than the perfect match value. This software also attempts to make a present or absent 
call by comparing the results to the mean intensity of the negative controls on the 
arrays. A probe set is called present if there is significant difference between the 
negative control and the sample. The addition of heterologous synthetic DNA, rather 
than by analysing so called housekeeping genes, which will be differentially regulated 
during development, was used as a control in the experiment to compare hybridisation 
between the chips so that the results could be scaled, such that expression changes were 
of the same magnitude. 
Once the results from the microarrays have been generated, the potential for 
error in the data does not end there. One of the principal sources of error is the 
presence of outliers. An outlier is an extreme value in a distribution of replicates; this 
can be high or low compared to the other values. One source of outliers is uncorrected 
image artefacts, but they can also be caused by uncorrectable factors in cross-image 
comparison, such as cross-hybridisation or the failure of one probe to hybridise 
properly. Outliers are generally identified by detecting random error on a probe by 
probe basis, although this often generates false positive and negative outliers. Large 
sample sizes are necessary to detect outliers, random clustering of two results can make 
a third result which is further away appear like an outlier, although it is representing 
acceptable variation in the system. 
Once microarray data has been generated, the results must be validated. In 
many cases a microarray study is generating a hypothesis, and like in any experiment, the 
validity of the hypothesis depends upon how well it can be tested (Popper, 1959). Two 
approaches for confirming the results from the microarrays are in silico and laboratory 
based analysis (Chuaqui et al., 2002). The in silico approach uses data that is publicly 
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available but also may be based upon proprietary data held by companies or institutes. 
The agreement between array results and analysis of the literature provides both 
confidence in the overall data and of unique and novel discoveries made in a study 
(Chuaqui et al., 2002). Laboratory based verification of the results often starts with 
performing validation experiments on the samples that were hybridised to the 
microarrays (Chuaqui et al., 2002). This may be through real time RT-PCR (Rajeevan et 
al., 2001) or Northern blots (Taniguchi et al., 2001). The analysis of the data using these 
methods can confirm the expression values in the data, but consistent validation is not 
always achieved, especially if the genes being analysed are not more than four fold 
differentially regulated between two samples. However other experiments have shown 
that expression changes greater than 1.8 fold between two samples are confirmed using 
real time RT-PCR in 90-95% of cases (Personal communication S. Blakemore). The 
crucial part of the analysis is the analysis of new samples in the light of the findings 
from the arrays. Independent samples can be analysed using a variety of methods 
depending upon whether DNA, RNA or protein is being analysed. Only a limited 
number of genes can usually be studied in the secondary confirmation, so it is important 
to analyse genes that are potentially important and informative as defined by the initial 
study outline. The choice of genes for secondary study introduces more bias into the 
analysis of the data. Many biologists have their favourite genes, and pathways and pet 
hypotheses; the choice of genes made following the initial confirmation is likely to be 
affected by experimenter bias. Genes that have the greatest variation in expression 
patterns are often an attractive target for an investigator. Greater initial confidence can 
be given to large expression changes, so less validation is required, and large changes in 
expression levels are often assumed to have the most significant effect on the biology. 
Experimenter bias is inevitable because it is difficult to perform a double blind 
experiment when biological knowledge of the system is required for the analysis. Some 
genes with only a small change in their expression levels could produce significant 
variations in the biology, but these genes are often ignored. However, this is 
understandable due to the low confidence associated with genes expressed at low levels. 
The advent of microarray technology has led to many new discoveries in 
multiple different fields, that would previously have been much more difficult and time 
consuming to achieve. However, microarrays only analyse RNA expression levels and 
this does not give a complete picture of what is happening in a cell or tissue. Many 
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other post-transcriptional regulatory mechanisms exist which determine the activity of a 
protein after the RNA encoding that protein has been generated. A recent survey by the 
National Cancer Institute indicates that changes in mRNA levels correlate with changes 
in protein expression less than 50%  of the time (Chuaqui et al., 2002). This is a startling 
statistic, but there a number of possible explanations, including further examination of 
the methodology used to examine the protein expression levels and the absolute 
differences between protein and mRNA expression levels (Chuaqui et al., 2002). Also 
as the genes being investigated are biased towards the most highly upregulated genes, 
these changes may not directly correlate with protein levels. Even if a protein is made it 
does not determine whether that protein is functional in a cell, as proteins often require 
post-translational modification. However, microarray experiments can still provide 
many new insights into the workings of cell types or a tissue of interest, but like any 
other experiment they will not provide all the answers and must be used in conjunction 
with other experiments to provide functional information about genes of interest. 
1.8 	Aim of project 
The conversion of embryonic stem cells to neurons is generally inefficient and 
the regulatory mechanisms are not well understood. The generation of an ES cell line 
which can be differentiated towards the neural lineage, and purified to produce a pure 
population of neurons would greatly assist the ability characterise the molecular changes 
that occur during differentiation. This was achieved through the homologous 
recombination of an eGFP gene into the neuronal specific gene mapt, producing an ES 
cell line with eGFP under the transcriptional regulation of the endogenous mapt gene. 
This cell line can be used to analyse the effect of different factors on the differentiation 
of ES cells to neurons and to better understand the role that different factors have in 
directing differentiation. 
Here, I will analyse the molecular changes that are occurring using DNA 
microarrays. Through the analysis of the gene expression changes in known genes, the 
mechanisms and the lineage direction that occurs during ES cell differentiation can be 
better understood. Furthermore, microarray data analysis provides a system where 
genes not previously characterised, or genes not known to be important for neuronal 
differentiation can be identified. 
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2 	Materials and Methods 
2.1 	Materials 
Unless otherwise stated, all chemicals were of analytical, molecular biology or 
tissue culture grade, as appropriate, and supplied by BDH Laboratory supplies or Sigma. 
Electrophoresis grade agarose was supplied by BioWbittacker Molecular Applications 
(Rockland, USA). Restriction and modifying enzymes were from Roche Molecular 
Biochemicals or New England Biolabs and radioisotopes were supplied by Amersham 
Pharmacia Biotech. Synthetic oligonucleotides were supplied by Proligo. 
2.1.1 	Solutions 
lx TAE 	0.44M Tris-acetate, 0.01M EDTA, pH 7.7 
0.5x TBE 	0.045M Tris Borate, 0.0IM EDTA 
20x SSC 	3M NaCl, 0.3M rn-Na Citrate, pH 7.0 
PBS 	5 tablets of PBS salts dissolved in IL of water 
LB broth 	% (w/v) tryp tone (Difco) 
0.5% (w/v) yeast extract (Difco) 
85mM NaCl 
LB agar 	1.5% (w/v) agar (Difco) in LB broth 
GMEM 	Ix GMEM (Gibco) 
10% (v/v) foetal calf serum (HiClone) 
0.1% MEM non-essential amino acids (Gibco) 
4mM Glutamine (Gibco) 
2mM sodium pyruvate 
0.1mM 2-mercaptoethanol (Sigma) 
30mM Sodium bicarbonate 
human recombinant Leukaemia inhibitory factor (made in house by D. Rout by 
transfection of COS-7 cells with an expression plasinid and harvesting of conditioned 
media) (LIF) IOOU/ml 
DMEM/F12 0.5x DMEM 0.5x F12(HAM) (Gibco) 
N2 supplement 	25mg/mi Insulin 
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I OOug/tnl Apo-transferrin 
6ng/ml Progesterone 
I 6ug/ml Putrescine 
30nM Selenium Chloride 
SOug/ml BSA 
N2B27 medium 0.5x DMEM/F12 
0.5x Neurobasal medium (Gibco) 
0.5x N2 supplement 
0.5x B27 supplement (Gibco) 
Trypsm solution 0.025% trypsin (Gibco) 
1.3mM EDTA 
0.1% chicken serum (Flow Labs) 
in PBS 
Church & Gilbert hybridisation buffer 	0.5M Na2HPO4 (pH 7.2) 
70g/L SDS 
1mM EDTA 




0.5mg/mi Proteinase K (Roche) added just before use 
Denaturing buffer 1.5M NaCl 
0.5M NaOH 
Neutralising buffer 1.5M NaC1 
0.5M Tris (pH 7.5) 
0.5M EDTA 
Wash solution 40mM Na2HPO4 (pH 7.2) 
0.1% SDS 
2.2 	Molecular biology methods 
General molecular biology methods were as described in (Sambrook and 
Russell, 2001). 
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2.2.1 Cloning and subcloning 
Cloning of DNA fragments involved restriction enzyme digestion and gel 
purification. Restriction enzyme digestions were performed according to the enzyme 
manufacturer's protocol. Digested DNA was subsequently run on agarose gels (TAE) 
for resolution of the fragments. DNA was recovered from the gel by cutting a piece of 
the gel containing the desired band and extracting the DNA using Quiaquick gel 
extraction kit (Quiagen) according to the manufacturers instruction. The concentration 
of the recovered DNA was estimated by agarose gel electrophoresis (TAE). 
2.2.2 Transformation of bacterial cells 
Competent DH10P bacteria were routinely used for transformations. 
Competent bacteria were prepared in the following way. A single colony from a freshly 
streaked plate was grown in LB broth overnight at 37°C. 1 ml of the culture was used 
to inoculate I OOml of LB broth and returned to a shaking incubator until it reached an 
O.D.5 0.3-0.6. Cells were harvested by centrifugation at 3000g at 4°C. The pellet was 
resuspended in 5m1 of TSB (10%  PEG 3350,5% DMSO, lOnM MgCl2, 10mM MgSO4 
in LB broth). The mixture was incubated on ice for 10 minutes, after which 10% 
glycerol was added, it was aliquoted and snap frozen in liquid nitrogen and stored at - 
70°C. For transformation, DNA was mixed with water to a total of 801.d, 5 1.il of 5x 
KCM buffer (0.5M KCl, 0.15M Ca Cl2, 0.25M Mg C4) was added and the mixture was 
chilled on ice. 1001.d of competent cells was thawed on ice and added to the DNA mix. 
The mixture was incubated on ice for 20 minutes and then at room temperature for a 
further 10 minutes. 800p.l of LB broth was added to the cells and they were transferred 
to a shaking incubator at 37°C for 40-60 minutes before being plated on LB agar 
containing suitable selection. Recombinant bacterial colonies were screened for the 
presence of inserts by plasmid preparation and restriction enzyme digestion. 
2.2.3 Nucleic Acid Isolation 
2.2.3.1 Plasmid isolation 
Plasmid purification was performed from overnight cultures of single bacterial 
colonies in LB broth using Qiagen's minispin kit or maxiprep kit for small and large 
scale preparations respectively, according to the manufacturer's instructions. 
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2.2.3.2 ES cell genomic DNA isolation 
ES cells grown for genomic DNA isolation were grown to over-confluence in 
24 well plates or 25ml flasks. The cells were rinsed in PBS twice and lysed overnight at 
37°C in lysis buffer. The lysate was transferred to an eppendorf tube and an equal 
volume of isopropanol was added. The tube was inverted several times until a DNA 
precipitate was visible. DNA was pelleted by centrifugation at 13 000rpm in a benchtop 
centrifuge for 10 minutes, washed with 70%  ethanol and resuspended in a suitable 
volume of sterile water. The concentration of DNA was established by 
spectrophotometer analysis at 260nm. 
2.2.4 Southern blotting 
lOg of genomic DNA was digested with 80U of restriction enzyme for 3 hours 
in the appropriate buffer and at the appropriate temperature, then a further 40U were 
added for another 1-2 hours. The digested DNA was run on a 1% agarose gel (TAE) 
overnight. The following morning, the gel was photographed under short ultra violet 
light to nick the DNA, and then placed in denaturing buffer with light agitation for 20 
minutes. The buffer was then replaced and incubation repeated. The gel was then 
soaked in neutralising buffer twice for 20 minutes. Then the gel was blotted onto a 
nylon membrane in 20x SSC overnight. Following transfer, the membrane was washed 
in 2x SSC and the baked at 120°C for 40 minutes. The membrane was then hybridised 
with the appropriate racliolabelled probe. 
2.2.5 Radiolabelling of DNA 
DNA was labelled with HighPrime labelling mix following the manufacturers' 
instructions. Briefly, 20-40ng of linear, denatured DNA template was incubated with 
HighPrime (containing polymerase, random hexamers, nucleotides and buffer) and 
40i.iCi 32P-dCTP for 20-40 minutes at 37°C. Unincorporated nucleotides were removed 
by passing the reaction through a ProbeQuant G50 spin column (Amersham Pharmacia 
Biotech). The reaction product was then denatured by boiling for 5 minutes, placed on 
ice for 2-3 minutes and added to the hybridisation mixture. Routinely, the probes 
measured 1.5-10' cpm/nil of radioactivity. 
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2.2.6 Hybridisation of membranes with radioactive probes 
Membranes were pre-hybridised for 1 hour in approximately 20m1 Church & 
Gilbert buffer (Sambrook and Russell, 2001) at 65°C. After the addition of the probe, 
membranes were hybridised overnight at the same temperature. The next day, the 
hybridisation mix was removed and the membranes washed in 2x SSC, 0.1% SDS twice 
for 20 minutes followed by two washes in 0.2x SSC, 0.1% SDS, before light air drying. 
They were subsequently wrapped in Saran wrap and exposed to either film (KODAK 
X-omat) in an intensifying screen at -70°C for 1-7 days or in a phosphoimager screen 
for 1 hour-2 days. 
2.2.7 Polymerase chain reaction (PCR) 
In general DNA was amplified in a reaction containing 10mM Tris-HCI pH8.3, 
50mM KC1, 1.5mM MgCl2, 0.5M of each primer, 200p.M dNTPs and I unit of Taq 
(Roche). The PCR was performed in a GeneAmp 9700 thermal cycler from Perkin-
Elmer Applied Biosystems. In general the following reactions conditions were used. 
94°C 5 minutes 
30 cycles 
94°C 1 minute 
58°C 1 minute 
72°C 1 mInute 
72°C 10 minutes 
4°C 
Following PCR amplification, 10 of Taq polymerase was added to the reaction and the 
tube incubated at 72°C for 10 minutes to enable TA cloning of the product. 
2.2.8 Reverse transcription PCR (RT-PCR) 
3J.g of total RNA was used in 20j.i.1 reaction containing 0.5M of polydT primer 
(Gibco BRL), 200 units Superscript II (Gibco BRL), 10mM dNTPs and 20 units RNase 
inhibitor (Roche) in 75mM KC1, 3mM MgC12, 10mM DTI', 50mM Tris-HC1 pH 8.3. 
The RNA and primer were first denatured at 65°C for 5 miin and incubated on ice for 3 
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mm. The rest of the reagents except the enzyme were added and the sample was 
incubated at 42°C for 2 min. Following addition of the enzyme, the reaction was 
incubated at 42°C for 50 mm. At the end of the reaction the RNA strand was degraded 
with 2 units of RNase H (Gibco BRL) at 37°C for 20 IT 
2.2.9 SYBRGreen quantitative RT-PCR 
To confirm the expression profile of results generated from microarray 
experiments quantitative RT-PCR was carried out on the same cDNA samples that were 
hybridised onto the microarrays. The SYBRGreen system involves the incorporation of 
a fluorescent dye into the minor groove of newly synthesised cDNA, so that the amount 
of RT-PCR product can be tracked throughout the amplification. Using a master mix 
reduces the variation caused by pipetting various different solutions and Taq 
polymerase. The experiment is performed in a 96 well optical PCR plate (applied 
biosystems). 
For each reaction the following reagents are require- 
d-1 g of cDNA in 4.tl volume 
12.51.d of 2x SYBRgreen PCR master mix (Applied Biosystems) 
7.5.tl of DEPC H 20 
0.5p.l Forward primer (1 0.tM) 
0.5d Reverse primer (10.iM) 
A dilution series in triplicate was generated from IO.tg/.d murine genomic 
DNA. Genomic DNA was diluted by 10, 100, 100 and 10000 fold and 4.d added to a 
well. A well containing only water was also included. Reagents as described above 
excluding cDNA were added to each well. 
The plate was then sealed with an optical adhesive cover (Applied biosystems), 
then centrifuged at 1000rpm for 1 minute. 
Samples were then run in ABI PRISM 7700 at following conditions: 
92°C 5mm 
40 cycles 
92°C 1 mi 
60°C 1 mm 
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Results were then analysed using the software on the system. This involves the 
generation of a graph with the extent of SYBR green fluorescence at each time point. 
The amount of fluorescence is proportional to the amount of synthesised DNA. At a 
point where all the samples and controls are being amplified at a linear rate the amount 
of stating material in the samples can be quantified by comparing the samples to the 
known DNA concentrations. 
2.3 	Cell culture techniques 
All cells were maintained at 5% CO2 at 37°C in a humidified incubator (Heraeus, 
B5060 EC/CO2). All manipulations were undertaken in a laminar flow hood (ICN). 
To avoid bacterial or fungal contamination, all surfaces were cleaned with 70% 
industrial methylated spirits (IMS) before commencing work. Tissue culture grade 
plastics were supplied by Iwaki and Nunc. 
2.3.1 Routine culture of ES cells 
ES cells were cultured in 0.1% gelatine coated plastic in GMEM supplemented 
with human recombinant leukaemia inhibitory factor (LW) as described previously. LIF 
was prepared by D. Rout by transfecting COS-7 cells with human LIF expression 
plasmid and then the supernatant was harvested. The supernatent was tested on ES 
cells by limiting dilution, and the smallest amount capable of maintaining self-renewing 
colonies was designated as one unit per ml. Routinely, 100 units of LIF per ml were 
used in the cultures. 
To passage the cells, the medium was removed and the cells washed twice with 
PBS. Trypsin solution was added to just cover the cells and the flask was incubated at 
37°C for 1.5-2.5 minutes. The trypsin activity was quenched by addition of 5m1 of 
medium per I ml of trpsin. The cells were then pipetted into a single cell suspension. 
The cell suspension was then centrifuged (200g, 3 mm) and the cell pellet resuspended 
in 10 ml of warm medium. An aliquot of the cells was seeded into a new flask 
containing pre-warmed medium. Routinely, cells were passaged at 1:5-1:10 split every 2-
3 days. 
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2.3.2 Freezing and thawing cells 
Cells growing in a flask are trypsinised to a single cell suspension and 
centrifuged at 200g for 3 minutes. The cell pellet was resuspended in 10% freezing mix 
(GMEM containing 10%  dimethyl sulfoxide, AnalaL, BDH) in GMEM and spun down 
at 200g for a further 3 minutes. Cells were then resuspended in imi of freezing mix and 
transferred into a cryotube (Nunc). The cryotube was then placed at -80°C overnight 
and then transferred to a liquid nitrogen cell bank (XCLI 10, Minnesota Valley 
Engineering Cryogenics). 
To freeze cells in plates, the medium was removed and replaced with freezing 
mix to just cover the cells. The plate was then transferred to a polystyrene box and 
stored at -80°C (Ure et al., 1992), before being transferred to a liquid nitrogen bank. 
To thaw cells in vial, the vial was re moved from the liquid nitrogen bank and 
thawed in a 37°C waterbath. The contents were then transferred into a 30m1 Universal 
tube containing I Omi of pre-warmed medium and centrifuged at 200g for 3 minutes. 
The cell pellet was gently resuspended in 10 ml of medium and seeded into a 25cm 2 
flask. 
To thaw cells frozen in plates, I ml of pre-warmed medium was added to each 
well. The plate was then held between hands until thawed. Two-thirds of the medium 
was carefully aspirated and replaced with fresh medium (Ure et al., 1992). 
2.3.3 Neuronal differentiation of ES cells 
2.3.3.1 Monolayer Differentiation 
Monolayer differentiation of ES cells was performed in 6cm tissue culture dishes 
(Nunc) or 6-well plates (Nunc) coated with 0.1% gelatine. The plates were coated in 
gelatine for at least 30 minutes at room temperature; excess gelatine was removed by 
aspiration. 1 nil of N2B27 medium was then added to each well that had been coated 
with gelatine to aid equal distribution and attachment of the ES cells in the well. The 
degree of confluence of ES cultures is essential to achieving efficient neural 
differentiation. ES cells should be trypsinised before differentiation when the flasks are 
70-80% confluent. Before addition of trypsin, ES cells are washed with PBS twice and 
incubated with Ixtrypsin for 1.5 to 2 minutes at 37°C. Either a glass pipette or a P1000 
should be used to ensure ES cells are dissociated to single cells. Failure to dissociate ES 
cells to single cells will lead to less efficient differentiation. Trypsin was quenched by 
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addition of GMEM plus 10%  FCS. For every I ml of lx trypsin, 4rnl of GMEM plus 
10% FCS was added. ES cells were then spun down at 5000g for 3 minutes. GMEM 
plus 10% FCS was then aspirated off leaving a cell pellet. The ES cell pellet was 
resuspended in N21327. The number of cells was then determined by counting with a 
haemocytometer. Routinely 2x10 5 cells were plated into each well in N21127 medium, in 
a total volume of 2.5m1. N21527 was aspirated every 2 clays and replaced with fresh 
N2B27, pre-warmed to 37°C. 
2.3.3.2 Serum-free EB differentiation 
Serum-free EB differentiation was performed exactly as described above except 
ES cells were plated onto 10cm bacterial grade Petri dishes that were not coated. 5m1 of 
N2B27 was added to the dishes before addition of ES cells. Routinely 106  ES cells were 
added to each dish, with the final volume of N2B27 being lOmi. Medium was changed 
every 2 days. To change medium EBs were carefully pipetted into a 30ml universal tube 
and allowed to settle at the bottom. The medium was then aspirated away and replaced 
with lOmi of fresh, N21527, pre-warmed to 37°C; the cells were then returned to a new 
10cm bacterial grade Petri dish. 
2.3.3.3 Replating differentiating cultures 
In experiments where cells were replated part way through the culture, cells were 
replated in a Nunc 4 well plate coated with I x poly-d-lysine (Sigma) for at least 30 
minutes at 37°C, then the wells washed with PBS twice, and the wells then coated with I 
x laminin (Sigma) for at least 30 minutes at 37°C. The laminin was aspirated away just 
prior to use and 0.5 ml of N21327 added to aid equal distribution of the cells. ES cells 
were initially differentiated using the monolayer protocol as described in 2.3.3.1 until 
day 7. At this point the cells were washed twice with PBS pre-warmed to 37°C. The 
cells were then trypsinised by adding lml of lx trypsin and incubating at 37°C for 2 
minutes. The cells were then gently pipetted up and down using a P1000 pipette to 
achieve a single cell density. The trypsin was quenched by the addition of 4 ml of 
GMEM plus 10% FCS, and the cell suspension transferred to a 30m1 Universal tube. 
The cells were then centrifuged at 3000g for 5 minutes, and the media was aspirated 
away to leave a cell pellet. The cell pellet was resuspended gently in lOmi of pre-
warmed N2B27. The density of the cells was analysed by counting using a 
haemocytometer. The appropriate numbers of cells were then added to each well. The 
65 
medium was replaced every 2 days with fresh N2B27. At day 12 the cells were 
trypsinised as described previously and resuspended in 5 ml of PBS plus 10 % (v/v) 
FCS. 
2.3.3.4 Factor addition conditions 
46C ES cells were differentiated as described in 2.3.3.1 to day 4, when the media 
was changed N2B27 plus Si.g/ml Puromycin (Sigma) was added. At day 6 this was 
replaced with N2B27 plus the factor being analysed. At day 8 the cells with fixed with 
4%PFA in PBS (w/v) and immunocytochemistry was performed for the Tuji antibody, 
and the nuclear stain DapI. Cells were counted as described in 2.6.4. 
	
2.4 	Introduction of DNA into cells 
2.4.1 Electroporation of ES cells 
Flasks of 90% confluent ES cells were trypsinised and at least 2 x 10' cells 
pelleted and resuspended in 0.7m1 of PBS. I 5O.tg of linearsied targeting vector DNA 
resuspended in 0.1tnl of PBS was added to the cells, and left to sit for 10 minutes at 
room temperature, then DNA-cell mix was transferred to a sterile electroporation 
cuvette (BioRad 0.4cm gap) for electroporation. The electroporation was performed in 
a BioRad Genepulser elecetroporator at 0.8kV and 3iF. Immediately after the 
electroporation the wells were plated onto 10cm gelatinised tissue culture plates 
containing lOmi of pre-warmed GMEM plus LIF, at a density of 106  cells per plate. A 
control plate of cells not exposed to DNA is also plated at the same density. After 24 
hours the medium was changed to selection medium containing the appropriate 
selection. Cells were grown in selection medium for 7-10 days, until colonies appeared 
and all the cells had been killed in the control plate. Single colonies were picked into 24-
well plates coated with gelatine. Cells were expanded and each clone split into two 24-
well plates, one of which was frozen as a stock (Ure at al 1992), while the other one was 
used for DNA extraction and Southern blot analysis. 
2.5 	Histochemistry 
2.5.1 Immunocytochemistry 
For immunocytochemistry, cells were rinsed twice with PBS and fixed in 4% 
paraformaldehyde in PBS for 20 minutes at room temperature. They were rinsed twice 
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with PBST (PBS plus % Tween20) for 10 minutes each time to permeabalise the cell 
membranes, and then incubated in PBST with 3% serum and IO% bovine serum 
albumin (BSA) (blocking solution) for 30 minutes, to prevent non-specific binding of 
the antibody. The cells were rinsed twice again with PBST and incubated in the primary 
antibody, diluted appropriately in the blocking solution overnight at 4°C. Following the 
incubation, the cells were rinsed 3 times for 10 minutes each with PBST, and incubated 
for 1 hour in the dark, at room temperature, with the secondary antibody at the 
appropriate dilution in PBST. The secondary antibody was then washed off by washing 
the cells 3 times with PBS, before being observed under a microscope. 
2.5.2 Image acquisition and manipulation 
Images were captured via a Zeiss Axiovert inverted microscope using a 
Hamamatsu Orka colour camera and Improvision Openlab 2.2.5 software on a 
Macintosh G3 computer. Contrast and brightness enhancement of acquired images was 
also performed with Adobe Photoshop v5.0 to enhance weak fluorescence of some 
images, and improve the contrast. 
2.6 	Embryology 
2.6.1 Maintenance of animals 
Mice were housed and bred within the animal unit of ISCR according to the 
provision of the animals (Scientific Procedures) Act 1986. They were maintained in a 
stabilised environment on a 14 hours light / 10 hours dark cycle. 
2.6.2 Recovery of embryos 
For the collection of embryos at specific developmental stages, matings were set 
up overnight and the females examined for the presence of a vaginal plug the next 
morning. Noon on the day of finding a vaginal plug was designated 0.5 dpc (E 0.5). 
Embryos were dissected from the uterus in PBS. 
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2.6.3 In situ hybridisation 
Whole mount in situ hybndisation was performed as described previously 
(Wilkinson, 1992) with the following modifications. Samples were fixed overnight at 
4°C in 4% PFA in PBS. Treatment with IOtg / ml of Proteinase K was 8 minutes E8.5 
and 15 minutes E10.5 embryos. 
Digoxigenin-labelled antisense riboprobes were transcribed using the 
appropriate RNA polymerase (Roche) according to manufacturer's instructions. 
2.6.4 Imaging 
Digital images of whole-mount embryos were acquired using Openlab v.3.0 
(Improvision) and a digital camera attached to a Zeiss Stemi SVI I stereoscope with 
bright field optics. 
2.6.4.1 Cell counting 
Following immunocytochemistry cells were counted by taking all captured 
images and importing into Adobe Photoshop. eGFP or stained image was then overlaid 
onto the DapI image, and the opacity decreased to 50% so that cell nuclei were visible. 
The number of cells that were positive and negative for eGFP or the marker were then 
counted and recorded. 
2.6.4.2 DapI cell death analysis 
The extent of cell death was established by the examination of the DapI staining 
pattern. DapI positive spots in the images correspond to cells with highly condensed 
chromatin that were not alive when the cells were fixed. Examples of such cells (but 
not all such examples in the image) are seen in the boxed areas of figure 2.1. 
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Figure 2.1 	DapI staining patterns 
DapI staining, areas in red boxes contain cells with condensed chromatin that 
were not alive at the time of fixing. 
2.7 	Microarrays 
2.7.1 Tissue culture 
ES cells were differentiated exactly as described in 2.3.3.2. All ES cells were 
differentiated or kept undifferentiated originated from a single vial of passage 12 46C 
ES cells. 
2.7.2 Cell pellets 
Following appropriate differentiation, cell pellets were prepared for RNA 
isolation. For EBs, cells were allowed to settle in a 50 ml tube, cells grown on substrate 
were trypsinised, the trypsin quenched with FCS. The cell suspension was then spun 
down in a centrifuge at 200g. The medium was then removed by careful aspiration, 
leaving a cell pellet with no medium. Cells were then frozen by placing the 50 ml tube 
containing the cell pellet on dry ice for at least 5 minutes, before transferring to a -80°C 
freezer. RNA was isolated by Ted Cook from the transcriptome analysis group of 
GlaxoSmithKline, using an RNeasy kit (Qiagen). 
2.7.3 Preparing sample for hybridisation 
The cell pellets were submitted to Ted Cook in the Transcriptome analysis 
group at GSK. Total RNA was extracted using the RNeasy kit (Qiagen) and quantified 
using Agilent 2100 bioanylyser. The RNA was labelled by Simon Graham in the 
Transcriptome analysis group at GSK in the one cycle eukaryotic target labelling assay. 
Briefly this involves total RNA first reverse transcribed using a f7-Oligo(dT) Promoter 
Primer in the first-strand cDNA synthesis reaction. Following RNase H-mediated 
second-strand cDNA synthesis, the double-stranded cDNA is purified and serves as a 
template in the subsequent in vitro transcription (LVI) reaction. The IVT reaction is 
carried out in the presence of T7 RNA Polymerase and a biotinylated nucleotide 
analog/ribonudeotide mix for complementary RNA (cRNA) amplification and biotin 
labelling. The biotinylated cRNA targets are then cleaned up, fragmented, and 
hybridized to GeneChip expression arrays. 
The labelled samples were hybndised to the arrays by Simon Graham. This 
involves preparation of a hybridisation cocktail, containing the fragmented labelled 
target, probe array controls, BSA, and herring sperm DNA. This is then hybridised to 
the probe array during a 16 hour incubation. 
Following probe hybridisation the arrays are automatically washed on the 
fluidics station to remove any probe than has not hybridised to the arrays. 
Once the probe array has been hybridised, washed, and stained, it is scanned. 
The scanning workstation uses Affymetrix Microarray Suite or GCOS to control the 
scanner. The software defines the probe cells and computes the intensity for each cell. 
Detailed descriptions of the protocol carried out by Simon Graham are freely 
available at: 
http: / /www.affymetrix.com/support/downloads /manuals /expression  s2 man 
ual.pdf. 
2.7.4 Data Analysis 
The data was filtered and normalised by Simon Graham using proprietary GSK 
software and Rosetta Resolver. Essentially this involved first scaling the arrays based 
upon the hybridisation efficiency of the probe array controls such that the fluorescence 
value for each array was the same for each probe array control. Corrections were made 
for areas of the chips that were over or underhybrdised producing "bright" or "dark" 
areas. The expression level of each spot was then quantified and outliers were identified 
and corrected where possible. Only the normalised data was made available by GSK 
due to previous agreements made between GSK and Affymetrix. 
Gene expression changes were defined in terms of the relative change in 
expression level, i.e. how does the expression of any gene at any timepoint relate to the 
expression level in ES cells. To enable such representations, the expression level in ES 
cells will be referred to as 0 in all cases and if the expression increases by 100%, this will 
be referred to as 1, and if it decreases by 50% this will be -1, and so on. 
To avoid these errors a cut off value of fluorescence of 20 was taken as a 
threshold, above which all genes were taken to be "on" and below which all genes were 
considered to be "off" and all expression levels below 20 were changed to 20. 
Data was analysed using a number of different pieces of software. These were 
Microsoft Excel, Spotfire DecisionSite 8 and The Institute for Genomic Research 
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Multiple Array Viewer 3.01 (TIGR MeV). Where and how each piece of software was 
used is indicated in the Results. 
2.8 	Flow cytometry and fluorescent activated cell sorting 
2.8.1 Flow cytometry 
For flow cytometry analysis, cells were trypsinised and resuspended in PBS with 
10% FCS. Analysis was performed on FACSCaIIbur flow cytometer (Becton 
Dickenson) using CellQuest software. All flow cytometry analysis of cells expressing 
eGFP was analysed against ES cells that had been differentiated under the same 
conditions over the same time, but did not express a fluorescent protein. More 
differentiated cells have a higher autofluorescence than ES cells, so if cells are compared 
directly to ES cells there is an overestimation of the proportion of positive cells. Cell 
debris and dead cells were excluded from the analysis by electronic gating based on the 
forward scatter (size) and side scatter (cell granularity) characteristics. A second gate 
was then set at a point on the fluorescence scale to exclude 99% of all cells. All cells 
with a fluorescence value greater than this were considered to be positive. For time 
course experiments, the settings were determined before the experiment commenced 
using appropriate positive and negative controls, then saved and used for all of the time 
points to ensure consistency in the data acquisition. 10000 live cells were analysed for 
all experiments. 
Prior to analysis all cells were trypsinised as described previously and 
resuspended in 5 ml of PBS plus 10 % (v/v) FCS. 
2.8.2 FACS 
For sorting, experiments used a Cytomation MoFlo. 	To eliminate 
contamination the sorter had 70% ethanol washed through the tubes, and all surfaces 
sprayed down with 70% ethanol before the experiments commenced, cells were also 
kept in the presence of penicillin/streptomycin (Gibco). Cell sorting parameters were 
established using the same principles used in 2.8.1. 
Before the cells were sorted a cell suspension in PBS with lO%  FCS was made 
and the cells were kept on ice. The cells were sorted directly into tubes containing 
N2B27. To increase survival of cells following sorting cells were plated in Nunc 4 well 
plates, pre-coated with poly-d-lysin and fibronectin. lml of N2B27 plus 5% (v/v) FCS 
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was added to each well before addition of cells. Most of the medium was replaced after 
4 hours and again the following morning but with N21327 not containing FCS. Cells 
were plated at a range of densities from 5x10 4 to 5x105 cells per well. 
When high purity sorts were required, the samples were sorted twice, using the 
same sorting criteria during both sorts. Some sorting was performed by Steve le 
Moenic. 
2.9 	Statistics 
2.9.1 Paired Student T-TEST 
The student t-test is used to determine if two population means are equal. A 
paired student t-test involves determines the probability of whether they differ from 
each other in a significant way under the assumptions that the paired differences are 
independent and identically normally distributed. The samples do not need to be 
independent of each other; they should be related to each other, such as comparing 
treated and untreated samples. 
The paired student t-test can be performed in Microsoft Excel by entering the 
following formula in a cell: 
T'FEST([results experiment 	1],  [results experiment 2] ,[number of 
experiments],1) 
The result can then be used to determine if there is a significant difference 
between the experiments. 
If p<O.OS result is significant, displayed as * on graphs 
If p<O.Ol  result is highly significant, displayed as ** on graphs 
If p<O.00I result is very highly significant, displayed as 	on graphs 
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3 	Targeting mapt in ES cells 
3.1 	Introduction 
This chapter details the insertion of a promoter-less reporter/ selection construct 
into the neuronal specific gene mapt using gene targeting. Gene targeting is the 
homologous recombination of endogenous DNA with newly introduced DNA 
sequences (Thomas and Capecchi, 1987). This mechanism can systematically alter the 
mouse genome (Smithies et al., 1985; Thomas and Capecchi, 1986; Thomas et al., 1986). 
Gene targeting enables the alteration of any endogenous chromosome in a defined 
manner (Thomas and Capecchi, 1987), if the alteration is made in ES cells, mice with 
the desired alteration can be generated (Johnson et al., 1989; Thompson et al., 1989; 
Zimmer and Gruss, 1989). Homologous recombination has distinct advantages over 
random mutagenesis because, firstly, the nature of the mutation is controlled by the 
experimenter, producing a particular alteration in a specific gene, and secondly the 
targeting efficiency is such that non-selectable genes can be mutagemsed (Thomas and 
Capecchi, 1987). The frequency of homologous recombination is dependent upon a 
number of factors, the extent of homology, whether the vector is prepared from 
isogenic or non-isogenic DNA, whether a sequence replacement or sequence insertion 
vector is used and the location of the targeting site (Deng and Capecchi, 1992). All of 
these factors play some role in determining targeting efficiency, but by far the most 
important factor is the extent of homology between the endogenous and the 
homologous sequences (Deng and Capecchi, 1992). The frequency of recombination 
increases exponentially when homology arms are greater than 1kb in length. Saturation 
frequency occurs at 14kb of homology (Deng and Capecchi, 1992). 
The vector used here is a promoter-less knock-in construct, designed such that 
the insertion is in-frame, and the insertion generates a fusion protein. Expression is 
dependent upon the chromosomal promoter at the site of integration. This is similar to 
the promoter trap strategy used during gene trapping (Friedrich and Soriano, 1991; 
Reddy et al., 1991; Stanford et al., 2001; von Melchner and Ruley, 1989). Following 
activation of the inapt promoter, the RNA that is generated is composed partially of 
exon I of mapt but also the entire eGFP coding region. 
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The targeting construct was inserted into EI4S1 ES cells, which contain a 
Hygromycin thym.idine kinase (HyTK) cassette, targeted into the sox2 locus U. 
Kawaguchi in preparation). Hence, cells that express sox2 can be subjected to positive 
or negative selection (Lupton et al., 1991). ES cells containing a HyTK cassette cannot 
contribute to the germ line of chimaeras (Al-Shawl et al., 1988; al-Shawi et al., 1991; 
Braun et al., 1990; Ellison et al., 2000), but it was considered more valuable to have an 
ES cell line with dual selection for sox2, rather than an ability to make a second line of 
mapt.-eGFP mice. Therefore, cells can be positively or negatively selectable for .cox2 
expression at different stages of differentiation. 
Neuronal differentiation of ES cells expressing eGFP under the control of mapt 
has been previously reported (Tucker et al., 2001; Wernig et al., 2002). Wernig et al 
focused upon using the cassette as a reporter of neuronal differentiation following ES 
cell derived neural stem cell transplantation (Wernig et al., 2002), and Tucker eta/looked 
at the effects of cytokines on neurite outgrowth (Tucker et al., 2001). However, these 
ES cells require growth on a layer of feeder cells (Li et al., 1992). Feeder dependent ES 
cells differentiate less efficiently using the established protocols of this lab, and the 
presence of feeder cells makes it more difficult to analyse whether any factor is acting 
directly on the differentiating ES cells, or is having an indirect effect mediated by the 
feeder cells. Thus, the reporter cassette was targeted into the mapt locus of a feeder 
independent ES cell line (Hooper et al., 1987). 
We will use this reporter to analyse the conversion of neural stem cells to 
neurons, and so it is essential that these experiments are performed in a feeder 
independent differentiation system. 
3.2 	Vector 
The construct used to target the endogenous mapt gene (Figure 3.1) was 
obtained courtesy of K. Tucker and Y. Barde of the Freidrich Miescher Institute in 
Base!, Switzerland. The eGFP has no promoter, and instead relies upon the correct 
integration in-frame of eGFP into exon I of mapt, and the endogenous mapt promoter 
controls expression (Tucker et al., 2001). The targeting efficiency of knock-in strategies 
can be low, to select ES cell clones that have had the vector inserted, the ES cells are 
were grown in selective media which kills all clones that have no insertion. To select 
clones in this way, a drug resistance gene must be expressed in ES cell, and as ES cells 
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do not express mapt, in this instance, the selectable marker is a neomycin resistance 
gene, driven by a ubiquitous promoter phosphoglycerate kinase (PgK). The reporter 
gene is a mutated Aeqiioria victoria green fluorescent protein; enhanced green fluorescent 
protein (eGFP) (Cormack et al., 1996). 
The principal advantage of a fluorescent protein is that it can be directly 
visualised in live cells using fluorescent microscopy, without any need to process the 
tissue (Chalfie et al., 1994). eGFP differs from wild type GFP because of two amino 
acid substitutions at positions 64 and 65 (Phe-64 to Leu, Ser-65 to Th.r), and codon 
usage is optimised for mammalian expression. These substitutions generate a 
fluorescent protein 35 times more fluorescent than wild type GFP when excited at 
488nm (Cormack et al., 1996). 
When eGFP has been inserted into exoni of map!, a fusion protein will be 
generated composed of the first 31 amino acids of mapt exon I followed by eGFP 
(Tucker et al., 2001). Normally Mapt localises to microtubules, due to the microtubule 
localisation domain within the 3' region of exon 1, however due to the position of the 
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Figure 3.1 	mapt targeting strategy 
The targeting vector undergoes homologous recombination with the regions of homology 
within the genomic locus. This produces the targeted locus, which will go on to produce a 
mapt-eGFP fusion protein. 
3.3 	Screening strategy for homologous recombinants 
To screen for correctly targeted clones, genomic DNA extracted from G418 
resistant clones was screened by Southern hybridisation with probes flanking the regions 
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of homology. The 5' flanking probe was a 0.8kb Smal-EcoRl fragment from plasmid 
pMAPT_2.5Kb. This fragment has homology immediately upstream of the 5' 
homology arm (see fig. 3.1). In order to identify correctly targeted clones, DNA from 
G418 resistant clones was cut with the BamHI restriction enzyme, hybridised with the 
probe, and compared to DNA from wild type ES cells. Wild type DNA gives an 8.8kb 
band, which reduces to 3.0kb upon correct integration of the targeting vector due to the 
presence of a new BamHI site. The 3' flanking probe was a 0.75kb BamI-EcoRl 
fragment from plasmid pMAPTB2-H. This fragment has homology immediately 
downstream of the 3' homology arm (see fig. 3.1). DNA from G418 resistant clones 
and wild type DNA was cut with KpnI and hybridised with the probe. Wild type DNA 
gives an 8.8kb band, which increases to 12.0kb upon correct integration of the targeting 
vector due to the integration being between the original KpnI sites. To confirm that 
only one copy of the construct was inserted into the cell line, an eGFP probe was 
prepared. The pTKOII probe, which contains eGFP sequence, was digested with Nod, 
and hybridised to the 3' blot, following washing to remove the original 3' probe. This is 
to confirm that the clone identified as correctly targeted only has one insertion of the 
vector, and there has been no random insertion elsewhere. 
3.4 	Targeting pTKOII in ES cells 
The targeting vector pTKOII was electroporated into EI4SI ES cells (J. 
Kawaguchi in preparation), from parental cell line EI4Tg2A (Hooper et al., 1987), 
obtained courtesy of J. Kawaguchi, as described in Chapter 2. EI4S1 ES cells were 
electroporated with plasmid pTKOII, selected for 6-8 days in Itg/ml G418, colonies 
picked, expanded and genomic DNA extracted from each clone. 
From 192 clones picked, 48 were initially screened with the 3' probe, of the 48 
clones, only 40 of the samples contained DNA. These 40 clones were screened by 
Southern hybridisation, and 13 had the correct 3' targeting (figure 3.2a). To confirm 
that the legitimate replacement event occurred, the clones were screened using the 5' 
probe. Due to non-specific binding of the probe, it is difficult to confirm correct 
targeting. One clone was selected, henceforth known as TK23, which grew well as an 
ES cell, and when differentiated expressed eGFP (figure 3.3). TK23 was screened for 
correct 5' targeting, and correct integration could be seen by Southern hybridisation 
(figure 3.2b). To check that TK23 had no further random integrations of the targeting 
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vector, the 3' blot was screened with a probe hybridising to the eGFP coding region, 
and in the 11(23 ES cell line, only one integration had occurred (figure 3.2c). Hence, 
the TK23 ES cell line has correct targeting of the pTKOII targeting vector. 
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Figure 3.2 	Southern blotting of targeted clones 
Genomic DNA prepared from ES cells, digested with appropriate restriction endonuclease, ran 
on agarose gel, blotted and hybridised with the appropriate probe. A: 3' probe, B: 5' probe, C: 









Figure 3.3 	TK23 Cells express eGFP following differentiation 
Following monolayer differentiation, TK23 cells express eGFP in neuronal-like cells, seen by 
fluorescent microscopy. 
3.5 	Fidelity of mapt-eGFP expression 
A variety of protocols can be used in order to convert ES cells to neurons 
(discussed in chapter 1). Each has various advantages and disadvantages depending 
upon the aim of the experiment. The efficiency and timing of neuronal differentiation 
can vary between each method (Stavridis and Smith, 2003), but in all cases, the mapt-
eGFP cassette should be expressed from the onset of neurogenesis, when other 
neuronal markers can be detected. 
In order to access the fidelity of eGFP expression we made use of a recently 
developed differentiation strategy that enables neural differentiation of ES cells in 
defined conditions (Ying et al., 2003b). This method, referred to as the monolayer 
protocol, involves differentiating ES cells as a monolayer, attached to a gelatine-coated 
substrate, in serum-free medium, without the need for exogenous cytokines (Ying and 
Smith, 2003; Ying et al., 2003b). Following monolayer differentiation, 
immunocytochemistry was used to confirm the cell types in which eGFP was expressed. 
In all cases, neuronal markers (Tull, Map2) were expressed exclusively in cells that also 
express eGFP (figure 3.4), and all eGFP positive cells are negative for the astrocyte 
marker GFAP (figure 3.5). All Tuji positive cells were eGFP positive and vice versa 
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(table 3.1), but not all eGFP positive cells were Map2 positive, despite having neuronal 
morphology. This suggests that mapt-eGFP is expressed at an early stage of neuronal 
commitment, earlier than some other neuronal markers. 
As eGFP is expressed exclusively in neurons, and in all neurons, this system can 
be used to analyse the progression of TK23 ES cells to neurons. Previous reports have 
shown map: expression in oligodendrocytes (LoPresti, 2002; Muller et al., 1997), but cells 
with the morphology of oligodendrocytes, and expressing the oligodendrocyte marker 
04 (Sommer and Schachner, 1981) were rarely seen following monolayer 
differentiation, and these cells were not eGFP positive. Oligodendrocytes would also 
not be expected to arise under these culture conditions without further manipulation of 
the differentiation protocol through the addition of factors and increased differentiation 
time (Billon et al., 2002). Furthermore Wernig et a/ saw no eGFP in oligodendrocytes 
(Wernig et al., 2002). 
Figure 3.4 	Neuronal specificity of eGFP 
Immunocytochemistry with neuronal specific antibodies, all cells expressing neuronal markers 
are eGFP positive. All eGFP positive cells are also positive for Tuji, but not all eGFP positive 
cells are Map2 positive, suggesting that neurons express mpt before map2. 
Figure 3.5 	No non-neuronal expression of eGFP 
Imrnunocytochemistry with astrocyte antibody GFAP, all cells positive for GFAP are eGFP 
negative. 
3.6 	Timing of neuronal commitment following monolayer differentiation 
Many ES cell differentiation protocols allow neurons to be generated (Abe et al., 
2003; Barn et al., 1995; Kawasaki et al., 2000; Tropepe et al., 2001). However, it is 
unclear when neurons are generated during the differentiation, and over what time 
frame they continue to be born. Elucidating temporal regulation of neuronal 
differentiation from ES cells will help to clarify mechanisms involved in ES cell 
neurogenesis, and determine how closely this correlates with neuronal differentiation 
during normal mammalian development. Tucker ci al detected mapt driven eGFP 
fluorescence from 9 days post coitum (dpc) (Tucker et al., 2001). As ES cells represent 
cells at about embryonic day 3.5 dpc (Brook and Gardner, 1997), if the ES cell 
differentiation protocol is following similar timing to events during development, 
neurons should start to arise after about 6 days of ES cell neural differentiation. 
ES cells were differentiated using the monolayer protocol (2.3.3.1)(Ying et al., 
2003b), and cells were collected every day from day 4 to day 13, and analysed by flow 
cytometry (fig. 3.6). Each experiment was performed in triplicate, and on three 
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exclude 99% of cells from time-matched differentiations from ES cells not expressing 
eGFP (2.8.1). 
Figure 3.6 	Example of TK23 flow cytometry 
Typical differentiation to days 4, 7 and 12 of TK23 differentiation. The left graphs are the dot 
plots of size on the x-axis versus cell granularity. The circle on the left graph contains all viable 
cells. This is then plotted on the right graph and on the right graph gated cells are plotted as 
fluorescence on the x-axis versus number of number of cells with that level of fluorescence on 
the y-axis. Ri is set such that 99% of time matched differentiation of non-modified ES cells. 
The proportion of TK23 cells within Ri determines the proportion of cells that are positive. 
The proportion of viable cells within Ri is indicated on each graph. The TK23 plot produces a 
shoulder rather than a second peak suggesting a range of different levels of eGFP accumulation. 
eGFP positive cells start to appear at day 6 of monolayer differentiation, when 
approximately 4% of the total population of cells are eGFP positive (fig 3.7). The 
proportion of positive cells continues to rise to 17% by day 12 of differentiation (fig 
3.7). The total proportion of neurons then drops slightly on day 13 to about 15.5% (fig 
3.7). This may be due to the emergence of astrocytes in the culture. Thus, the timing of 
neuronal differentiation following monolayer differentiation mirrors the timing of 
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Figure 3.7 	Timing of emergence of neurons following monolayer differentiation 
The emergence of neurons is analysed by the presence of eGFP in differentiating cells from 
TK23 ES cells. Neurons start to appear between days 5 and 6. The proportion of eGFP 
positive neurons continues to rise to a maximum of 17% at day 12. The experiment was 
performed on 3 independent occasions, each with 3 experimental replicates. Error bars 
represent standard deviation of results at each time point. 
Direct observations by fluorescent microscopy suggest that the proportion of 
neurons of the total population is higher than the results from the flow cytometer 
suggest. ES cells differentiated using the monolayer protocol become quite dense, 
especially at later stages of differentiation, due to extensive proliferation (Ying et al., 
2003b). Neurons in particular can form very dense patches with many interconnecting 
neurites, often forming bundles of fibres. When cells are trypsinised, neurites are 
detached from the neurons, and although neurons can survive when all neurites are 
removed, many neurons are likely to be killed. Hence, the number of neurons observed 
by flow cytometry could be an under representation of the true number. 
To check whether the flow cytometry analysis gives an accurate representation 
of the number of neurons in the culture, ES cells were differentiated for 12 days using 
monolayer differentiation, fixed, and analysed for the neuronal marker Tuji (Geisert 
and Frankfurter, 1989), and a nuclear stain (Dapi). The number of Tuji and eGFP 
positive cells were then quantified by cell counting and the proportion of eGFP positive 












1 1 68 0 0 27 40 
1 2 106 0 0 40 38 
2 1 85 0 0 33 39 
2 2 122 0 0 43 35 
3 1 40 0 0 23 58 
3 2 110 0 0 59 54 
Total 531 0 0 225 Average 44 
Table 3.1 	Proportion of neurons after 12 days ascertained by cell counting 
Table showing the proportion of neurons of the total population ascertained by cell counting 
following immunocytochemistry. Each cell count represents a microscope field with a xlO lens 
within a well. Cells were counted as described in 2.6.4.1. 
When the proportion of neurons in the population is analysed by 
immunocytochemistry, the mean percentage of neurons in the total population is 44% 
(table 3.1). 
3.7 	Discussion 
Following confirmation that eGFP is expressed exclusively in all neurons 
differentiated from TK23 ES cells, it is possible to use eGFP to quantify, and analyse 
neuronal differentiation of ES cells, confirming the previous in th'o (Tucker et al., 2001) 
and in vitro results (Wernig et al., 2002). It is important to confirm the fidelity of the 
expression of eGFP because subsequent experiments assume that a cell expressing 
eGFP is a neuron. Although this is defining a population of cells by the expression of a 
single gene, and a more rigorous definition would normally be necessary to describe a 
specific cell type. The analysis of ES cell neurogenesis here focuses upon the 
conversion of neural stem / progenitor cells to neurons, and not the conversion to 
specific types of neurons, which does need more rigorous examination (Kim et al., 2002; 
Wichterle et al., 2002). The development of a functionally mature neuron is likely to 
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involve many subsequent steps after the conversion from a neural stem / progenitor cell 
to a neuron (Song et al., 2002) and this conversion is beyond the scope of this thesis. 
The analysis of neuronal differentiation of ES cells was performed in the 
monolayer differentiation protocol, which has a number of distinct advantages over 
previously reported differentiation techniques; principally the differentiation is occurring 
in defined conditions (Ying and Smith, 2003). Differentiation of ES cells to neurons in 
defined conditions has previously been reported (Tropepe et al., 2001), although this 
occurred in aggregated cultures, and at low efficiency. Embryoid bodies formed during 
cellular aggregation contain extrembryonic endoderm, ectodermal, mesodermal and 
endodermal cells (Keller, 1995). Therefore, it is difficult to analyse whether any 
exogenous factor is having a direct effect on the differentiation, because it cannot be 
excluded that it is influencing a cell from a different lineage to generate signals that then 
influence neural and neuronal differentiation. Although this could also be the case 
following monolayer differentiation, the probability is reduced due to the efficient 
conversion to a neural fate and cells are more dispersed in the culture, so each cell will 
receive lower levels of cell-to-cell contact and autocrine / paracrine signalling. 
The acquisition of neuronal fate, as defined by the expression of mapt-eGFP 
appears to occur progressively over the course of the differentiation. The conversion 
from neural stem / progenitor cells to neurons does not occur simultaneously in a well; 
rather, different colonies of cells differentiate progressively within their local 
environment, apparently independently of other colonies. A similar mechanism occurs 
during the conversion of ES cells to neural progenitors (Ying et al., 2003b). Hence, 
multiple colonies are differentiating at the same time, but they are not necessarily at the 
same stage of differentiation. The increase in the number of neurons is a cumulative 
effect of multiple colonies differentiating simultaneously, but at different rates, with 
neurons independently being born at the same time across a well. These observations 
suggest that it is cell-to-cell interactions, and the local environment of a progenitor cell 
that directly influence the differentiation. The effect of the signalling molecules and 
cell-to-cell contact is discussed in chapter 4. 
When TK23 ES cells are differentiated to neurons, and the number of neurons 
analysed, the proportion of the population composed of neurons when analysed by 
immunocytochemistry is greater than when the neuronal number is analysed by flow 
cytometry. A number of factors could influence this apparent difference in the 
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detection of neuronal differentiation. Cells are killed during the initial trypsinisauon of 
the cells and subsequently when they are being analysed, if this occurs principally in 
neurons, it will reduce the proportion of neurons measured in the population. This 
could contribute to some of the effect but, as other cells types will also be killed during 
the dissociation of the cells, it may not be the most significant factor. It is probable that 
the decrease in detection of neurons by flow cytometry is due to the low level of eGFP 
in some of the neurons, and there has not been time for sufficient accumulation of 
eGFP by the neurons for them to be recorded as positive by the flow cytoineter. When 
the differentiated cells are analysed, the eGFP positive cells form a shoulder rather than 
a second peak, i.e. the positive cells are distributed throughout the positive region. This 
may be due to cells either expressing or having accumulated a range of different levels 
of eGFP. Low levels of eGFP may not be discriminated from autofluorescence by the 
flow cytometer and the gating to determine the positive population must be very 
conservative to ensure that the positive population does not contain any negative cells, 
but this will invariably lead to positive cells in the negative population. This lowers the 
proportion positive cells in the population, regardless of the expression level of eGFP. 
When the same antibody is used to identify neurons by flow cytometry and fluorescent 
microscopy, although not statistically significant, there is a reduced level of detection of 
neurons measured by flow cytometry than cell counting (Sergent-Tanguy et al., 2003). 
Flow cytometry is much less time consuming when analysing neuronal number, and 
provides a high throughput method for analysing the commitment of neural progenitors 
to neurons. If the differentiation to neurons is compared internally within an 
experiment, and the differentiation to neurons is measured by comparison to a control 
then there is no reason not to use flow cytometry, but when measuring early neuronal 
differentiation of TK23 cells the number of neurons recorded by flow cytometry is an 
under-representation of the true number of neurons. Any subsequent measures of the 
absolute number of neurons in a differentiation must give newborn neurons enough 
time to accumulate eGFP to a level such that it can be unambiguously detected by a 
flow cytometer. 
3.8 	Summary 
• eGFP has been successfully inserted into the neuronal specific gene mapt 
• All TK23 derived neurons express eGFP 
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• Neuronal differentiation of TK23 can be quantified 
• Conversion of neural progenitors to neurons in unaltered monoIyer 
differentiation protocol is less efficient than conversion of ES cell to neural 
progenitors (When compared to Ying et al 2003b) 
4 	Investigating Neuronal Differentiation of ES Cells 
4.1 	Introduction 
Up to 80% of ES cells convert to neural progenitors (as defined by the 
expression of soxi) during monolayer differentiation (Ying et al., 2003b), but a smaller 
proportion of ES cells become neurons. This implies that the conversion of ES cells to 
neural progenitors following monolayer differentiation occurs efficiently, and the 
conversion of the neural progenitors to neurons is less efficient. To ascertain whether 
the proportion of neurons that are generated during monolayer differentiation can be 
altered a series of experiments were performed where the basic monolayer protocol was 
altered. 
Following ES cell differentiation as embryoid bodies, after 8 days of 
differentiation the embryoid bodies are dissociated to single cells and plated onto an 
adhesive substrate of poly-d-lysine and laminin (Li et al., 1998a). Laminin provides a 
substrate to support the attachment and neurite outgrowth of neurons (Bain et al., 1995; 
McKerracher et al., 1996), but replating also dramatically reduces the density of the cells. 
This affects the signals that cells receive and this may be partially responsible for the 
differentiation of neural progenitors to neurons. The effect of density on differentiation 
is also seen at the start of monolayer differentiation. The initial plating density of ES 
cells at the start of monolayer differentiation has a significant role in the efficiency of 
neural differentiation. If ES cells are plated too sparsely, the survival of cells is lower, if 
the initial plating is too dense, neural differentiation is less efficient (Ying et al., 2003b). 
The main candidate for mediating the suppression of differentiation to neurons is the 
Notch pathway (Beatus and Lendahl, 1998; Justice and Jan, 2002). The Notch signalling 
cascade is important at various stages of development, especially in the differentiation of 
progenitor cells into a differentiated phenotype through a mechanism known as lateral 
inhibition (Beatus and Lendahl, 1998; Justice and Jan, 2002). Notch signalling helps to 
maintain progenitor populations by inhibiting progenitors from differentiating when 
differentiation has already occurred. This is partially due to the inhibition of proneural 
genes, which are required for the differentiation of neural progenitors to neurons. The 
Notch pathway is activated by the Notch ligand Delta, which is upregulated in 
differentiating neurons, an upregulation of Delta in a differentiating cell leads to 
upregulation of Notch in a progenitor cell, thereby preventing differentiation of the 
progenitor. By decreasing the density of the culture, this decreases the level of Notch-
Delta signalling that the neural stem / progenitor cell receives, and increases the 
probability that a neural stem / progenitor cell will not be inhibited from generating 
neurons. The effect of cell density on the efficiency of differentiation was analysed later 
in the differentiation, to ascertain whether there was any effect. 
Another method that could increase the proportion of neurons is to change the 
conditions of the medium by the addition of exogenous factors. A number of factors 
have been shown to increase the proportion of neurons that are being generated from 
ES cells (Bain et al., 1995; Lee et al., 2000b; Li et al., 1998a; Okabe et al., 1996), and 
neural stem cells (Ahmed et al., 1995; Collazo et al., 1992; Doetsch et al., 2002; Kuhn et 
al., 1997). However, many of these experiments were performed in undefined 
conditions, in the presence of either serum, or cellular aggregates being required for 
differentiation. Monolayer differentiation using TK23 cells allows us to assay the effects 
in defined conditions. Some of the factors that have been previously shown to affect 
neuronal differentiation will be analysed here. By analysing  the effect of a series of 
factors that are already known to affect the differentiation from neural progenitors to 
neurons, greater understanding of how and why the monolayer differentiation proceeds 
as it does may be ascertained. The supporting evidence for the use of each factor is 
discussed below. 
Brain derived neurotrophic factor (BDNF) is a neurotrophin and signals 
through the receptor tyrosine kinase TrkB. This signalling is enhanced by the p75N1 
receptor working in co-operation with TrkB (Huang and Reichardt, 2003). Signalling 
through the Trk receptors can influence cell survival, proliferation, axon and dendrite 
outgrowth and patterning (Huang and Reichardt, 2003). BDNF is essential for normal 
brain development, but the direct targets following signalling are unknown (Cheng et al., 
2003). One of the modes of action of BDNF is the regulation of Nitric oxide (NO), 
NO can decrease proliferation and increase neuronal differentiation of neural 
progenitors (Cheng et al., 2003). There is also evidence that the increase in 
neurogenesis seen following voluntary exercise (van Praag et al., 1999) may be mediated 
by an increase in BDNF (Johnson et al., 2003). 
Bone morphogenic protein 2 (BMP2) is a member of the transforming growth 
factor-3 (TGF-(3) superfamily (Hogan, 1996). The action of BMP2 is mediated by 
all 
heteroterameric serine / threonine kinase receptors and the downstream transcription 
factors Srnadl, 5 or 8 (Derynck et al., 1998; Heldin et al., 1997; Massague, 2003). The 
mechanism of action of BM -P2 in the developing brain is to inhibit  the differentiation of 
neural precursors in the ventricular zone by activating Notch signalling (Irvin et al., 
2001), and induce idi, id3 and hes5 in neuroepithelial cells (Nakasbima et al., 2001), with 
the activation of hes5 dependent upon BMP and Notch signalling (Takizawa et al., 2003). 
Epidermal growth factor (EGF) along with fibroblast growth factor-2 (FGF2) 
are two of the most widely used extrinsic molecules in neural stem cell biology. 
Although the EGF pathway has been widely studied in Drosophila (Shilo, 2003), little is 
known about the vertebrate pathway, although it is likely to be similar due to its 
involvement in similar types of patterning. EGF dependent neural stem cells have been 
identified in the embryonic and adult brain (Ahmed et al., 1995; Reynolds et al., 1992; 
Reynolds and Weiss, 1996). The EGF responsive cell only arises after it has been 
specified by FGF and BMP signalling (Lillien and Raphael, 2000). In the developing 
embryo, the EGF responsive cells may be radial glia, which are specified and maintained 
by EGF signalling (Gregg and Weiss, 2003). In the adult brain, the transit amplifying 
type C astrocytes in the subvenincular zone are EGF responsive, and increase their 
proliferation and decrease neuronal differentiation following EGF treatment (Doetsch 
et al., 2002). This suggests that EGF may be specifying and maintaining a particular 
type of stem / progenitor cell. 
Fibroblast growth factor 2 (FGF2) or basic FGF (bFGF) signals through FGF 
receptors (FGFR) and initiate three major intracellular pathways, mitogen activated 
kinase (MAPK), Phosphatidylinositol-3-OH kinase (P13K) and Phospholipase C (PLCy) 
(Marshall, 1995). FGF2 is often used as a mitogen for neural stem / progenitor cell 
cultures (Taupin et al-, 2000; Vescovi et al., 1993), but although FGF2 is the most 
widely used of the FGF family as neural stem / progenitor cell mitogens, it may not be 
the most potent. FGF2 has little effect on neural induction of ES cells, but FGF4, 
which is expressed at high levels during ES cell differentiation (Ving et al., 
2003b) (Chapter 5), does induce neural cells. 
Neurotrophin 3 (NT-3), like BDNF and other neurotrophins signal though a 
receptor tyrosine kinase, but it acts though TrkC rather than TrkB, although NT3 can 
activate TrkA and TrkB in some cell types, but at a low affinity in the presence of 
p75 (Huang and Reichardt, 2003). TrkC and NT-3 increase the survival and 
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differentiation of cortical progenitor cells, through two independent pathways (Barnabe-
Heider and Miller, 2003), although in sympathetic neurons it is required for neuronal 
but not precursor survival (Francis et al., 1999). In mice that lack NT-3, two thirds of 
spinal sensory neurons are lost, because of increased neuronal apoptosis and 
interestingly precocious differentiation of neural progenitors to neurons, depleting the 
precursor pool (Farinas et al., 1996). These varying results demonstrate that the effects 
of NT-3 are context dependent. 
During embryoid body differentiation of ES cells in serum, retinoic acid (RA) is 
required to induce neural progenitors (Aubert et al., 2002; Bain et al., 1996). When EBs 
are subsequently dissociated to single cells, RA is removed (Li et al., 1998a). In the 
developing embryo, RA is involved in hindbrain patterning, where neural progenitors 
respond in a stage dependent manner to different concentration of RA (Begemann and 
Meyer, 2001). Retinoic acid can also inhibit FGF signalling and both induce neuronal 
differentiation and promote ventral gene expression (Diez del Corral et al., 2003; 
Novitch et al., 2003). In adult rat hippocampal progenitors, RA exposure increases 
NeuroD expression, causing cell cycle exit and increase the expression of Trk receptors, 
and application of neurotrophins then increases neuronal maturation (Takahashi et al., 
1999). 
Sonic hedgehog (SHH) is a key signalling molecule in the development of the 
ventral neural tube. SHH is required for the growth of various region of the CNS 
including ventral and dorsal region of the diencephalon and midbrain (Ishibashi and 
McMahon, 2002). SHH is very important as a graded patterning signal along the entire 
ventral neural tube (Copp et al., 2003), but it has also recently been identified to elicit a 
strong, dose dependent proliferation of neural progenitors in vitro (Lai et al., 2003). 
Shh can also induce the differentiation to certain spinal cord neurons (Dutton et al., 
1999a; Dutton et al., 1999b). 
4.2 	The effect of cell density on neuronal differentiation efficiency 
During monolayer differentiation, there is an initial exponential increase in cell 
number (Ying et aL, 2003b); cultures can be dense when neurons start to emerge, 
although local density of the cells can vary across a well. To analyse the effect of 
replating, cells were differentiated using the monolayer protocol up to day 7, then the 
total population of cells were replated at densities from 1.8x10 4 to 8.8x104 cells per cm2 , 
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on a poly-d-lysine and laminin coated substrate (2.3.3.3). The proportion of Mapt-
eGFP positive neurons in the total population was analysed by flow cytometry five days 
later, at day twelve. 
When the total population of cells is replated, there is a significant difference in 
the proportion of neurons at the lowest density (analysed by T-Test (2.9.1)), it is almost 
three-fold greater than at the highest density (fig 4.1). When plating more sparsely than 
5.3x1 04  cells per cm2 is the efficiency greater than when cells are not replated. When 
plating at the highest density there is a significant decrease in the proportion of neurons 
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Figure 4.1 	Effect of replating differentiating cells at day 7 at different densities 
ES cells are differentiated using the monolayer differentiation protocol to day 7. Cells are then 
taken off the substrate using trypsin, and replated at defined densities densities on poly-d-lysine 
and laniinin coated substrate in N21327 media. At day 12 the total population is again removed 
from the substrate by trypsinisation and analysed by flow cytometer to determine the proportion 
of neurons. The effect of replating was analysed by paired student t test and the lowest plating 
density of 1.8 x 10 cells per cm2 produced significantly more neurons (p=0.011), and the 
highest plating density of 8.8 x 10 cells per cm 2 produced significantly fewer neurons (p=0.034). 
The experiments were performed on three independent occasions with three treatment 
replicates. 
From this result I infer  that replating the cells at the lowest density either 
provided an instructive cue for neural progenitors to differentiate to neurons, or 
removed inhibition that was preventing neural progenitors from differentiating into 
neurons. There may be other consequences of replating such as differential survival of 
certain cell populations or that laminin is providing an instructive signal to differentiate 
to neurons. 
More information about what is happening during the differentiation can be 
ascertained from the flow cytometer results. The flow cytometer can measure both the 
size and granularity of a cell, as well as the level of fluorescence (see chapter 1.6). When 
this data is plotted on a graph, the location of the cells within the plot gives a further 
indication of the events occurring when the density of the cells is changed. The location 
of the eGFP positive cells at each density varies (fig 4.2). At the lowest cell density the 
eGFP positive cells cluster near the bottom left corner of the plot, i.e. the cells are 
smaller and have a lower granularity, with increasing density the cells are less clustered, 
suggesting less uniformity within the differentiation (fig 4.2). This implies that neurons 
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Figure 4.2 	Dot plots of replated cells on day 12 at different densities 
The left hand graphs are dot plots of cell size on x-axis versus cell granularity on y-axis. Cells 
lying within circled region are all live cells, all cells outside this region are dead, dying or 
clumped and cannot be analysed. The region analysed is the outlined area on the left graphs. 
Cells within this region are plotted on the right hand graphs with cell fluorescence on x-axis and 
cell count on y-axis. Ri is set to exclude 99% of negative cells from time matched controls. 
Hence Ri is set at the same level for all the replated samples. All cells lying within region Ri on 
right graphs are eGFP positive. Cells which lie within the RI region have been made to appear 
as red dots on the left graph. Note some cells outside the region of live cells are red, this is due 
to the software only allowing single, and not combinations or different gates to be coloured 
differently. 
Lowering the cell density could either alter the levels of secreted factors the cells 
are exposed to, or alter cell-to-cell signalling. Some secreted factors are likely to bind to 
the extra cellular matrix, and it is difficult to establish the exact local concentrations of 
the factors, but with a lower local density, there is likely to be a lower level of growth 
factors. Reducing the cell density also reduces the extent of possible cell-to-cell 
interaction. Therefore, it is difficult to ascertain the exact mechanism that is promoting 
neuronal differentiation at low densities. 
4.3 	Effect of exogenous factors 
To understand the effects of any additional factors, the factors must act directly 
on neural stem / progenitor cells, and not any other cell types. To more effectively 
identify any effect that an exogenous factor has on neural progenitor cells, the 46C ES 
cell line rather than TK23 was used. 46C was chosen because neural progenitors 
derived from 46C cells that express soxi can be purified from other cell types by the 
addition of puromycin (Ying et al., 2003b), this enable factors to be directly added to a 
population of predominantly neural progenitor cells, ensuring that the factors are 
directly effecting the neural progenitor cells. 
46C ES cells were differentiated by the monolayer protocol for 4 days, and then 
puromycin was added to the medium for two days. At day six, following addition of 
puromycin, 90-95% of the cells were eGFP positive, as ascertained by flow cytotnetry 
(Appendix), confirming that selection works and the factors would principally act on 
cells expressing soxi, and hence neural progenitors. Two days later the puromycin was 
removed by washing the cells with PBS, each factor was then added in N2B27, all 
factors were added at concentrations that have previously shown to have an effect, and 
the factors were obtained from the same company that the authors in the publications 
used. Two days after this, the cells were fixed with PFA, and stained with a nuclear 
stain (DapI), to enable counting of the cells and the neuronal specific antibody Tuji 
(Geisert and Frankfurter, 1989), to count the number of neurons. The experiment was 
performed on three independent occasions, in triplicate. Three images of each well 
were taken at random, and the image with the median cell number as ascertained by 
observing the extent of DapI staining was counted. The effect of a factor was 
determined by counting the number of neurons (determined by the expression of Tuji) 
(2.6.4.1), the number of non-neuronal cells (negative for TujI) (2.6.4.1), and the extent 
of cell death. The level of cell death was determined by analysing the DapI staining 
pattern, cells that did not have a DapI staining pattern indicative of live cells were 
counted (2.6.4.2). This determined the number of dead and dying cells, to ascertain if a 
factor had an effect on cells survival. The effect of the factors was determined by 
comparing the factor to a differentiation from the same starting population of cells, 
under the same conditions, but no exogenous factor was added. Statistical significance 
of the results was analysed by paired student T-Test (2.9.1). 
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Figure 4.3 	The effect of different factors on neuronal differentiation 
46C ES cells were differentiated by the monolayer protocol for 4 days, and then puromycin was 
added to the medium for two days. The factors were then added for 2 days in N2B27. The 
effect of each factor on monolayer differentiation was analysed by counting the number of 
neurons (red bar), determined by counting the number of cells positive for the neuronal specific 
marker Tuji, the number of non-neuronal cells (blue bar) determined by counting the number 
of Tuji negative cells, the extent of cell death (green bar) was determined by counting the 
number of cells with DapI staining pattern indicating that the cell was dead. The effect of each 
factor was compared to the result obtained when no factor was added. The experiment was 
performed with three biological replicates; each biological replicate had three treatment 
replicates. BDNF (lOng/mi, R&D Systems) had no statistically significant effect on the 
differentiation, neither did BMP2 (SOng/mi, R&D Systems), FGF2 (lOng/mi, R&D Systems) or 
NT3 (lOng/mi, R&D Systems). EGF (20ng/ml, R&D Systems) very highly significantly 
(p=1.03 x 10-5) decreased the number of non-neuronal cells, retinoic acid (RA) (10-6M, Sigma) 
significantly decreased the number of neurons (p0.010)  and produced a highly significant 
decrease in cell death (p0.004), Shh (300nM, R&D Systems) significantly increased the number 
of neurons (p0.021). 
Following administration of BDNF to the differentiating cells, there is an 
increase in the number of neurons, and a slight increase in the non-neuronal cells, but 
there is considerable variation between samples (fig 4.3). There is also a slight decrease 
in the amount of cells death. BDNF may act at different stages of the differentiation, to 
promote neural progenitor cell proliferation and differentiation, but also promoting the 
survival of any of the cells at any of the stages. 
BMP2 decreases the number of neurons but has little effect on the number of 
non-neuronal cells, and a slight decrease in the amount of cell death (fig 4.3), although 
these are not statistically significant. This mode of action appears to be that BMP2 may 
partially inhibit neuronal differentiation. Although it is unclear from the results, as to 
whether there is also a differentiation to cells other than neurons. However, if there are 
any residual ES cells in the wells, then they will be making LIF, and LIF in combination 
with BMP promotes astrocyte differentiation from neural progenitors (Nakashiina et al., 
2001). 
Following the addition of EGF there is a decrease in the number of neurons, 
and a very highly significant decrease in the number of non-neuronal cells, and a 
decrease in the amount of cell death (fig 4.3). EGF could be acting at a number of 
points, which cannot be described more accurately from this experiment; it could be 
increasing the self-renewal of an early progenitor cell, or preventing the differentiation 
to a highly proliferative neural progenitor or preventing the proliferation of this cell 
type. In each case this would reduce the number of non-neuronal cells. 
FGF2 appears to have no effect on the number of neurons or the non-neuronal 
cells and the extent of cell death (fig 4.3), which suggests that the cells FGF2 does not 
induce the cells to proliferate or differentiate at this stage of the differentiation. 
NT3 increased the number of neurons in the total population and decreased the 
number of non-neuronal cells and the extent of cell death (fig 4.3), although there is 
considerable variation in all cases. In this instance NT-3 may be promoting the 
differentiation of a precursor cell, which reduces the proliferative population, although it 
may also be acting to increase neuronal survival. 
Following the addition of retinoic acid there is a significant decrease in the 
number of neurons, the total number of non-neuronal cells also decreases and there is a 
highly significant decrease in cell death (fig 4.3). Retinoic acid may prevent a precursor 
cell from differentiating to neurons, rather than inhibiting neuronal survival as cell death 
is decreased. 
The effect of SHH appears to the most dramatic of all of the factors. There is a 
significant increase in the number of neurons, and there is a decrease in the number of 
non-neuronal cells and the level of cell death (fig 4.3). SHH seems to increase the 
efficiency of conversion of neural or neuronal progenitors to neurons, with a small 
impact on the total number of cells, there is only a small decrease in cell death which 
would not be expected to account for the increase in the number of neurons, so 
although SHH may increase cell survival, the significant increase in the proportion of 
neurons is as a result of the increase in differentiation to, rather than survival of 
neurons. 
4.4 	Cell sorting 
To date no individual cell type or population have been directly derived from ES 
cells without genetic selection, immunopanning or FAGS (Ying and Smith, 2003). 
Using the differentiation protocols established in this lab, a predominantly neural 
culture can be achieved (Li et al., 1998a; Ying et al., 2003b), but this does not 
subsequently lead to a pure neuronal culture, and glial differentiation also occurs as this 
is not suppressed. As eGFP is expressed in all neurons, fluorescent activated cell sorting 
(FAGS) of differentiated TK23 cells has the potential to isolate neurons from all other 
cell types. 
ES cells were differentiated using the monolayer protocol to a number of 
different time points; the total population was trypsinised and run through the FACS 
analyser. By analysing cell size, granularity, auto-fluorescence, and the level of eGFP, 
neurons are sorted (fig 4.4). Neurons were successfully recovered following sorting, 
although the survival following sorting was very poor. To maximise the viability of the 
neurons following sorting, cells were sorted at a number of different time points. 
Sorting 7 days after the start of monolayer differentiation gave the greatest viability of 
neurons, and all subsequent experiments were at this time point. Despite very stringent 
sorting criteria, it was difficult to obtain a pure population of neurons; this was 
determined by observation of non-neuronal cells in cultures following plating of the 
sorted cells. To overcome this problem, the same cells were sorted twice to remove the 
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Figure 4.4 	Sorting cells twice to increase purity 
A, dot plot of all cells cell size on x-axis versus cell granularity on y-axis, R4 is the region 
containing all viable cells. B, dot plot of fluorescence measured through channels 1 and 2, 
channel I detects eGFP, channel 2 detects auto fluoresce of dead cells, all viable eGFP positive 
cells are selected by region R5. C, graph of fluorescence in channel I on x-axis, versus cell 
count on the y-axis, region R6 contains all eGFP positive cells. Only cells that lie in region 4, 5 
and 6are positive and selected. This sample is then run through the FAGS machine a second 
time. D, dot plot of fluorescence measured through channels 4 and 5, all viable eGFP positive 
cells are selected by region R5. E, graph of fluorescence in channel 1 on x-axis, versus cell 
count on the y-axis, region R6 contains all eGFP positive cells. Note contaminating cells 
outside regions R5 and R6 still present after first sort. 
To confirm the purity of the samples, sorted wells were fixed four hours after 
sorting, and stained with the neuronal specific antibody Tuj I (Geisert and Frankfurter, 
1989) and the nuclear stain DapI. Following sorting twice, all viable cells, as determined 
by DapI staining pattern, express eGFP and are positive for Tuji (table 4.1 and fig 4.5). 
This confirms that a pure population of neurons can be derived from ES cells following 
fluorescent activated cell sorting. These neurons extended neurites and appeared to 
form growth cones (fig 4.5). 
FAGS sorting of differentiated TK23 ES cells can produce a pure population of 
neurons, however to achieve a pure, viable population of neurons, stringent sorting 
criteria are necessary. A pure population of neurons has a number of potential 
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applications, including as a source of cells for cell replacement therapy, neurite 
outgrowth assays, drug screening and for disease modelling. 
Well Number Dapi Positive Cells Tuji Positive Cells eGFP Positive Cells 
1 2 2 2 
2 1 1 1 
3 2 2 2 
4 1 1 1 
5 1 1 1 
6 2 2 2 
7 3 3 3 
8 2 2 2 
9 2 2 2 
Total 16 16 16 
Table 4.1 	Neuronal sorting purity 
Following FACS twice, all wells contained only neurons, as ascertained by identification by 
eGFP expression and immunoreactivity for Tuj 1. 
a 
Figure 4.5 	TK23 cells following sorting 
A, cells fixed 4 hours post sorting, b, cells fixed 4 days post sorting. Green eGFP, red Tuji, 
blue DapL 
4.5 	Discussion 
When ES cells are differentiated in monolayer differentiation, the cells become 
very dense. To further analyse monolayer differentiation, the cell density was altered 
part way through the differentiation. The initial plating density can seriously affect the 
efficiency of conversion of ES cells to neural stem cells in monolayer differentiation; 
too dense and ES cells differentiate less efficiently, too sparse and ES cells do not 
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survive as well (Ying et al., 2003b). Decreasing the density at later stages of 
differentiation also increases the efficiency of the conversion of neural stem cells to 
neurons, although this too appears to have an effect on the rate of proliferation and 
survival of the neural stem cells. By taking these results together, it suggests that the 
density of the cells affects the differentiation of ES cells to neurons at all stages. The 
cell density will have two main effects; it will alter the cell-to-cell interactions and the 
level of autocrine signalling locally. During differentiation changing the medium at early 
stages of differentiation is important for the differentiation, and reducing the frequency 
to less than every two days has a negative impact on the differentiation, but when the 
medium is changed less frequently after day 6 of the differentiation, neuronal 
differentiation or survival is better (Q. L. Ying unpublished). This implies that there is 
autocrine /paracrine signalling that that can increase or decrease the proportion of 
neurons. Late autocrine/paracrine signalling appears to be having a positive effect on 
the differentiation, which may be mediated by the production of neurotrophic factors 
by the differentiating ES cells (discussed in Chapter 6). By altering the cell density and 
lowering the level of locally produced autocrine signalling this should have a negative 
impact on the differentiation and survival of the neurons, suggesting that the main 
positive effect of reducing the cell density is to reduce the cell-to-cell signalling. 
Laminin is unlikely to play an instructive role in the differentiation to neurons, it is 
principally used during neuronal differentiation to aid attachment promote neurite 
outgrowth (Luckenbill-Edds, 1997), rather than to increase neurogenesis. However, 
laminin may act as an indirectly as an instructive factor through the recruitment of 
integrins and other growth factors to the cells that can influence differentiation. 
Previous attempts to study the effect of a series of exogenous factors, although 
informative, have occurred in undefined conditions, so the exact effect of the mitogen is 
more difficult to quantify. Following the addition of a series of exogenous mitogens, 
the differentiation is affected in various ways depending upon the mitogen. This shows 
that there is a general phenomenon that the differentiation can be manipulated by the 
addition of exogenous factors, and that the differentiating ES cells respond differently 
depending upon the mitogen being added. The absolute number of cells, the 
proportion of neurons in the population and the absolute number of neurons can be 
quantified following the addition of factors. 
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It is important to try to understand the cell type(s) upon which each factor is 
acting. A general scheme of differentiation will be assumed such that a neural stem / 
progenitor cell differentiates through a neuronally restricted, transit-amplifying 
precursor before differentiating to a neuron. This model is based upon the time-lapse 
studies of the Temple lab (Qian et al., 1998; Qian et al., 2000). Assuming this model fig 
4.6 illustrates all of the points at which a factor could act. Further, as the cells have 
been grown under selective conditions, and are predominantly expressing soxi, and are 
neural progenitors, although a number of the factors could act on neural induction and 
specification, which is not their function here. 















Figure 4.6 	Neuronal differentiation scheme 
The differentiation scheme used in the analysis of the results. A factor can act at a number of 
different points in the differentiation, or in a combination of different ways. 1. Promote NSC 
self-renewal, or survival 2. inhibit NSC self-renewal, or survival 3. promote NSC neuronal 
differentiation, 4. inhibit NSC neuronal differentiation, 5. promote transit amplifying cell self-
renewal, or survival 6. inhibit transit amplifying cell self-renewal, or survival 7. promote 
neuronal terminal differentiation, 8. inhibit neuronal terminal differentiation, 9. promote 
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neuronal survival, 10. inhibit neuronal survival. 11. promote NSC glial differentiation, 12. 
inhibit NSC glial differentiation, 13. promote glial progenitor cell self-renewal, or survival 14. 
inhibit glial progenitor cell self-renewal, or survival 15. promote glial terminal differentiation, 16. 
inhibit glial terminal differentiation, 17. promote glial survival, 18. inhibit glial survival. 
The neurotrophins BDNF and NT-3 appear to both increase the number of 
neurons by the same amount, although no increase in neuronal number is statistically 
significant. It would be expected that the factors have a similar effect because they both 
signal through different members of the same family of tyrosine  kinase receptors, yet as 
they do signal through the different receptors, one would expect the result to be 
different. Increasing number of neurons is likely to be partially mediated by the survival 
of neurons in the differentiation. The slight decreases in cell death may be partially 
mediated by the low levels of autocrine signalling in the differentiation (chapter 6). The 
addition of neurotrophins should increase the survival of neurons following 
differentiation. NT-3 can cause precocious neuronal differentiation of progenitor cells, 
if this is happening here it would lead to an increase in the number of neurons and a 
decrease in the total cell number because previously proliferating cells have been 
instructed to differentiate. BDNF can also increase the differentiation of the neural 
precursors, which may be happening here, but not at the expense of proliferation. 
However, due to variation between the experiments it is difficult to ascertain the exact 
effect of either neurotrophin, other than they increase the number of neurons produced 
in the differentiation. 
FGF2 and EGF are the most widely used neural stem cell mitogens, and are 
often used to amplify a neural stem / progenitor cell population during either 
maintenance or differentiation of primary neural stem / progenitor cells (Gritti et al., 
1996; Reynolds et al., 1992; Reynolds and Weiss, 1996) or during ES cell differentiation 
(Okabe et al., 1996). The effect of the two factors here suggests that there is only an 
EGF and not an FGF2 responsive population of cells in the differentiation. Although 
further work is required to identify the exact population of EGF responsive cells that 
produce a drop in the total number of non-neuronal cells. EGF reduces the total 
number of neurons and non-neuronal cells, and decreases cell death. However, it may 
be due to a proliferative cell that gives rise to neurons is not being generated. This may 
be through either the inhibition of differentiation or the maintenance of a progenitor. 
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However as the efficiency of differentiation is unaffected, it implies that EGF has no 
effect on differentiation of neuronal progenitors to neurons, but probably prevents 
differentiation from neural precursors to an intermediate precursor which generates 
neurons. The lack of response of the cells to FGF2 may be due to one of two reasons, 
there are no receptors on for FGF2, or there is FGF2 or another FGF, which is already 
present in the medium. If the FGF receptors that FGF2 act through are saturated, any 
additional FGF2 will not have an effect because it is trying to stimulate already saturated 
receptors. 
BMP2 reduces the total number of neurons, with only a slight decrease in the 
number of non-neuronal cells and there is a slight decrease in cell death, although none 
of the effects of BMP2 are statistically significant. The effect of BMP2 may then be 
similar to that of EGF; maintenance of the progenitor pool. BMP2 signalling has been 
identified to be important for neuronal differentiation (Li et al., 1998b), but BMP 
signalling can also activate the Notch pathway (Irvin et al., 2001), and increase is 
involved in increasing the expression of Idi, 1d3 and HesS (Nakashima et al., 2001), all 
of which prevent neuronal differentiation. In this instance BMP2 appears to prevent 
the differentiation and proliferation of a neuronal precursor, without affecting its 
differentiation. It would be intriguing to discover whether EGF and BMP2 are 
maintaining the same neural precursor at the same stage of commitment. 
Retinoic acid has the greatest deleterious effect on neuronal differentiation as it 
significantly decreases the number of neurons, with only a slight decrease in the number 
of non-neuronal cells, and there is a highly significant decrease in cell death. RA may be 
respecifying the identity of the differentiating cells, the cells may become partially 
quiescent, and neither proliferate or differentiate because they are waiting for 
proliferation and differentiation signals that are expressed at low levels at this point 
during the differentiation. Although more work would be necessary to identify the cells 
that are altering their behaviour in response to RA. The decrease in cell death may be 
due to a lower number of neurons, as many neurons die when they are produced during 
monolayer differentiation (Ying and Smith, 2003), and if there are not as many neurons 
the population undergoing apoptosis will be reduced, although RA could also be acting 
as a survival factor for specific cells in the culture. 
Sonic hedgehog appears to be the factor that has the greatest impact on the 
efficiency of conversion of neural progenitors to neurons. SHH could be acting in a 
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number of ways, either through the proliferation of a precursor that differentiates to 
neurons, or through the direct conversion of neural progenitors to neurons. It is 
difficult to say the exact effect from this experiment, but there is little decrease in non-
neuronal cells, suggesting that any differentiation must be accompanied with 
proliferation to repopulate the progenitor pool. SHH is a key regulator of a number of 
different stages of neural and neuronal commitment, so it is unlikely that the effect of 
Shh is one effect on a single cell type. 
The factors are likely to be acting on some similar and some different cell types 
and more work is required to identify the exact function of each of the different factors, 
and identify the exact cell type(s) that they are affecting. The .coxl expressing cells are 
likely to be analogous to neurectoderm cells in the developing embryo (Wood and 
Episkopou, 1999). This means that the cells are quite plastic and able to respond to a 
number of different factors. The differentiation potential of the neurectoderm is 
unclear, as in M'VO it is difficult to manipulate. It is unknown whether cells across the 
entire neurectoderm have the same potential for proliferation and differentiation and 
whether they respond in the same way to patterning signals. At the same time, it is still 
unclear how the ES cell derived soxi expressing cells relate to cells in the embryo, and 
whether the differentiation generates cell types that are analogous to cells along the 
entire neural tube or rather cells restricted to a specific domain. Further work on the 
similarities between the neural tube and ES cell derived neural progenitors should help 
to elucidate the similarities and differences between these two populations. 
Overall, the effect of these factors is quite variable, although each factor can be 
reconciled with the model proposed in fig 4.6. Significantly more work is necessary to 
identify the effect that each factor is having. This would include better identification of 
the cells responding to the different factors and how the cells are responding. A 
broader range of antibodies are necessary to identify the types of neurons produced, the 
regions which the progenitors belong to, and any differentiation to other cell types such 
as astrocytes, and non-neural lineages. Also, analysis of the rate of proliferation of the 
cells by BrdU incorporation would better enable analysis of how the proliferation of the 
cells changes. Further a more accurate measure of cell death, such as TUNEL would 
help to identify which cells were undergoing apoptosis. If these techniques could be 
combined with time-lapse video microscopy, the cell types that are being affected by the 
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different factors could be identified. Without this analysis the effect of any factor can 
only be a supposition. 
A pure population of neurons can be isolated from the total population of 
differentiated cells using FAGS, the neurons can survive and extent neurites. A pure 
population of neurons has a number of potential applications including; cell 
replacement therapy, drug screening, disease modelling and analysis of neuronal 
differentiation. CNS cell replacement therapy is relatively expensive to perform, and 
needs specialised equipment and personnel to be successful. Hence, this is not a long-
term tractable solution for treating the millions of people around the world with GNS 
disorders. Therefore, although this may an interesting avenue to pursue in the short 
term, as a long-term therapy for neuron replacement, surgery will not provide an 
affordable solution. A pure population of neurons will be useful for drug screening. 
Drug screening is more effective when performed on a pure population of neurons of a 
single type. To obtain large numbers of neurons is difficult from primary cultures due 
to large number of organisms that are required. Ideally, hundreds of compounds are 
screened simultaneously each in a different well of neurons originating from the same 
starting population. ES cell derived neurons are potentially an infinite resource, due to 
the unlimited proliferative capacity of ES cells. Furthermore, lineage selection could be 
combined with other lineage direction strategies to give a pure population of a specific 
sub-type of neurons. However, the disadvantage of sorting a large number of neurons 
is that it is very labour intensive. A sort can take up to two hours depending upon the 
number of cells being sorted, and this requires to be overseen by a technician at all 
times. A further application in the drug screening field is the modelling of diseases 
using neurons derived by lineage selection. If ES cells were genetically modified to 
contain a disease-inducing gene, a pure population of neurons could be generated 
containing the modification. These neurons could then be used to analyse the effects of 
deleterious mutations specifically in neurons (Gorba and Allsopp, 2003). 
4.6 Summary 
Lowering the density of the culture at day 7 increases the proportion of neurons 
that are generated 
Exogenous factors can affect monolayer differentiation 
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• Factors can increase  and decrease the proportion of neurons, the total cell 
number and the total number of neurons 
• SHH appears to have the greatest effect in directly promoting neuronal 
differentiation without affecting cell number 
• A pure population of neurons can be obtained from differentiated TK23 ES 
cells 
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5 	Microarray Analysis of Neuronal Differentiation 
5.1 	Introduction 
Although the addition of factors and alteration of the density of the 
differentiating cells can provide us with some clues as to the events occurring during 
differentiation, many questions remain unanswered including: why do ES cells 
predominantly differentiate to neural progenitors and neurons, what factors promote or 
inhibit this, and is neural differentiation of ES cells comparable to normal murine 
development? To help achieve some answers to these questions, microarray analysis 
was performed to identify the transcriptome of ES cells during conversion to neural 
progenitors and subsequent differentiation to neurons. A time-course experiment was 
designed such that the changes in gene expression throughout the differentiation could 
be analysed. Obtaining information about how and why ES cells differentiate provides 
not only answers to regulatory mechanisms involved in ES cell neuronal differentiation, 
but also gives a framework for more specific studies of lineage direction. 
Experiments assessing gene changes following the differentiation of ES cells to 
neural cells have been performed previously (Aubert et al., 2002; Aubert et al., 2003). 
Although this work provided new information about the differentiation of ES cells to 
neural cells, it was principally focused upon identifying genes expressed specifically in 
neural progenitors through use of subtractive libraries, and the analysis was based upon 
the presence or absence at different stages of RA treated and untreated cells. 
Characterisation of expression changes at different stages of differentiation using non-
biased profiling will provide more answers to when genes are up- or down-regulated and 
to what extent their expression profiles change. The level of expression of certain genes 
may also change between different time points, which would be missed with just 
analysing the presence and absence of genes. 
Gene expression changes were defined in terms of the relative change in 
expression level, i.e. how does the expression of any gene at any timepoint relate to the 
expression level in ES cells. The results from this analysis are presented and discussed 
in the following pages. However, there are various problems associated with plotting 
genes that are up- or down-regulated on the same graph, especially if the expression 
level is both above and below a starting point within the same experiment. To enable 
109 
such representations, the expression level in ES cells will be referred to as 0 in all cases 
and if the expression increases by 100%, this will be referred to as I, and if it decreases 
by 50% this will be -1, and so on. It is not feasible to simply compare the transcript 
levels of different genes throughout the differentiation because there may be variations 
between the hybridisation efficiencies of different probes to different probe sets, so the 
changes in expression level can only be compared internally  to each probe set. 
One source of error when analysing changes from a basal level, is if the 
expression initially is considered to be absent, and the expression level increases, but 
remains below the threshold level of gene expression required for gene expression to be 
considered present. This is a problem especially using Rosetta Resolver v3.2 because if 
hybridisation to the mismatch probe is greater than to the perfect match probe the 
expression value is given as a negative value. To avoid these errors a cut off value of 
fluorescence of 20 was taken as a threshold, above which all genes were taken to be 
"on" and below which all genes were considered to be "off" and all expression levels 
below 20 were changed to 20. A second source of error in this analysis is the extent of 
upregulation when genes go from absent to present, genes going from absent to present 
will appear to be very dramatically upregulated, but the gene is simply being turned 
"on". The fold changes in these instances are not as relevant, but it will aid in the 
highlighting of genes that are only expressed following differentiation, which may be 
some of the most interesting genes for neurogenesis. 
This experiment was performed in collaboration with GlaxoSmithKline, who 
hybridised the samples I provided to Affymetrix U74v2 chips, analysed the chips for 
hybridisation, and then gave me the fluorescence values for each of the chips after 
normalisation and scaling with Rosetta Resolver v3.2. 
5.2 	Strategy 
The transcriptional analysis will use Affymetrix U74Av2 microarrays. These 
microarrays were originally designed against build 74 of the Unigene database. There 
are three arrays in the U74v2 set, each containing approximately 12 000 ESTs, although 
only the A chip was used here. The A chip contains predominantly characterised 
sequences, but also contains uncharacterised ESTs. The probes are generated by 
photolithography, and each oligonucleotide probe is a 25mer. 
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To ensure that the results from the experiments are readily analysed, and 
statistically significant, a number of criteria must be met. Firstly, the differentiation 
must commence from a single starting population of ES cells; the passage number of 
cells can cause variation in basal gene expression profiles, which can make interpretation 
of the results difficult (S. Bates personal communication) (Bartosiewicz et al., 2000). 
Secondly, the experiment must have triplicate treatment replicates. With three 
microarrays for each time point, there can be greater confidence that the variations are 
due to biological differences, especially when the changes are small (Lee et al., 2000a). 
Thirdly, at least 2 x 0 cells are necessary for each microarray, removing any need to 
amplify the RNA. Amplification introduces further uncontrollable variation, as it is very 
difficult to amplify without introducing any bias (Lockhart and Winzeler, 2000). 
Amplification can cause both over and under replication of transcripts, which results in 
important gene changes being missed, and introduces more false positive and negative 
results (Lockhart and Winzeler, 2000). 
The 46C ES cell line was used during our investigation. 46C ES cells contain 
eGFP driven by the endogenous soxi promoter; hence, eGFP is expressed in neural stem 
/ progenitor cells during ES cell neural differentiation (Ying et al., 2003b). As eGFP 
can be visualised in neural progenitors, the efficient conversion of ES cells to neural 
progenitors can be directly visualised by fluorescent microscopy allowing real-time 
monitoring of differentiation. This, as discussed earlier, is vital as differentiation can be 
highly variable. 
Neural differentiation of ES cells could use one of three possible protocols, 
namely: monolayer, embryoid bodies in serum with RA, or embryoid bodies in serum-
free medium. Embryoid body differentiation with serum and RA was not used because 
serum introduces many undefined factors into the medium and differentiations 
performed in serum are less homogenous, as well as promoting extensive mesoderm 
induction. Retinoic acid induces the formation of neural stem cells (Aubert et al., 2002; 
Bain et al., 1996), but also leads to posterior fates within both the neural tube and ES 
cell differentiations(Marshall et al., 1992), and we wanted to generate neurons with no 
specific regional bias. Monolayer differentiation occurs in defined conditions, removing 
the variability due to the presence of serum in embryoid body differentiation, and is not 
reliant upon the addition of retinoic acid (Ying et al., 2003b). Monolayer differentiation 
also produces neurons that seem more mature; they generate long processes, have 
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growth cones, and appear to form networks with other neurons. However, it is difficult 
to generate enough cells for the microarrays using monolayer differentiation. 
Monolayer differentiation is reliant upon local cell density both during the initial plating 
and at later stages during the differentiation, this is difficult to maintain at optimal levels 
in a large culture. When ES cells are differentiated as embryoid bodies in serum-free 
medium, the differentiation kinetics are similar to monolayer differentiation, and a 
comparable proportion of ES cells convert to neural progenitors and neurons, over the 
same time (Okabe et aL, 1996)(M. Li in preparation). Using this approach the 
experiment can be scaled-up sufficiently to generate enough cells for the microarrays, 
yet maintain efficient neuronal differentiation. Following 8 days of differentiation the 
embryoid bodies can be plated at single cell density, on an adhesive substrate aiding 
maturation of the neurons. However, due to the scale of the differentiation, it was not 
feasible to plate cells onto adhesive substrate at day 8, and the cells were maintained as 
embryoid bodies (fig 5.1). Although this is not expected to produce mature neurons, 
neural stem / progenitor cells will still convert to neurons, which is the focus of this 
experiment. 
To maximise the homogeneity of the differentiation, ES cells were maintained in 
N2B27 plus LIF while attached to a gelatine coated substrate for 48 hours before the 
start of the differentiation. The effect of withdrawing serum from ES cells could be 
informative, so these cells were also hybridised to the inicroarrays, at a time point 
known as pre-differentiation control (PDC). This media will maintain ES cell for a 
short period of time, the LIF does not appear to be promoting neural differentiation, 
but rather it inhibits neural differentiation (Ying et al., 2003b). Withdrawing serum 
removes the effect of BMPs, which are present in serum and inhibit neural 
differentiation of ES cells (Ying et al., 2003a). 
To ensure that most of the important genes for neurogenesis were expressed 
over the course of the experiment, samples were collected up to and including twelve 
days after the start of differentiation. This time scale covers ES cell self-renewal, neural 
induction and neurogenesis, additionally by day 12 gliogenesis has commenced. Sample 
collection was every two days, to try to ensure that all changes in gene expression were 
recorded on the microarrays. To ensure that none of the observed gene changes were 
due to time in culture, ES cells maintained in normal ES cell medium (see Chapter 2) 
were collected at each of the time points as a time in culture control. 
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Figure 5.1 	Experimental design 
From an initial starting population of ES cells, cells were either maintained as ES cells in normal 
ES cell medium for 12 days, or first put in N2B27 plus LIF on gelatine coated substrate for 48 
hours, before differentiating as embryoid bodies in N2B27. 
5.3 	Samples and preparation 
To minimise the biological variation, embryoid bodies were differentiated in a 
series of 10cm Petri dishes. For each time point three 10cm dishes were pooled to 
generate the sample for each chip, this was done in triplicate, so each time point is 
composed of three sets of three plates of embryoid bodies, i.e. three biological 
replicates. The ES cells maintained as time in culture controls were split one in four 
into four flasks. Three flasks were collected two days later for RNA extraction, one 
flask per chip, and the fourth flask was split for the next time point (fig 5.1). 
Cells were collected as described in chapter 2 and cell pellets were stored at - 
70°C before RNA extraction and purification (transcriptome analysis group, 
GlaxoSmithKline, Stevenage). Quality of the RNA was checked using an Agilent 
Bioanalyser, before being prepared for chip hybridisation. 
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5.4 	Gene changes are not caused by time in culture 
In order to confirm that the changes in gene expression are due to biological 
differences between the samples, and no changes were due to the time that the cells 
have spent in culture, the gene expression changes in ES cells over time in culture 
controls were analysed. Although ES cells are permanent cell lines, that have been in 
culture for years prior to this experiment, no experiment has previously been performed 
to see if there are progressive changes in gene expression with time spent in culture of 
ES cells. Although significant expression changes are not expected, it is important to 
confirm that any changes in expression patterns seen following the differentiation of ES 
cells are mirrored  by the undifferentiated ES cells, if this were the case; the change in 
expression profile would be due to time spent in culture, rather than a consequence of 
the differentiation. 
To ascertain whether changes in gene expression patterns occurred due to time 
in culture, the mean expression level for each Affymetrix probe at the different days of 
ES cell maintenance was plotted on a line graph. Due to the density of the data on the 
line graph, only a proportion of the data can be analysed at any one time. To facilitate 
the identification of genes whose expression changes over time during the maintenance 
of ES cells, each line was coloured according to the standard deviation of that probe 
over all the ES cell microarrays. Each line is a colour from blue to red for low to high 
standard deviation, enabling genes with high standard deviation to be identified. This 
should help to identify whether changes occur due to time in culture, or just normal 
variations. Although this is a crude measure, and genes expressed at higher levels will 
have a greater standard deviation, any genes that has significantly increased or decreased 
expression levels over the duration of the experiment should be readily identifiable 
(Appendix). A series of genes with relatively high standard deviations were then plotted 
on a separate graph to identify the genes and see changes over time (fig 5.2). 
The expression profile of genes that have a higher standard deviation shows that 
rather than there being any up or down regulation of expression levels with time, there 
is a fluctuation around a mean. Many of the genes with high standard deviations are 
ribosomal proteins, or other genes involved in metabolism. If there are changes due to 
the density of the cultures this could be reflected in the metabolism of the cells, as this is 
likely to be affected by cell contact, temperature and pH of the medium. Further 
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confirmation that there were no changes in the expression patterns due to the time in 
culture are seen in the clustering of the microarrays according to the similarity of the 
gene expression profiles performed by Simon Graham (fig 5.3). There is no temporal 
clustering of the ES cell chips, demonstrating that there are no gene changes due to the 
time in culture. Thus, as there were no changes in the gene expression profiles due to 
the time that the ES cells have spent in culture. This implies that any gene expression 
changes in the differentiating samples represent changes due to the differentiation of the 
ES cells, rather than time spent in culture. 
Day 	Dy.2 	D.c4 	Dy6 	 Day 	Dy1O 	Day 12 
High 
Standard Deviation 
Figure 5.2 	Variations in genes with higher standard deviations 
Each line on the graph represents an Affymetrix probe, the gene relating to this probe is 
annotated next to the corresponding line. Each line is coloured according to the standard 
deviation of the entire data, from blue to red, with blue being the lowest and red the greatest 
standard deviation. 
5.5 	Hierarchical clustering 
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Before analysing  the data to identify genes that were previously unreported to be 
important for neuronal differentiation, confirmation that the differentiation proceeded 
as expected is necessary. This analysis was by analysing the hierarchical clustering 
generated by Simon Graham in Rosetta Resolver (fig 5.3). Hierarchical clustering 
involves the clustering of experiments by the similarity of each experiment to all other 
experiments. The similarity of data is represented in a dendrogram. The clustering was 
performed using average linkage clustering, whereby the distances between all pairs of 
objects are calculated, and the average of this value is used. The software includes an 
algorithm such that the data is separated into a series of partitions. The first (Pr) 
consists of single object 'clusters', the last P 1 , consists of single group containing all n 
cases. At each stage two clusters are joined which are the closest together (most 
similar). 
The first subdivision of the dataset is into three groups; ES cells, PDC to day 6, 
and day 8 to 12, day 8 to day 12 is then further divided into two groups, day 8 and 10 
then day 12. These grouping correspond with the expected phases of ES cell neural and 
neuronal differentiation, ES cells, neural induction, neurogenesis and a combination of 
neuronal maturation and gliogenesis (fig 5.3). 
Figure 5.3 	Hierarchical clustering of timepoints 
The similarity of the timepoints was analysed by comparing the gene expression profiles across 
all genes. The similarity of two chips is then measured, and chips are grouped according to their 
similarity. This analysis generates a dendogram which is seen in the figure. The gene expression 
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profile of the different time points have been grouped into three broad domains of ES cells, 
PDC to D6 and D8 to D12. There are then further subdivisions within these groups. All chips 
at any timepoint are most similar to each other demonstrating good biological replicates. ES cell 
time points are grouped in a non-temporal manner. Differentiation is grouped into two initial 
domains which correspond with neural induction and neurogenesis and then the neurogenesis 
group is further subdivided, which can be inferred  to represent neuronal induction, and 
gliogenesis or neuronal maturation. In the heat map, gene expression is displayed as a colour 
range from green being absent to red present. Only a small proportion of the total heat map is 
shown. 
5.6 	Confirmation of neuronal differentiation 
The clustering of time points by their gene expression profile fits with the 
predicted model, but to confirm that this is not due to non-neural or non-neuronal 
differentiation, or an artefact, specific genes known to be important for ES cell neuronal 
differentiation were analysed. The expression profiles of these genes were confirmed 
with SYBR green real time PCR (2.2.8) on the samples hybridised to the microarrays, as 
a secondary validation of the Affymetrix results. 
To confirm that ES cell are differentiating the expression pattern of the POU 
(Pit-Oct-Unc) domain containing transcription factor oct4 (Scholer et al., 1990b) was 
analysed, oct4 is expressed almost exclusively in ES cells (Nichols et al., 1998; Pesce and 
Scholer, 2001; Scholer et al., 1990a). The microarray expression profile shows that oct4 
is dowaregulated after the start of differentiation, when serum is removed in PDC; it 
then remains stable during days 2 and 4, before being progressively down-regulated 
from day 6. By day 12, the expression level has reduced to about lO%  of the expression 
level in ES cells; this pattern of expression is confirmed by real time RT-PCR analysis 
(fig 5.4a). The level is not reduced to zero because there are likely to be some residual 
ES cells in the culture, which still express oct4. 
Verification that the ES cells converted to neural progenitors was seen by the 
expression of nestin (Dahlstrand et al., 1992; Lendahl et al., 1990), though expression of 
nestin is not absolutely specific for neural progenitors (Kachinsky et al., 1994; Sejersen 
and Lendahl, 1993), it is used to identify neural progenitor cells (Shi et al., 2004). Nestin 
expression begins to be upregulated at day 6, and continues being upregulated to day 12, 
when the expression level is approximately ten fold greater than at day 4, these changes 
in expression levels are confirmed by real time RT-PCR (fig 5.4b). Although soxi and 
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sox2 are often seen as more robust markers of neural progenitors (Wood and 
Episkopou, 1999), sox2 is also expressed in ES cells (Avilion et al., 2003; Yuan et al., 
1995), and the Affymetnx probes for soxi do not appear to work, as it is not seen to be 
up regulated here (fig 5.11), or in independent experiments (Aubert et al., 2003; 
D'Amour and Gage, 2003). As the experiment was performed using 46C ES cells, 
eGFP could be visualised by fluorescent microscopy to check the progress of the 
differentiation. eGFP was observed by fluorescent microscopy from about day 3 of the 
differentiation. Although the number of cells with eGFP was not quantified, this data 
indicates that the soxi locus is transcriptionally activated, and as such if the probes 
worked, soxi should be detected at appreciable levels on the microarrays. 
To confirm that neurons were generated, the expression profile of map! (Binder 
et al., 1985; Kosik et al., 1989) was examined. Mapt is up regulated at day 10, when the 
expression level is 50% greater than at day 8, and there is a further increase at day 12 (fig 
5.4c). Neuronal differentiation and neural determination  appear to be occurring later in 
embryoid body differentiation, than monolayer differentiation (Chapter 3). 
A marked decrease in oct4 coincides with an increase in nestin expression levels, 
which is followed by an increase in the expression level of map!. This suggests that the 
differentiation proceeded as expected and ES cells were converted to neural precursor 
cells, and subsequently to neurons. 
Oct4 
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Figure 5.4 	Changing expression levels of oct4, nestin and mapt 
The graphs show the expression levels of each of the different genes, the blue bars are the 
expression levels seen following RT PCR, the maroon bars are the expression levels from the 
Affymetrix chips. Results were scaled so that they can be seen on the same graph. 
5.7 	Temporal clustering analysis 
The Affymetrix Mu74v2a rnicroarrays contain 12 422 spots, each representing a 
different expressed sequence tag (EST) although a gene may be represented by more 
than one EST on the array. To better understand the changes that were occurring 
globally over the course of the differentiation only the genes that were differentially 
regulated compared to the expression in ES cells were analysed. ESTs whose 
expression at any time point was I00% greater than in ES cells and ESTs whose 
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expression at any one time point was 500/0  less than in ES cells were analysed. In total 
2002 ESTs were differentially regulated over the course of the experiment, 1187 ESTs 
were upregulated, 766 ESTs were downregulated, and 52 ESTs were both up and 
downregulated (fig 5.5). 
These genes were then analysed in three groups, genes that were just 
upregulated, genes that were just downregulated and genes that were both up and down 
regulated. Separating the data in this way enable genes to be separated into three 
classes; those that are required to be upregulated for neural and neuronal differentiation, 
genes that are required to be down-regulated for neural and neuronal differentiation and 
genes that are expressed in ES cells and are required to be downregulated for neural 
induction, but are also involved in neural and neuronal differentiation. 
Figure 5.5 	Venn diagram of differentially regulated genes 
All genes that are differentially regulated over the course of the experiment are represented in 
the above Venn diagram. If at any one time point the expression level of an EST was l00% 
greater than in ES cells, that EST was considered to be upregulated, and ESTs whose expression 
at any one time point was 50% less than in ES cells was considered to be downregulated. 2002 
ESTs were differentially regulated, 1187 ESTs were upregulated, 766 ESTs were downregulated, 
and 52 ESTs were both up and downregulated. 
The upregulated genes were first analysed in The Institute for Genomic 
Research Multiple Array Viewer 3.01 (TIGR MeV), using the K means / medians 
support (KMS) algorithm. KMS runs the K-Means or K-Medians algorithms multiple 
times using the same parameters in each run. Owing to the random initialization of K- 
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depending on the data set and the input parameters. The KMS algorithm allows 
generation of clusters of genes that frequently group together in the same clusters 
("consensus clusters") across multiple runs. The output consists of consensus clusters in 
which all the member genes clustered together in at least 80%  of the K-Means / 
Medians runs. 
The genes were clustered into 14 clusters, plus one cluster of unassigned genes 
(fig 5.6). The large number of clusters suggests that there are a number of different 
phases over which genes are upregulated over the course of the differentiation. Some 
genes start to be upregulated early, and continue to be upregulated. Other genes are 
upregulated later during the differentiation, but the rate of subsequent increase in 
expression does vary. Some genes are upregulated steadily over the course of the 
differentiation. There are also a small number of genes that are initially upregulated, but 
their express then starts to decrease, although staying above the expression level in ES 
cells. There is considerable variation in the number of genes contained within each 
cluster, suggesting that there significant variation as to the timing and extent of when 
genes involved in neural and neuronal differentiation are upregulated. 
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Figure 5.6 	KMS clustering of upregulated genes 
Using TIGR MeV 3.01, a KMS clustering analysis of the upregulated genes was performed. 
This enabled genes with similar expression profiles over the course of the experiment to be 
grouped together. The genes were grouped into 15 clusters, plus a one EST that could not be 
grouped with other ESTs. 
Some of the changes in gene expression patterns could be due to the 
upregiilation of particular types of genes such as transcription factors or receptors at 
specific points during the differentiation, and this maybe reflected in the K Means 
clustering. To ascertain whether changes in the types of genes were occurring 
simultaneously during the differentiation, the gene ontology (GO) of the different 
clusters of ESTs was analysed for each of the K Means clusters (fig 5.7). The GO 
biological component of the ESTs was used during the analysis. This description is too 
detailed in many cases to be displayed a graph, so all the functions were subcategorised 
into 18 groups. The full biological component, and the category each gene has been 
assigned is in the Appendix. 
















































































































































Figure 5.7 	GO description of EMS clusters of upregulated ESTs 
Using an abbreviated gene ontology (GO) description, the ESTs in each of the KMS clusters of 
upregulated ESTs were characterised to identify if there was an over or under-representation of 
types of genes at in different clusters to classify whether certain classes of genes behaved in a 
similar way. For each of the different clusters there appears to be a range of different types of 
genes present, suggesting that genes are being clustered by their effect rather than the type of 
gene. 
The GO description of the ESTs within each of the different KMS clusters 
appears to reveal no further detail as to the function of the different clusters, suggesting 
that there the changes in gene expression over the course of the differentiation are from 
upregulation of genes with a particular function, rather than genes that act in a particular 
way (such as transcription factors or signal transduction genes). 
The down-regulated genes were also analysed by KMS clustering to identify how 
the down-regulated genes were clustered (fig 5.8). The down-regulated genes are also 
clustered into 10 groups, with one further group of unclustered genes. There appears to 
be more heterogeneity in the patterns seen in the down-regulated genes, with the time 
of down-regulation and the extent of down-regulation varying considerably. Some 
clusters of genes are genes that have been down-regulated from the onset of 
differentiation, and stay at a similar expression level below the expression level in ES 
cells. 
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Figure 5.8 	KMS clustering of downregulated genes 
Using TIGR MeV 3.01, a KMS clustering analysis of the downregulated genes was performed. 
This enabled genes with similar expression profiles over the course of the experiment to be 
grouped together. The genes were grouped into 10 clusters, plus a group of 578 genes that could 
not be grouped with other genes. 
Although the GO analysis of the KMS clustering of the upregulated genes did 
not appear to reveal any further insight into the data, the analysis was repeated to see if 
any patterns could be appreciated in the down-regulated data (fig 5.9). 
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Figure 5.9 	GO description of KMS clusters of down-regulated ESTs 
Using an abbreviated gene ontology (GO) description, the ESTs in each of the KMS clusters for 
the down-regulated ESTs were characterised to identify if there was an over or under- 
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representation of types of genes at in different clusters to classify whether certain classes of 
genes behaved in a similar way. For each of the different clusters there appears to be a range of 
different types of genes present, suggesting that genes are being clustered by their effect rather 
than the type of gene. 
The GO description of the KMS clusters appears to reveal no further detail as 
to the function of the different clusters, suggesting that there the changes in gene 
expression over the course of the differentiation are from downregulation of genes with 
a particular function, rather than genes which are functioning through a similar 
mechanism. 
The ESTs that were both up and down-regulated during the differentiation were 
analysed by KMS clustering to identify how these ESTs were clustered (fig 5.10). The 
up and down-regulated ESTs are also clustered into 15 groups, with one further group 
of unclustered genes. The ESTs are clustered into quite small clusters, with only a few 
ESTs in each cluster. There is a very diverse range of expression profiles, although 
some of the ESTs have very similar expression profiles, suggesting that they be 
performing a similar function, either biochemically or through functional consequence. 
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Figure 5.10 	EMS clustering of up and downregulated genes 
Using TIGR MeV 3.01, a KMS clustering analysis of the up and downregulated genes was 
performed. This enabled genes with similar expression profiles over the course of the 
experiment to be grouped together. The genes were grouped into 15 clusters, plus a group of 41 
genes that could not be grouped with other genes. 
Although the GO analysis of the KMS clustering of the upregu1ted or the 
downregul2ted ESTs did not appear to reveal any further insight into the data, the 
analysis was repeated to see if any patterns could be appreciated in the up and down-
regulated data due to some of the great similarity between expression profiles of the 
ESTs (fig 5.11). 
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Figure 5.11 	GO descriptions of KMS clusters of up and down-regulated ESTs 
Using an abbreviated gene ontology (GO) description, the ESTs in each of the KMS clusters for 
the up and down-regulated ESTs were characterised to identify if there was an over or under-
representation of types of genes at in different clusters to classify whether certain classes of 
genes behaved in a similar way. For each of the different clusters there appears to be a range of 
different types of genes present, suggesting that genes are being clustered by their effect rather 
than the type of gene. 
The GO description of the KMS clusters appears to reveal no further detail as 
to the function of the different clusters, suggesting that there the changes in gene 
expression over the course of the differentiation are from downregulation of genes with 
a particular function, rather than genes which are functioning through a similar 
mechanism. 
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The KMS clustering and GO analysis reveals that there are a number of genes 
that share a similar expression profile, but do not have the same biological function. 
This suggest that the differentiation of ES cells depends upon a number of different 
classes of genes converging to produce the differentiation, and no one class of gene is 
solely responsible for changes in phenotype, although this does not preclude the 
possibility that changes in expression of a single gene can produce a change of cell 
phenotype. 
5.8 	Temporal changes in types of genes 
Although there appear to be no links in the expression profile of genes over the 
course of the differentiation, and the type of gene, certain types of genes such as 
transcription factors or signalling molecules may be up and down regulated at a similar 
time, thus inducing global changes in the cell types in the differentiation. Using the 
same abbreviated gene ontology scoring system (Appendix) the changes in the types of 
genes that were up and downregulated at the different timepoints were analysed. As the 
total number of genes that are both up and downregulated increases over the course of 
the differentiation, at each time point there is an increase in the number of genes of all 
types. Hence the changes in the types of genes were analysed as a percentage of the 
total number of genes up or downregulated at each time point (fig 5.12). 
Although there are variations in the types of genes that are being expressed at 
each of the different time points, there is a degree of similarity between the different 
time points, and there appears to be a similar proportion of each of the different gene 
classes at each of the time points. This suggests that all of the cell types in the 
differentiation express a similar proportion of each type of gene, and rather than there 
been dramatic up or downreguahion of certain classes of genes, instead there is a shift 
and as genes of one type are being upregulated, other are being downregulated. 
Although the overall expression profile is informative, it may be more useful to compare 
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Figure 5.12 	Changes in gene types over time 
The abbreviated GO biological description for each of the genes either up or downregulated at 
each time point was identified. As there is a general increase in the number of genes up and 
downregulated over time, the types of genes are displayed as a percentage of the total number of 
genes up or downregulated at each time point. 
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Figure 5.13 	Changes in gene types at each time point 
The abbreviated GO biological description for each of the genes either up or downregulated at 
each time point was identified. These were then compared on a day by day basis to identify 
when certain classes of genes were being up or downregulated. 
The most noticeable changes appear to be in the regulation of transcription, 
metabolism and cell growth genes. At all time points, with the exception of day 2, there 
are more downregulated than upregulated transcription factors, and the proportion that 
genes involved in transcription make up of the entire set of genes varies considerably at 
each time point. This suggests that there are a number of different transcription factors 
that are up and downregulated at different time points. This would be expected as it is 
the transcription factors that will be driving the expression of a number of different 
genes that need to be differentially regulated to achieve neural and neuronal 
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differentiation. The major disparity in downregulated genes are then genes involved in 
metabolism. The downregulation of genes involved in metabolism may be due to a 
number of different reasons, but it suggests that the metabolic processes in the 
differentiating cells are dramatically reduced compared to ES cells. This may be because 
differentiation is occurring at the expense of homeostasis and many of the metabolism 
genes are involved in keeping cells in a steady state, or there could be a downregulation 
due to the lack of nutrients for the cells in the minimal, defined media that the cells are 
being differentiated in compared to the serum containing media that ES cells are 
maintained in. Cell growth genes are downregulated more than they are upregulated, 
but this downregulation as a proportion of all the genes decreases with time. This may 
be because there is an initial reduction in the amount of cell growth, as cells start to 
differentiate, furthermore the neural progenitors and many types of neurons are smaller 
in size than ES cells, so may require fewer genes associated with cell growth to be 
expressed to achieve their size. 
5.9 	Expression patterns of genes important for neurogenesis 
Many genes have been identified that have roles in the formation of the CNS; 
either during neural induction, neuronal differentiation or neuronal maturation. 
Through the analysis of genes that are present on the microarrays, it is possible to 
discover how closely neural differentiation of ES cells mirrors normal embryonic 
development. 
5.9.1 Neural induction 
The first stage of specification of neural tissue is known as neural induction. 
The exact mechanism of neural induction is not defined, but various experiments 
suggest that it is either a result of FGF signalling, which then requires the inhibition of 
BMP signalling to maintain the specified neural tissue (Pera et al., 2003; Sheng et at, 
2003; Stem, 2001), or it is just a result of BMP antagonism (Wilson and Edlund, 2001). 
All of the BMP and FGF family members and their receptors that were present on the 
microarrays were identified, and plotted onto graphs to see how the expression profiles 
changed over time. 
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Figure 5.14 	Expression of Fgfs and Fgfrs 
The changing levels of FGF.c and Fs over the course of the differentiation, compared to the 
level of expression of each gene in ES cells are shown in the graph above. 
Considering the known importance of the FGF pathway during development, a 
striking result from this experiment is that there are relatively few changes in FGF 
expression patterns (fig 5.14). The largest changes are the down-regulation of f4, 
which by day 12 is expressed at 10% of the level at which it is expressed in ES cells. 
Egf15 appears to be the most upregulated FGF, increasing to eight fold the level of 
expression compared to ES cells. The FGF receptor Jfr2 is upregulated at day 2 by 
nearly three fold and continues to be upregulated at day 4, this level then drops slightly, 
before being upregulated again at day 12. F&Irl  is also upregulated and at day 12 it is 
expressed at two-fold the level of ES cells. 
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Figure 5.15 	Expression of BMPs, BMPRs, and BMP antagonists 
The changing levels of BM-s, BMPRc, and BMP antagonists throughout the differentiation, 
compared to the levels in ES cell are shown in the graph above. 
The first change in the expression profiles of the BMPs is the down-regulation 
of bmp4. Although the level of bmp4 fluctuates throughout the differentiation, it remains 
expressed at a lower level than the expression in ES cells (fig 5.15). The Bmp receptors 
change very little throughout the differentiation, and the expression profile just 
fluctuates around the level in ES cells. Fol/istatin is the most upregulated BMP 
antagonist, and starts to be upregulated from day 6, when it is expressed at 3.5 fold of 
the level in ES cells, and continues to be upregulated to day 10, when it is expressed at 
six times the level of ES cells, before dropping back to 3.5 fold at day 12. Other BMP 
antagonists, no and cerberus are also upregulated, but to a much smaller extent. Bmp 1 
and BmplO are the only BMPs that are upregulated during the differentiation, and no 
BMP receptors change their expression profile by more than 1.5 fold. 
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Figure 5.16 	Expression of Wnts 
The changing levels of lVnts over the course of the differentiation, compared to the level of 
expression of each gene in ES cells are shown on the graph above. 
Wnt signalling also plays an important role during neural induction, however 
there is very little early upregulation of any Wnts (fig 5.16). LVnt3 and wntlOb are initially 
downregulated following withdrawal of serum, and wntlOb continues at this lower level 
throughout the differentiation until there is a slight increase to just above ES cell levels 
at day 12. Wntl is the earliest upregulated Writ, and it increases to 1.5 times the level in 
ES cells at day 6, and continues to be upregulated to 2.5 times at day 12. Wnt7b is 
upregulated to 1.5 times the level in ES cells at day 10, and then further upregulated to 
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Figure 5.17 	Expression of Wnt antagonists 
The changing levels of Wnt antagonists over the course of the differentiation, compared to the 
level of expression of each gene in ES cells. 
Some of the Wnt antagonists are upregulated over a similar timescale some of 
the Wnts (fig 5.17). SJ1p2 is upregulated at day 4 to over 50%  greater than the level in 
ES cells, and it continues to be upregulated up to day 12 when it is just over five times 
greater than in ES cells. Sjrp 1 follows a similar pattern, but the level of expression is 
lower. Dkk 1 is upregulated to double the level in ES cells at day 8, and then increase to 
three times the level at day, but drops back down again at day 12 to just under double 
the level of ES cells. 
5.9.2 Neural stem / progenitor cell specification and maintenance 
A number of different classes of genes are responsible for neural stem / 
progenitor cell specification and maintenance. Different family members of various 
genes are likely to be responsible for establishing patterns throughout the CNS, but the 
general mechanism of differentiation is likely to be similar. To analyse which different 
family members are being expressed during the differentiation, families of genes were 
analysed together. 
The SOX family of genes are known to be important for both neural induction, 
neural progenitor self-renewal and neuronal differentiation. During the initial stages of 
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differentiation, there are initially only small changes in the expression patterns of the 
different SOX genes, and although sox2 is expressed in ES cells, the expression profile 
does not change much over the course of the differentiation (fig 5.18). Soxi 1 is the first 
upregulated SOX gene, and is expressed at more than double the level in ES cells at day 
6, and continues to be upregulated to about six times the level in ES cells by day 12. 
The second SOX gene upregulated is soxl7, which is upregulated six times between days 
six and eight, and is stable at day 10 then drops back to about four fold the levels of ES 
cells at day 12. This increase in the expression of soxl7, could be due to the appearance 
of non-neural cells in the differentiation, namely gut endoderm cells, which express 
sox17 (K.anai-Azuma et al., 2002). The expression profile of sox4 is similar to the 
expression of soxi 1, but it is upregulated at a lower levels. Soxi is the last upregulated 
SOX family member and is upregulated by more than double the level in ES cells at day 



































Figure 5.18 	Expression of SOX genes 
The changing levels of SOX genes over the course of the differentiation, compared to the level 
of expression of each gene in ES cells. 
Various groups of genes that are known to be involved in the specification and 
maintenance of neural stem / progenitor cells. The upregulation of soxi 1 suggests than 
151 
it may be important for neural and neuronal differentiation. Soxi 1 is a member of the 
group C family of SOX genes, along with sox4 (Jay et al., 1995). Soxi 1 has previously 
been shown to be expressed in the developing nervous system (Hargrave et al., 1997; 
Kuhlbrodt et al., 1998), where it can interact with the POU domain containing proteins 
Brnl and Brn2. In the developing cortex brnl and bm2 are expressed in late progenitor 
and early neuronal cells (Sugitani et al., 2002). When both are knocked-out, there is a 
lack of proliferation of neuronal progenitors, resulting in a decreased number of 
neurons in layers IV to II (Sugitani et al., 2002). SOX1 I has not previously been shown 
to be involved in the maintenance of neural progenitors, but many other SOX genes 
have been shown to be involved in maintaining a progenitors, and preventing premature 
neuronal and glial differentiation (Bylund et al., 2003; Kim et al., 2003; Stolt et al., 2003). 
Due to the high degree of conservation between the SOX genes and the expression 
profile of soxi 1, a function of soxi 1 could be to maintain a specific progenitor pool. 
This could be partly in co-operation with Bml and Bm2, but also other POU domain 
containing transcription factors. SOXI 1 can bind the targets of SOX2 (Wiebe et al., 
2003), so Sox i 1 may also interact with factors that are known to bind to so-v2 such Pax6 
(Kamachi et al., 2001). Pax6 and soxil are expressed in the same regions of the 
developing chick telencephalon, and so could interact directly. 
The exact timing of the expression of the soxi 1, brnl, brn2 and pax6 do seem to 
coincide with each other, giving more weight to the possibility that they do interact (fig 
5.19). The genes all become upregulated at day 6, and proceed to be up-regulated to a 
similar extent over each of the subsequent days. Such similarity would not be expected 
if the genes were not being expressed in a comparable population of cells. 
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Figure 5.19 	Soxil and associated genes 
The expression profile of soxi 1 and genes thought to be associated with soxl 1 are shown above. 
The expression patterns of brnl, brn2 and pax6 were confirmed by SYBRgreen real time RT-
PCR, which are shown on the graph. 
Proneural genes encode bJ-ILH transcription factors that are known to play 
major roles in maintenance and differentiation of neural progenitor cells (Bertrand et al., 
2002; Ross et al., 2003; Schuurmans and Guillemot, 2002). Analysing the expression 
profile of all of the proneural genes found on the chips should give an indication of 
when neural progenitor cells are specified, and when they start to differentiate to 
neurons. The expression profile of proneural genes after day 2 demonstrates that math3, 
is initially up-regulated between days 6 and 8, and then further up-regulated from day 8 
to 10, when ngnl, ngn2, and mashi are also upregulated. All of these genes are further 
up-regulated from day 10 to 12, along with neuroD (fig5.20). The expression profile 
demonstrates that the proneural genes are progressively up-regulated from day 6 of the 
differentiation. NeurvD is initially upregulated following the withdrawal of serum, but is 
then downregulated again and is maintained at a level just above the expression level in 
ES cells. To confirm the expression patterns of the proneural genes, the expression 
profile of some of the proneural genes was analysed by real time RT-RCR. The 
expression profile of mash! appears to be different when analysed by real time RT-PCR. 












expression profile is very similar to that seen by the Affymetrix results; mash! just 
appears to be being expressed slightly earlier than previously thought. This may be due 
to the sensitivity of the real time RT-PCR compared to the microarray, and the 
detection of lower amounts of RNA. Ngnl expression levels when analysed by real-time 
RT-PCR also come on at day 8 rather than day 12, but the expression profile of ngn2 is 
the same when analysed by real time RT-PCR or on the microarrays. These small 
differences in the initial detection of expression may just be that the probes on the 
Affymetnx chips do not hybridise very efficiently to mash! and ngn1 so low levels of 
expression are not detected. 
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Figure 5.20 	Expression of proneural genes 
The changing levels of the proneural genes are shown in a, the expression level of the different 
proneural genes varies over the course of the differentiation. The expression profiles are 
confirmed by SYBR green real time RT-PCR, (b) ma,thl, (c) ngn1, (d) ngn2. 
The expression profile of proneural genes is intertwined with the expression 
profiles of genes that inhibit proneural gene products. The Id gene family inhibit the 
binding of proneural proteins to their site of transcriptional activation (Bertrand et al., 
2002). All of the Id genes are expressed in ES cells, and are initially down-regulated 
following the withdrawal of serum (fig 5.21). The genes do not come back to the level 
of ES cells until day 8, when id2, 3 and 4 are expressed at a similar level again. 1d2 and 
id3 continue to be upregulated slowly to thy 12; id4 is upregulated more and by day 12 is 

















Figure 5.21 	Expression of Id genes 
The changing expression levels of the Id genes over the course of the differentiation the 
expression of each gene is compared to the expression level in ES cells at each umepoint. 
Another family of genes important in both promoting and inhibiting the 
function of proneural genes are the Hes genes (Bertrand et al., 2002). The expression 
profiles of the Hes genes vary considerably, as would be expected by their divergent 
functions (fig 5.22). Hey1 starts to be expressed after day 4, and is up-regulated until day 
8, after which the expression level remains constant. This timing of expression is similar 
to 1d2, although 1d2 continues to be up-regulated following day 8, but to a lesser extent. 
Hes5 is up-regulated after day 6, and continues to increase until day 12, when Hes5 
expression is seventeen times greater than in ES cells, although this represents changing 
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The changing expression levels of the Hex genes over the course of the differentiation, 
compared to the expression level in ES cells for each gene. 
Genes in the Notch pathway were also examined for the timing of expression. 
Delta-like 1 (dill) is initially upregulated following the withdrawal of serum, to about three 
times the level in ES cells, then it drops back down again at day 2, then the expression 
profile starts to increase slowly and at day six, it is then double the level of ES cells, and 
twelve fold the level of ES cells by day 12 (fig 5.23). Notchi is not upregulated until day 
10, but is upregulated by a similar extent to dill, but the expression is at a slightly lower 
level. Of the other Notch pathway genes, there is very little change, and only lunatic 
fringe (g) and maniac fringe (mJizJ become upregulated at day 10 and 12, and notch3 is 
expressed after day 8, and continues to accumulate until day 12 when it is expressed at 
























Figure 5.23 	Expression of Notch pathway genes 
The changing expression levels of the Notch pathway genes over the course of the 
differentiation, compared to the level of expression of each gene in ES cells. 
The hedgehog pathway is important at various stages of neural differentiation, 
especially in patterning. The expression patterns of the genes initially do not vary much, 
although there is a decrease in gIil after withdrawal of serum (fig 5.24). Smoothened 
(smob), the transducer of the SHH signalling is first upregulated at day six, when it is 
expressed at twice the level of ES cells, and continues to be slowly upregulated to four 
times the level of ES cells by day 12. The SHH receptor patched (ptcl) is upregulated 
with a similar profile, but at much lower levels, and is only expressed at twice the level 
of ES cells by day 12. SHH is not upregulated until day 8, when it is expressed at nearly 
twice the level of ES cells, and is then dramatically upregulated so that by day 12 it is 
expressed at over eight fold greater than in ES cells. The downstream targets of SHH, 
the Gli proteins, are also not upregulated until day 8, but they slowly increase their 






























Figure 5.24 	Expression of Hedgehog pathway genes 
The changing expression levels of the Hedgehog pathway genes over the course of the 
differentiation shown as the level of expression compared to the level in ES cells. 
5.9.3 Regional markers 
The CNS can be broadly divided into  four different regions; forebrain, 
midbrain, hindbrain and spinal cord. The positional identity of neurons generated 
during ES cell differentiation is unknown. GABAergic neurons often constitute the 
major neuronal cell type when no exogenous factors are added to the differentiation, 
but it is unknown which GABAergic neurons in the CNS these neurons are similar to, 
and if other cell types are also generated but predominantly GABAergic neurons 
survive. Each region is taken in turn to see if genes characteristic of these regions are 
being expressed. 
From the forebrain specific markers that are on the U74v2 chips, only d/x2 is 
upregulated above the level in ES cells. The other forebrain markers do not change 
over the course of the differentiation (fig 5.25). D1x2 is expressed in similar cells to 
Jàg1 in the developing forebrain, suggesting that any dlx2 positive cells may not be 















ES PDC Day 2 Day 4 Day 6 Day 8 Day Day 
Cells 	 10 	12 
 
Figure 5.25 	Expression of forebrain markers 
The changing expression levels of the forebrain genes over the course of the differentiation the 
expression is relative to the expression level in ES cells for each gene. 
The only characterised midbrain specific marker present on the U74v2 arrays is 
en,grailedl (en 1), which is upregulated from day 8, but dramatically increases between day 
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Figure 5.26 	Expression of midbrain markers 
The changing expression levels of the midbrain specific gene enl over the course of the 
differentiation, compared to the expression level in ES cells. 
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Two hindbrain markers, hoxa2 and hoxbl are both upregulated during the course 
of the differentiation, progressively increasing their level of expression from day 8 
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Figure 5.27 	Expression of hindbrain markers 
The changing  expression levels of the hindbrain genes over the course of the differentiation, 
expression is compared to the expression level in ES cells. 
Following the identification of genes known to be expressed in the spinal cord 
on the chips, no genes are upregulated over the course of the differentiation (fig 5.28). 
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The changing expression levels of the spinal cord genes over the course of the differentiation, 
compared to the expression of each gene in ES cells. 
5.9.4 Neuronal markers 
To investigate further the degree of neuronal conversion of the neural 
precursors within the EBs, a number of different neuronal specific markers were 
analysed. A number of genes that are specifically expressed in neurons, including 
markers of more mature neurons were found to be expressed in the EBs. These 
included microtubule assoiated protein 2 (map2), a microtubule protein (Goedert et al., 
1991), ynaptosomal-associated protein, 25 kDa (snap25), a synaptic protein (Kandel et al., 
2000), neurofilament light-chain (nfs) a cytoskeletal protein (Kandel et al., 2000), and netrini 
(ntnl) a chemo attractant, secreted to attract axon growth (Dickson and Senti, 2002). All 
of these proteins are upregulated towards the end of the differentiation, although the 
proteins associated with axon outgrowth and synapse formation were not upregulated 
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Figure 5.29 	Expression of neuronal markers 
Neuronal specific genes, including genes associated with axon outgrowth and synapse formation 
emerge towards the end of the differentiation. 
ES cell derived neurons are mainly GABAergic neurons. The prevalence of one 
neuronal cell type could be because GABAergic neurons are uniquely specified or are 
the only viable subtype. Indeed, there is considerable cell death during neuronal 
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differentiation of ES cells, but it is unclear whether this is a general phenomenon or 
specific to certain cell types. To address this issue a number of neuronal subtype 
specific genes were identified from the microarray; these were markers of cholinergic 
neurons (ache), glutamatergic neurons (gria2 and gadi) and GABAergic neurons (s/c6al) 
(fig 5.30). However, only glutamatergic and GABAergic neurons appear to be present 




















Figure 5.30 	Expression of neuronal subtype markers 
Expression profiles of neuronal subtype markers for cholinergic neurons (ache), glutamatergic 
neurons (gia2 and gad1) and GABAergic neurons (s/thai). 
5.10 Discussion 
From the initial data analysis one can conclude that the array data is a relevant 
reflection of real gene expression changes during neural induction and differentiation. 
The changes in the gene expression profiles that are seen are as a result of 
differentiation of the cells, and not due to the cells spending 12 days in culture. The 
density of the ES cells at the time of trypsiriisation was not identical while the ES cells 
were being kept in culture. This could be due to slight differences in cell number being 
plated, or there may have been slight differences in the extent to which the ES cells 
were dissociated to single cells, although it is difficult to pinpoint an exact cause of the 
variation. 
The differentiation of ES cells to neural progenitors and neurons was effective 
because specific markers of ES cells are down-regulated over the course of the 
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differentiation, and the down-regulation of ES cell markers coincides with the 
emergence of first neural progenitor, and neuronal markers only emerge after neural 
progenitor markers. From the clustering analysis there are also clear groupings of the 
timepoints into a number of different groups which correspond with the expected 
biological groupings of ES cells, neural induction, neural progenitor proliferation and 
neuronal differentiation, and day 12 corresponds with a combination of neuronal 
maturation and possibly gliogenesis. 
The KMS clustering reveals that within the upregulated, downregulated and up 
and down-regulated genes there are a number of genes that share similar expression 
profiles, suggesting that these genes may be involved in the same regulatory network. 
However, these genes appear to share no functional similarity, suggesting that they may 
instead be involved in producing different aspects of phenotypic changes during 
differentiation. It was not expected that the expression profile of genes with similar 
functions would be differentially regulated in the same way during the differentiation, 
and instead there would be clusterings of genes by their effect on the phenotype of the 
cells. 
The differential regulation of different types of genes over the course of the 
differentiation reveals that genes involved in transcription are the class of genes that are 
most up and downregulated at most of the different time points. Dynamic changes in 
the profile of transcription factors being expressed would be expected because 
transcription factors are responsible for regulating the expression of a number of 
different genes and are the genes most likely to result in phenotypic changes in the cells. 
The changes in expression of cell growth and metabolism genes are likely to be due to 
the changed associated with growing the cells in minimal media and at certain stages of 
the differentiation, cells using available energy to differentiate and actively remodel, 
rather than just expand. 
The initial changes in gene expression levels of the genes known to be involved 
in neural induction are quite striking. They support the idea that neural induction 
initially involves the FGF pathway, and there is a down-regulation of BMP 
transcription. Both Y4 and bmp4 are expressed in ES cells, and they are progressively 
down-regulated over the course of the differentiation. BMP signalling needs to be 
repressed for efficient neural induction (Ying et al., 2003a), but this does not appear to 
be mediated by BMP receptor antagonism. Fol/istatin is expressed in ES cells, but not at 
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particularly high levels, and it is unclear if it is expressed at levels high enough to inhibit 
the BMPs expressed at this stage. If there was a differential requirement for BMP 
receptor antagonism between ES cells and day 6, as is predicted by the default model, 
one would expect BMP receptor antagonists to be upregulated. Day 6 is when neural 
markers start to emerge, such as nestin (fig 5.4), if BMP receptor antagonism was 
required for the formation of these cell types, one would expect BMP receptor 
antagonists to be upregulated before they emerge. One of the functions of BMP is to 
phosphorylate SMADI, which enables translocation of SMADI to the nucleus to 
activate transcriptional targets (Kretzschmar et al., 1997). In Xenopus FGF, through 
MAPK signalling can phosphorylate SMADI such that it stays in the cytoplasm and 
cannot translocate to the nucleus (Pera et al., 2003), thus inhibiting BMP signalling. 
Although whether that is occurring here cannot be analysed from this experiment 
because it involves post-translational modification of SMAD 1. FGFR2 is upregulated 
by day 2 of the differentiation, when the FGF4 expression level is below that in ES cells, 
but it is still being expressed. FGF4 can signal through FGFR2 (Dell'Era et al., 2001; 
Mansukhani et al., 1992), suggesting that it is FGF4 signalling through FGFR2 that is 
responsible for neural induction, at least in ES cell differentiation. Other fti are 
expressed at low levels, withf/5 expressed at the highest level, but it is at a much lower 
level thanf/4. 
Signals to convert ES cells to neural progenitors must arise before the first ES 
cells have been converted to neural progenitor cells, so this data supports the hypothesis 
that FGF signalling is required for neural induction (Ying et al., 2003b), and contradicts 
previous reports that ES cells convert to neural cells through a default mechanism 
(Tropepe et al., 2001; Wiles and Johansson, 1999). BMP1 starts to be upregulated at 
the same time asfollistatin, hence, the role of follistatin here may be to antagonise BMPI, 
and maintain the cells that have converted to neural progenitors, as neural progenitors. 
The expression profiles of the Wnt genes and their antagonists suggest that they 
are involved in the later stages of neural induction, at a similar point to when BMP 
antagonists start to be expressed, so they may play a role in the stabilisation and 
maintenance of neural progenitors. Sj1p2, a Writ antagonist has been shown to both 
induce the formation of neural progenitors and increase the number of neural 
progenitors following ES cell differentiation (Aubert et al., 2002), although its function 
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may be to prevent Wnt repression of neural differentiation in cells that have already 
been primed to become neural progenitors. 
The role of the SOX genes in ES cell differentiation may be further complicated 
by the possible addition of SOXI I to the SOX group BI genes that are already known 
to be important.  The proteins that it can interact with, namely, brnl, brn2 and pax6 are 
expressed in a similar pattern to soxi 1, which suggests that it plays some role in neural 
differentiation. This leads to the possibility that different SOX genes may function in 
different regions of the CNS, and whether they are expressed singly or in combination 
will affect the different transcription factors that they can promote and inhibit. As they 
may also bind with the same partner proteins, the relative affinity of the SOX proteins 
to the partner proteins may confer a further level of control to the differentiation. 
The expression profile of the proneural genes in this experiment shows that 
there is variation between the sensitivity of the Affymetnx chips and analysing the 
presence of RNA by quantitative RT-PCR. Previous reports have suggested that 
microarrays are poor at detecting low levels of transcripts, although this appears to vary 
on a gene by gene basis, as there does not appear to be a detection threshold; below 
which Q-RT-PCR can detect transcripts and the arrays cannot. A broad array of 
proneural genes are expressed, which suggests that the differentiation is not limited to a 
single neural progenitor cell population, as proneural genes are often expressed in non-
overlapping expression patterns, and they can cross-inhibit each other (Schuurmans and 
Guillemot, 2002). The proneural genes are upregulated from day 8, with the NeuroD 
family member math3 (Bertrand et al., 2002) upregulated the most by day 8 of the 
differentiation, from the Affymetrix expression data (fig 5.20), although this may be 
because it is most effectively detected by the microarrays. There is further increase in 
the expression levels at day 10 and 12. The inhibitors of proneural genes; Hesi, Hes5 
and the Id genes also start to be upregulated after day 8, which will result in the 
inhibition of proneural protein function. The suppression of proneural gene function 
by Id and Hes proteins is in co-operation with Notch. The changes in the expression 
profiles of Id and He: genes are mirrored by changes in the Notch pathway, as Notch! 
and Delta-likel are upregulated at day 10 and then further still at day 12. These changes 
in expression mirror the known changes in expression during development, suggesting 
that the same pathways are involved in the self-renewal, proliferation and differentiation 
of ES cell derived neural progenitors and the developing embryo. 
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SHH signals through Patchedi repression of Smoothened, resulting in activation 
of a protein complex containing Gli proteins, which in the absence of SHH act as 
repressors, but in the presence of SHH the Gli proteins, are transcriptional activators. 
The transcriptional targets of active Glis include gui, g/i2 and pici (Ruiz i Altaba et al., 
2003). These genes are not upregulated from the level in ES cells until day 10 and 12, 
so the low level of sbh may not be having any effect on the cells until day 10. This is late 
in terms of the normal development of neural tissue as SHH is expressed from about 
E7.5 onwards (Ruiz i Altaba, 1999). The lack of early SHH makes the EB 
differentiation less like the formation of neural tissue in the developing embryo, and 
may result in a dorsal bias in the progeny of differentiated ES cells, although this cannot 
be quantified due to the lack of ventral specific genes on the Affymetrix chips. 
There are a number of different regionally specific transcription factors 
upregulated during the differentiation of the course of the differentiation. Transcription 
factors that are known to be expressed in the forebrain, midbrain, bindbrarn but not the 
spinal cord are expressed during the differentiation, although not all transcription 
factors expressed in these regions are expressed during the differentiation. The 
emergence of different populations of cells suggests that there are either different 
progenitor populations in the EBs, or the same progenitor has become specified to 
different cell types. However, another possibility is that different neural progenitors 
emerge in different embryoid bodies, which is as a result of cells in different EBs 
receiving different signals that promote the differentiation of cells from different 
regions of the CNS. Hindbrain markers appear to emerge first, followed by the 
midbrain and forebrain markers emerging at a similar time, although the possibility of 
different cell types emerging in different EBs again cannot be excluded here, and the 
sequential expression of genes from different regions can be said to be occurring when a 
single EB is analysed over the course of the differentiation. However further 
investigation of regional markers from all the different brain regions would be necessary 
to confirm the sequential birth of different neuronal lineages. 
The expression of markers of mature neurons, such as synaptic proteins, was 
not expected. Therefore, there is some neuronal maturation within the EBs, which may 
include synapse formation and axon pathfinding. However, confirmation that both of 
these events have occurred cannot be made with just gene expression data, and would 
require further functional tests. When ES cells are differentiated without the addition of 
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exogenous factors, the neurons are predominantly GABAergic. However, other 
neuronal subtypes may also be formed during the differentiation. This suggests that the 
neural progenitors that form in the EBs are not just capable of generating GABAergic 
neurons, but also generate glutamatergic neurons, although other stimulatory signals 
may be required for the production of other neuronal subtypes. However, it still 
remains unclear whether there is a selective production or survival of mature neuronal 
subtypes. 
Although the EB differentiation system was used here, it would have been 
preferable to use the monolayer differentiation protocol, as this appears to generate the 
most homogenous differentiation, and is the most widely used differentiation protocol 
in the lab. The ES cells were not differentiated in this way because it was not technically 
possible to simultaneously differentiate the number of cells required for the microarrays, 
while maintaining the efficiency of the differentiation. The timing of the differentiation, 
and the cell types produced are likely to be similar, but it is unknown whether they 
would be exactly the same. The main advantage would have been that there would have 
been fewer other cell types, which would have made the results easier to interpret. A 
similar experiment in monolayer differentiation could help to identify the reasons for 
the differences between the two types of differentiation. 
5.11 Summary 
The expression profile of ES cells does not change when maintained in culture 
for 12 days 
Transcription factors are one of the most up and downregulated types of genes 
during the differentiation 
During the conversion of ES cells to neural progenitors, FGF receptor 
expression is upregulated before BMP antagonists are upregulated 
Embryoid body differentiation of ES cells involves many of the same genes as 
normal murine neural development 
• Forebrain, midbrain and hindbrain markers and genes involved in synapse 
formation and axon outgrowth are expressed, suggesting neural progenitors and 
potentially neurons from all three regions of the CNS develop without the need 
to add exogenous factors 
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6 	Identifying New Regulators of Neurogenesis 
	
6.1 	Introduction 
The transcriptome analysis discussed in the previous chapter provides allows 
identification of genes previously not known to be important for neural induction and 
neuron differentiation. These could be previously characterised or novel genes. Both 
classes of candidate genes will be of interest to add to our understanding of 
neurogenesis. 
Given that data concerning known regulators of this process are available from 
the arrays it is possible to identify novel candidates based on similar kinetics of 
expression changes of the 12 days. We are particular focused on mechanisms of 
neurogenesis and so genes expressed from day 6 and all remaining time points would be 
likely mediators of this process. Gene function can be studied in many ways, but for 
previously characterised genes such as classic growth factors, it may be possible to add 
the protein or related family members to differentiating cultures. For novel genes, the 
expression profile can be assessed for in vivo function during embryonic development 
using whole-mount in situ hybridisation. 
6.2 	Previously characterised genes of interest 
The expression profiles of a number of different genes that have been 
previously characterised functionally but have no known role in neurogenesis, either 
from ES cells or in the developing embryo are discussed here. Each gene was 
implicated in neurogenesis through an expression profile similar to known regulators. 
6.2.1 FGF15 
Characterisation of FGF family member expression previously (fig 5.14) 
identified FGFI 5 as a highly upregulated gene at late stages of the differentiation. Fj15 
is expressed in the developing neural tube, in a similar pattern to f&8 (Gimeno et al., 
2003; Gimeno et al., 2002; McWhirter et al., 1997). It has been reported that fy15 is 
dependent upon SHH signalling (Ishibashi and McMahon, 2002), however, we uindJ15 
is expressed before sbh (fig 5.14 and fig 5.23). Fg/15 transcription may be regulated by 
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has also been shown to modulate Wnt signalling (Ishibashi and McMahon, 2002). 
When overexpressed in the developing mouse, there is an expansion of the tf4 positive 
cells (McWhirter et aL, 1997). The exact function of FGFI5 is unclear, but it may be 
acting as a mitogen, or a cell survival factor on certain populations of progenitor cells. 
To confirm that the expression profile seen on the Affymetrix arrays is accurate, 
the expression of fg/15 was also analysed by Q-RT-PCR (fig 6.1). The Q-RT-PCR 
confirms thatJ15 starts to be upregulated from day 6, although the expression profile 










Figure 6.1 	Expression profile of &15 
The expression profile offjl5 seen by the Affymetrix results is confirmed by Q-RT-PCR. 
To test the effect that FGF15 has on the differentiation of neural progenitors to 
neurons, we added FGFI5 protein exogenously to culture media during differentiation 
(fig 6.2). Following the addition of FGFI5, there is a highly significant (measured by 
paired student T-Test (2.9.1)) increase in the number of neurons (70 0/6), yet the number 























Figure 6.2 	Addition of FGF15 as an exogenous factor 
46C ES cells were differentiated by the monolayer protocol for 4 days, and then puromycin was 
added to the medium for two days. The factors were then added for 2 days in N2B27. The 
effect of each factor on monolayer differentiation was analysed by counting the number of 
neurons (left graph), determined by counting the number of cells positive for the neuronal 
specific marker Tuj 1, the number of non-neuronal cells (centre graph) determined by counting 
the number of Tuji negative cells, the extent of cell death (right graph) was determined by 
counting the number of cells with DapI staining pattern indicating that the cell was dead. The 
effect of each factor was compared to the result obtained when no factor was added. The 
experiment was performed with three biological replicates; each biological replicate had three 
treatment replicates. FGFI5 (lOng/mi, R&D Systems) produced a highly significant (p=0.034) 
increase in the number of neurons, and no other statistically significant effect. 
6.2.2 Creatine kinase (brain) 
A second candidate regulator of neurogenesis from the arrays is creatine kinase 
(brain) (ckb). Creatine kinase is the rate limiting enzyme in the conversion of ADP to 
ATP (fig 6.3). Ckb is found in the cytoplasm and is used to generate ATP at subcellular 
sites of high ATP turnover (Friedman and Roberts, 1994; Wallimann et al., 1992). A 
role for regulators of metabolism during neurogenesis both during development and in 
the adult is not clear, but decreased levels of ATP lead to neuronal death (Gorman et al., 
2000). The expression profile of ckb was checked by Q-RT-PCR to check the 
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consistency with the results seen from the Affymetrix arrays (fig 6.3). This confirmed 
the expression pattern of ckb, showing that the expression of ckb increased after day 8, 
and was three times the level in ES cells by day 12. 
Creatine Kinase (Brain) 
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Figure 6.3 	Expression profile of creatine kinase (brain) 
Affymetrix and Q-RT-PCR expression of ckb over the course of the differentiation. The 
expression of creatine kinase (brain) increases from the level seen in ES cell after day 8, to three 
times the level seen in ES cells by day 12. 
The expression profile of ckb during mouse development has not been reported 
to date and so was investigated using in situ hybridisation (fig 6.4). The expression 
pattern identifies expression within the developing neural tube, predominantly restricted 
to cells in the dorsal side of the neural tube. Expression is excluded from the 
midbrain/hindbrain boundary (isthmus). There is also semi-regular expression of ckb in 
the forebrain and midbrain, suggesting that the gene is being expressed in clusters of 
cells. Sectioning  shows that this forebrain expression is restricted dorsally. The 
expression pattern is similar to neural crest, but neural crest cells should have migrated 
away by E10.5. The expression profile suggests that the cells expressing ckb are new-
born neurons that have migrated  away from the ventral side of the neural tube. There is 
also regionally restricted expression within the eye. 
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Figure 6.4 	In situ expression of creatine kinase (brain) at E10.5 
The expression of ckb is restricted to the developing neural tube( A-C whole mount e10.5 
embryos). It is expressed throughout the length of the neural tube (NT), although it appears to 
be excluded from the isthmus (I). The expression predominantly restricted to the dorsal side of 
the embryo ((Dorsal (D) to ventral (V) in A). In the forebrain and midbrain there is a regular 
patchiness to the expression (D elO.5 horizontal section of hindbrain). Cells expressing ckb 
appear to be migrating away from the dorsal side of the neural tube, at relatively regular 
intervals. The dorsal expression of ckb is confirmed upon sectioning of the forebrain, where 
there is a stripe of cells expressing ckb along the entire dorsal side, although there are semi-
regular clumps of cells that are not as tight to the dorsal side. 
As ckb is being expressed in the differentiating ES cells, and in developing 
munne neural tissue, the role of Ckb in ES cell neurogenesis was investigated. The 
experiment described in 4.3 was repeated, through addition of creatine phosphate, the 
molecule required for the conversion of ADP to ATP by Ckb, as an exogenous factor. 
This addition assumes that there does not have to be an increase in the level of the 
enzyme, merely that there is more substrate for the enzyme. Following the addition of 
creatine phosphate, there is a very highly significant (measured by paired student T - 
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Figure 6.5 	Addition of creatine phosphate as an exogenous factor 
46C ES cells were differentiated by the monolayer protocol for 4 days, and then puromycin was 
added to the medium for two days. The factors were then added for 2 days in N2B27. The 
effect of each factor on monolayer differentiation was analysed by counting the number of 
neurons (left graph), determined by counting the number of cells positive for the neuronal 
specific marker Tuji, the number of non-neuronal cells (centre graph) determined by counting 
the number of Tuj 1 negative cells, the extent of cell death (right graph) was determined by 
counting the number of cells with DapI staining pattern indicating that the cell was dead. The 
effect of each factor was compared to the result obtained when no factor was added. The 
experiment was performed with three biological replicates; each biological replicate had three 
treatment replicates. Creatine phosphate (5.tM, Sigma) produced a very highly significant 
(p0.004) increase in the number of neurons, and no other statistically significant effect. 
6.3 	Previously uncharacterised genes of interest 
The expression profiles of a number of different genes that have not previously 
been characterised were identified from the microarray results. Genes with a potential 
role in neurogenesis were found by looking for genes that have an expression profile 
similar to genes that are known to be important for neurogenesis. 
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6.3.1 100466f at 
One of the genes identified as having an expression similar to genes known to 
have a role in neurogenesis was an expressed sequence tag (EST), corresponding to the 
Affymetrix fragment 100466_at. This EST refers to the sequence with the accession 
number AA655823, and the unigene cluster Mm.4293. Real time RT-PCR was 
performed on the sequence to ensure that the expression profile seen by the Affymetrix 
arrays could be confirmed (fig 6.6). Following differentiation, there is a progressive 
upregulation of the expression of the sequence, starting off slowly, but increasing more 
after day 6 until day 12, when it is expressed at over four and a half times the level of ES 
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Figure 6.6 	Expression profile of 100466_f at 
Affymetrix and Q-RT-PCR expression of 100466J_at over the course of the differentiation. 
The expression of 100466f at increases from the level seen in ES cell after day 6, to over four 
times the level seen in ES cells by day 12. 
To check the expression profile of the sequence in the developing mouse 
embryo, in situ primers were designed against the EST sequence, and hybridised to a 
series of embryos at different stages of development (fig 6.7). The expression profile of 
100466f at is initially restricted to the trophectoderm at E8.5, and there is no 
expression in the embryo proper. AT E10.5 100466f at is expressed in the surface 
ectoderm of the embryo, and there is no expression in the developing neural tube. So 
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although the in vitv expression profile is similar to genes involved in neurogenesis, 




Figure 6.7 	In situ expression of 100466f at at E8.5 and E10.5 
The expression of 100466f at at E8.5 is just in the trophectoderm, with no expression in the 
embryo (A). At E10.5, the expression is restricted to the surface ectoderm of the embryo (B-D). 
6.3.2 96885_at 
A second EST was also identified to have an expression profile suggestive of 
involvement in neurogenesis is the Affymetrix probe set 96885_at. This fragment refers 
to the accession number AW122271, which is also the RIKEN cDNA 2510015F01. 
Real time RT-PCR was performed on the sequence to ensure that the expression profile 
seen by the Affymetrix arrays could be confirmed (fig 6.8). Although it appears to be 
expressed in ES cells, following differentiation the sequence is not upregulated until day 
10, when it expressed at 50%  greater than the level in ES cells, then at day 12 it is 














Figure 6.8 	Expression profile of 96885_at 
Affymetrix and Q-RT-PCR expression of 96885_at over the course of the differentiation. The 
expression of 96885_at increases from the level seen in ES cell after day 10, to almost double 
the level seen in ES cells by day 12. 
To check the expression profile of the sequence in the developing mouse 
embryo, in situ primers were designed against the EST sequence, and hybridised to a 
series of embryos at different stages of development (fig 6.9). The expression profile of 
96885_at at E10.5 is in the surface ectoderm of the embryo, and there is no expression 
in the developing neural tube. So although the in vitro expression profile is similar to 
genes involved in neurogenesis, 96885_at is unlikely to have any role in neurogenesis. 
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Figure 6.9 	In situ expression profile of 96885_at at E10.5 
The expression of 96885_at at E10.5 is restricted to the surface ectoderm of the embryo, with 
no expression in the developing neural tube (A-C). 
6.4 	Discussion 
Analysing the expression profiles of genes known to be important for 
neurogenesis and then looking for genes that have a similar expression profile can 
identify genes that were previously known to be important for neurogenesis, and genes 
which were previously uncharacterised and expressed in neural tissue of the developing 
embryo. 
F115 was already known to be expressed in developing neural tissue, but the 
exact function remains unknown. It is thought to be a target of SHH signalling, due to 
its absence when SHH is not present (Ishibashi and McMahon, 2002). However as it is 
upregulated here before shh, this suggests that is either not dependent upon SHH for 
expression, or it is expressed in other regions in a SHH independent manner. The 
effect of FGFI5 on the differentiating cells is quite dramatic, as it increases the number 
of neurons, but has little effect on the number of non-neuronal cells or cell death. The 
highly significant increase in the number of neurons without decreasing the number of 
non-neuronal cells suggests that there is increased proliferation and differentiation of 
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one or more cell types that may differentiate directly to neurons, and neuronal 
differentiation of these cells may be enhanced. FGFI 5 may be involved in the 
upregulation of tf4, although is not sufficient for its expression (Isbibashi and 
McMahon, 2002). FGFI5 may increase yc1inD1, accumulation in the cells, which will 
lead to an increase in proliferation of a progenitor population (Isbibasbi and McMahon, 
2002). If this is the case, a particular progenitor population that generated 
predominantly neurons could be being expanded, or there could be a dual effect of an 
increase in the progenitor population combined with promoting neuronal 
differentiation. 
Creatine kinase (brain) is upregulated during the differentiation of ES cells to 
neurons, the expression pattern of ckb shows that is expressed throughout the neural 
tube; it is interesting that the expression is restricted to predominantly the dorsal side of 
the embryo, with very little expression in the ventral side, although it does appear to be 
expressed. The expression profile suggests that it is being expressed in new-born 
neurons, although it may also be expressed in cells that are still capable of division, as 
there appears to be migration towards the dorsal side of the neural tube, as the intensity 
of staining decreases with increasing distance away from the dorsal side. 
Following the addition of creatine phosphate, there is a very highly significant 
increase the in the number of neurons, but little change in the number of non-neuronal 
cells and cell death. Although creatine phosphate is a component of an intracellular 
pathway, it must be taken up by the cells, into the cytoplasm. The action of creatine 
phosphate and creatine kinase could be a number of mechanisms that lead to an 
increase in the number of neurons. Firstly there will be an increase in the amount of 
ATP in the cells, this will lead to increased survival of neurons, and possibly other cell 
types, mitosis and neurogenesis are energy dependent processes, so an increase in ATP 
could simply increase the rate of division of the cells, which leads to more neurons. An 
increase of ATP in the cells caused by creatine phosphate will also lead to an 
accumulation of cyclic GMP and nitrous oxide, both of which have been shown to 
promote neurogenesis (Cheng et al., 2003; Zhang et al., 2002). So Ckb could be acting 
in a number of cell types to increase the number of cells, and convert neural progenitors 
to neurons, although it is unclear whether this is through the same or independent 
pathways. To better dissect the mechanism of action of creatine kinase would require 
further experiments. To separate the three different modes of action, NO or cGMP 
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inhibitors could be added singly or in combination to determine whether their increase 
contributes to the increase in the number of neurons. Taken together the expression 
profile data for ckb and the effect of adding creatine phosphate suggest a potential role 
in vivo for ckb in regulating neurogenesis. 
The expression profiles of the two ESTs are disappointing from the point of 
view of identifying previously uncharacterised genes that are important for 
neurogenesis. The expression profile following differentiation suggests that they may be 
expressed during neurogenesis, they are not expressed in the developing neural tube. 
These results demonstrate a weakness in the expression profile study carried out 
because cells other than neural cells are being generated during the differentiation and 
an expression profile that is similar to genes that are known to be important for 
neurogenesis does not necessarily mean that they are involved in neurogenesis. 
However, many other uncharacterised genes are also upregulated during the 
differentiation, and further study could yield new candidates that are important for 
neurogenesis. A future approach would require screening by in situ hybridisation novel 
candidates. 
6.5 	Summary 
• Analysis of genes with similar expression profiles to genes known to be 
important for neurogenesis can yield new candidates 
• The involvement of known genes in neurogenesis can be tested by their effect 
on ES cell neurogenesis 
• Both fjl5 and ckb appear to be important for neurogenesis, 
• Previously uncharacterised genes that were chosen here are not expressed in 
neural tube, but further characterisation of other genes could yield candidates 
important for neurogenesis 
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7 	General Discussion 
	
7.1 	Targeting mapt 
The initial aim of this project was to create an ES cell line that can be 
differentiated to obtain a pure population of neurons through lineage selection. The 
first step in this process was to generate an ES cell line that expressed an eGFP reporter 
gene under the transcriptional regulation of the neuronal specific gene ma t. Mapt was 
successfully targeted into ES cells with the eGFP containing targeting vector provided by 
K. Tucker and Y. Barde. The targeting was confirmed by Southern blotting, but the 
exact targeting efficiency was not possible to determine due to the difficulties associated 
with confirming correct 5' targeting, due to the non-specific binding of the 5' probe. 
The correctly targeted bands were difficult to identify above background when large 
numbers of clones were analysed simultaneously. 
The choice of the mapt locus for targeting was fortuitous due to the expression 
pattern of mapt following differentiation of ES cells. It is expressed at an early stage of 
neuronal differentiation, before map2, another neuronal microtubule protein. Using the 
TK23 ES cells the efficiency of the differentiation could be followed by flow cytometry, 
to analyse at each stage what was the proportion of the total number of cells that 
express eGFP, and are hence neurons. 
7.2 	Altering neuronal differentiation efficiency 
Through the addition of exogenous factors and altering the density of the 
differentiating cultures, the final number of neurons obtained at the end of the 
differentiation was optimised. Each of these effects provides an interesting handle into 
the possible mechanisms regulating neural and neuronal differentiation of ES cells. By 
interpreting the findings from these experiments in light of the results from the 
transcriptome analysis, the reason for the effect of adding the factors may be better 
understood. Although it must be stressed that two different differentiation protocols 
were used in each differentiation, independent experiments suggest that the cell types 
that arise following monolayer differentiation have a similar profile to the results 
obtained from serum-free EB differentiation (S. Pollard unpublished). It may be that 
the effect of a factor may be partially masked because the factor is being expressed at 
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saturating levels during the differentiation or redundant interactions through other 
related proteins. A good example of this might be the involvement of FGF signalling 
pathway FGF2 and FGF4 are both expressed during differentiations. 
The most striking effect on neuronal differentiation was seen following the 
addition of SHH. It had the greatest impact on the increase in the proportion of 
neurons of the total population. Shh is not expressed at the corresponding stage of EB 
differentiation, but the receptor for SHH, Pici, is expressed. At the equivalent stage of 
development to the differentiating cells, sbb would already be being expressed from the 
notochord and the floor plate, but as it is absent in the differentiation at this stage, the 
effect may be dramatic because receptors are available to be supplied with SHH, but 
there was not any present until it is added exogenously. It is important to note here that 
although many of the genes associated with neurogenesis are being expressed in the 
differentiation, they may not be expressed at the same time, and in the context of others 
factors that are normally present during embryonic development. Hence, to direct 
differentiation of ES cells to a particular lineage, the factors that they are producing, 
along with any exogenous factors that are added are likely to affect the differentiation, 
and alterations in the protocol must be made accordingly. 
A number of the factors that are having an effect, including NT-3, BDNF and 
EGF, do not appear to have receptors being expressed form the microarray results 
(Appendix), though this has not been examined comprehensively. This could be 
different in the monolayer protocol to the EB differentiation, as it is unclear which 
receptors are being expressed as they are differentiated. However, there may also be a 
positive feedback loop, with the receptors being present at low levels on the cells, but 
with the addition of the factor which binds the receptors, they are upregulated. 
To further characterise the effects of each of the factors, greater refinement to 
the experimental protocol is needed. The proliferation, differentiation and cell death in 
neural progenitors and neurons could be analysed following the addition of an 
exogenous factor or changing the density. Using a series of markers for these events, 
combined with markers for the different cell types should help to elucidate which cells 
are being affected, and how they are being affected. 
The factor suggested to be involved in controlling the differentiation efficiency 
after altering the density of the differentiating cells was the Notch pathway. Genes from 
the Notch pathway are expressed in the differentiation from day 6, the time when 
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neurons start to emerge in monolayer differentiation, implying that these genes are 
involved in ES cell neuronal differentiation. Further characterisation of the effect of the 
Notch pathway could be performed, such as differentiation of ES cells with a targeted 
deletion of the Notchi receptor. If this increases the efficiency of the differentiation, 
then the effect of density must be at least partially mediated by Notch. 
7.3 	Cell sorting 
Fluorescent activated cell sorting (FACS) has been heralded as an extremely 
useful mechanism by which to isolate discrete populations of cells from any 
heterogeneous pool of cells based on one or a number of different characteristics (Dc 
Rosa et al., 2003; Nolan et al., 1988). FAGS on the differentiated TK23 cells can yield a 
pure population of neurons, but the number of neurons that are obtained following 
sorting is low, especially if two rounds of sorting are required to achieve a pure 
population of neurons. There are a number of technical issues associated with FAGS 
that affect the number of cells isolated following sorting. Many FAGS experiments are 
designed to isolate rare populations of cells, although neurons are not the largest 
population of cells in the differentiation, they cannot be described as rare. Many sorting 
experiments also use multiple markers to a characterise the different cell populations, so 
greater confidence can be attached to the identity of the cells, and positive or negative 
expression of a particular marker in many different channels means that the gating does 
not have to be as conservative as when gating on a small number of channels. Only a 
small number of channels were simultaneously measured when trying to isolate a pure 
population of neurons from TK23 cells. The gating had to be quite conservative to try 
and exclude as many non-eGFP positive cells as possible, which inevitably leads to the 
exclusion of many eGFP positive cells, thus reducing the number of cells achieved. 
Due to the low number of cells that were isolated from the total population it was 
difficult to perform experiments on the purified neurons. A further problem associated 
with sorting is cell survival. FAGS is a very stressful to cells; the cells are first 
trypsinised, then kept on ice until sorting, before being passed through the sorter and 
then placed on ice again until plating. All of these stages induce stress in the cells, and 
reduces the probability that the neurons will survive the sorting, especially following 
removal of all neurites. Further, it may induce unwanted stress response pathways that 
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may impact on differentiation efficiency. These cells are then plated into serum-free, 
defined medium, so few trophic molecules are present in the medium to aid survival. 
Although FAGS could generate a pure population of neurons, for future work it 
may be better to redesign the reporter cassette in the inapt locus. This could be by the 
introduction of a selection marker, enabling neurons to be selected from all other cells 
on the basis of drug resistance. The selectable marker best suited to this would be 
neomycin resistance, as only one molecule from the neomycin resistance gene confers 
neomycin resistance a cell it is being expressed in. The cassette already contains 
ubiquitous neomycin resistance, so the whole cassette would have to be reconstructed. 
If this were the case then the fluorescent protein should be changed to a red fluorescent 
protein so that the construct can be inserted into 46CT (supertransfectable 46C) ES 
cells (Ying et al., 2003a). This would produce a cell line of great utility for studying the 
conversion of neural progenitors to neurons, as both cell types could be simultaneously 
quantified. 
7.4 	ES Cells and the default model of neural induction 
ES cells are thought to be equivalent to cells in the inner cell mass of the 
blastocyst, so the conversion of ES cells to neural cells can be seen as analogous to 
neural induction. The transcriptome analysis provides more clues as to why the 
differentiation of ES cells to neural progenitors is better reconciled with FGFs being 
required for neural induction than a requirement of BMP antagonism. It has previously 
been demonstrated that FGFR antagonism inhibits neural induction of ES cells, and the 
addition of exogenous BMP antagonists has little effect on neural induction. The 
expression profiles of FGFs and BMPs here show that FGFR2 is upregulated during 
normal differentiation of ES cells, suggesting a requirement for FGF signalling. There 
is no upregulation of any FGF molecules at this time, suggesting that it is fgf4, which is 
already been expressed that must be responsible for signalling through FGFR2. It was 
previously thought that Follistatin is expressed at high levels in ES cells, and this does 
not seem to be the case from the expression results seen here, no BMP antagonists 
appear to be expressed at high levels in ES cells. The expression of BMPs does not 
increase following the initial differentiation of ES cells, suggesting that there is little 
BMP to antagonise, and initial neural induction is normally independent of BMP, 
although exogenous BMP can inhibit neural induction (Ying et al., 2003b). However it 
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is unclear from these experiments whether BMP inhibits neural induction or converts 
cells that have been converted to neural progenitors to another cell type. 
7.5 	Neuronal differentiation 
ES cells have been differentiated to a number of different neuronal subtypes in 
m!t,v, so the lack of a diverse range of neuronal subtypes is not due to ES being unable to 
differentiate into an array of different neurons. There could be a number of possible 
reasons for this apparent lack of diversity, the first is that the neurons were produced 
but did not survive. This is not likely because there are probably some residual neurons 
in the differentiation of various types at the later timepoints even if they were 
differentiating and dying, but as there is no expression of other neurotransmitters above 
background level they are probably not being formed. This leads on to the second 
point; neurons may not have had enough time to differentiate to the final mature 
phenotype, and had not started to express neurotransmitters, this may be a possibility, 
because neurons can take a long time to form a final phenotype, but a more probable 
reason is that they did not receive the correct signals or had the correct substrate on 
which to differentiate. Various neuronal subtypes have been seen following ES cell 
differentiation, but unless the protocol is altered through the addition of exogenous 
factors, these cells often remain a rare population, so the presence of glutamatergic and 
GABAergic specific RNA, was probably due to the correct signals required for the 
generation of these cells were present already in the differentiation, but the signals 
required for other neuronal subtypes to be formed were not present. 
It was unexpected that neurons differentiated to the extent that that they did in 
the EBs. It is perceived that during ES cell differentiation, neurons need to be plated 
onto an adhesive substrate in order to form and extent neuntes, and then form synaptic 
connections with other neurons. However, differentiation to neurons is happening in 
the EBs, as can be seen by the expression of more mature neuronal markers. This may 
be because the cells are in an environment that is permissive for the differentiation of 
neurons, but due to the expression of a large number of inhibitory factors such as bmps 
and notch, there is much less neuronal differentiation than when the cells are 
differentiated at lower density on an adhesive substrate. 
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7.6 	New candidate genes 
Four genes were identified from the differentiation that had an expression 
profile that suggesting a role during neurogenesis. Two of those genes had been 
previously characterised, and two had not. Fj15 has previously been described to be 
expressed in the developing neural tube, but the exact function of it was unknown. It 
has been suggested that it may increase the expression of tff4 (Ishibashi and McMahon, 
2002), which would partially fit with the effects seen here as tcf4 is inhibited by Writ 
signalling, which is known to inhibit neurogenesis. Further examination of the role of 
FGFI 5, and the exact populations that it affects would be necessary to identify its exact 
mode of action. 
Creatine kinase (brain) is known to be expressed in the adult CNS, but its role 
during development was not known. It appears as though it may be expressed in 
specific progenitor cells, and when it is used to increase the amount of ATP in a cell by 
the addition of creatine phosphate, cell number and neuronal number is increased. This 
is a potentially very good candidate for increasing the number of neurons following ES 
cell differentiation. Creatine phosphate is a cheap exogenous molecule that can be easily 
added to the medium, it may aid neuronal survival as well as increasing proliferation but 
further work would be required to see the effect that it has on the phenotype of the 
neurons in the differentiation. This is either through the promotion of particular 
neuronal cell types to differentiate or to survive. 
The two ESTs that were analysed do not appear to be expressed in the 
developing nervous system at the stages that were analysed. Although they have an 
expression profile that correlates with other genes known to be important during neural 
and neuronal differentiation, they do not appear to be involved. It is not unsurprising 
that genes expressed in surface ectoderm arose during the differentiation, because 
surface ectoderm has the same germ layer origin as neural tissue and is physically closely 
associated with neural tissue during the development of the murine embryo (Hogan et 
al., 1994). 
Many other ESTs remain uncharacterised in this experiment, some of which 
have an expression profile that is suggestive of being expressed in neural tissue. Further 
characterisation of these genes is possible, but this would be more efficient if genes 
known not to be involved in neurogenesis could be excluded from the data. This could 
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be an in szlitv approach, and subtract the data from other Affymetrix data containing 
expression data about genes known to be expressed in neural tissue. 
A second approach using independent biological samples could help to identify 
more relevant candidate molecules. An experiment was carried out using FACS to 
isolate specific populations of differentiated cells based upon the expression of eGFP. 
Using the 46C and TK23 ES cell lines, differentiations were made and the total 
populations of cells were sorted to achieve populations that represented neural 
progenitor cells and neurons. Enough material was generated to perform quantitative 
real-time PCR; however, upon analysis of the expression patterns markers of ES cells, 
neural precursors, and neurons, the expression profiles did not match the expected 
outcomes. Therefore, the data could not be used to accurately predict the expression 
pattern of any candidate genes. For future work this confirmation step could be added 
by generating samples obtained by drug selection, rather than FAGS, which would 
reduce the variation introduced due to FAGS, and enable much larger samples of RNA 
to be generated simultaneously. A reliable independent analysis of expression profiles 
would save time and resources and enable samples that are expressed in the desired 
populations of cells to be focussed upon. 
7.7 	Applications of the data 
One of the most useful applications for this data will be as a baseline for future 
experiments looking at neuronal differentiation of ES cells. Subsequent transcriptome 
analysis experiments can be performed using either the Affymetrix platform or using 
cDNA arrays, but the differentiation can be in the presence of exogenous factors, or 
using a genetically modified ES cell line. Changes in the expression profile caused by 
the addition of the factor or the presence of the genetic alteration will cause changes in 
the gene expression profiles of genes associated with this alteration. This could provide 
information about the effect of alteration on the target genes, and help to give an 
explanation as to how and why the changes are altering the differentiation. 
Furthermore, this could lead to the identification of genes not previously known to be 
associated with either the pathway of the added factor or the genetic alteration. 
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7.8 Summary 
The general objective of this work was to investigate the mechanism involved in 
the conversion of ES cells to neurons, and more specifically the conversion of neural 
stem cells to neurons. The experiments described further characterise how ES cells 
differentiate to neurons and the mechanisms that are involved in the conversion of ES 
cells to neurons. The conversion can be manipulated by altering the differentiation 
conditions of the cells. By using microarrays to analyse the transcriptome of 
differentiating ES cells, it can be shown that ES cell neurogenesis partially mimics the 
events of development, with differentiation occurring over a similar timescale and 
involving genes known to be important for normal development. This data can also be 
used to identify genes that were not previously known to be involved in the neuronal 
differentiation of ES cells. Further analysis of the data is likely to yield novel insights 
into mechanisms of in neurogenesis. 
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8 Appendix 
Experiment Total cell Number of Soil GFP +ve Proportion of Soil GFP 
Number number Cells +ve Cells 
1 100000 92367 92.367 
2 100000 94678 94.678 
3 100000 93467 93.467 
Average 100000 	 93504 	 93.504 
Figure 8.1 Differentiation efficiency preceding factor addition 
Proportion of soxi eGFP positive cells at day six following monolayer differentiation, preceding 
the addition of exogenous factors 
Profile of All Genes Expressed During 
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Figure 8.2 	Profile of all genes expressed during differentiation 
The changing expression profile of all genes over the course of the differentiation cannot be 
readily analysed due to the high density of the data 
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Gene 
Name ES Cells PDC Day 2 Day 4 Day 6 Day 8 Day 10 Day 12 
TrkB 20 20 20 20 20 20 20 20 
TrkC 20 20 20 20 20 20 20 20 
Egf 20 20 20 20 20 20 20 20 
Egfr 20 20 20 20 20 20 20 20 
Egfr 20 20 20 20 20 20 20 20 
Egfr 20.01702 23.30595 20 20 20 20 20 20 
Figure 8.3 	EGF and Trk receptor expression 
The table shows the mean fluorescence level for each of the receptors over the course of the 




































Figure 8.4 	Real time primers 




Creatine Kinase (Brain) 	gaatcctcacctgggctaca 	caaacatcaaggatgcatgg 
100466f at 	 cttgttcgcggttccttg gcaggcatttattgacaagga 
96885_at agatggctctgctgtcctgt 	tcaccgaagtagagcacacg 
Figure 8.5 	In situ primers 
Primers designed to clone sequence for in situ hyL ndisation 
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GO Biological Process Description Name in Graph 
- Not Classified 
35S primary transcript processing Other 
acetyl-00A biosynthesis Metabolism 
acetyl-00A biosynthesis from pyruvate Metabolism 
acetyl-00A metabolism Metabolism 
acrnsome formation Other 
actin cytoskeleton organization and biogenesis Cytoskeleton 
actin cytoskeleton organization and biogenesis cytoskelton 
actin filament organization cytoskeleton 
actin filament severing cytoskeleton 
actin filament-based movement cytoskeleton 
activation of MAPK signal transduction 
activation of MAPK signal transduction 
acute-phase response Other 
acyl-CoA metabolism Metabolism 
acyl-CoA metabolism Metabolism 
aldehyde metabolism Nucleic acid metabolism 
amino acid biosynthesis Nucleic acid metabolism 
amino acid metabolism Nucleic acid metabolism 
amino acid metabolism Nucleic acid metabolism 
amino acid transport Nucleic acid metabolism 
angiogenesis Other 
anti-apoptosis Apoptosis 
antigen processing, exogenous antigen via MHC class II Other 
apoptosis Apoptosis 
apoptosis Apoptosis 
aromatic compound metabolism Metabolism 
aromatic compound metabolism Metabolism 
asparagine biosynthesis Nucleic acid metabolism 
ATP biosynthesis Metabolism 
ATP hydrolysis coupled proton transport Metabolism 
ATP synthesis coupled proton transport Metabolism 
autophagic vacuole formation Other 
autophagy Other 
B-cell homeostasis Other 
behavioral fear response Other 
beta-alanine transport Nucleic acid metabolism 
binding of sperm to zona pellucida Development 
binding of sperm to zona pellucida Development 
biosynthesis Metabolism 
biosynthesis Metabolism 
blood coagulation Other 
blood vessel development Development 
brain development Development 
branching morphogenesis Development 
calcium ion homeostasis Metabolism 
calcium ion transport Metabolism 
calcium-dependent cell-cell adhesion Cell adhesion 
calcium-mediated signaling signal transduction 
cAMP biosynthesis Metabolism 
carialicular bile acid transport Other 
carbohydrate biosynthesis Metabolism 
carbohydrate metabolism Metabolism 
carbohydrate metabolism Metabolism 
cartilage condensation Development 
catabolism Metabolism 
catecholamine metabolism Metabolism 
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cation transport Other 
cell adhesion Cell adhesion 
cell adhesion Cell adhesion 
cell communication signal transduction 
cell cycle Cell cycle 
cell cycle Cell cycle 
cell cycle arrest Cell cycle 
cell cycle arrest Cell cycle 
cell death Apoptosis 
cell differentiation Development 
cell fate determination Development 
cell fate specification Development 
cell growth Cell growth 
cell growth and Cell growth 
cell motility cell motility 
cell motility cell motility 
cell organization and biogenesis Cell growth 
cell proliferation Cell cycle 
cell proliferation Cell cycle 
cell surface receptor linked signal transduction signal transduction 
cell surface receptor linked signal transduction signal transduction 
cell-cell adhesion Cell adhesion 
cell-matrix adhesion Cell adhesion 
cell-substrate junction assembly signal transduction 
cellular defense response Other 
cellular morphogenesis Cell growth 
cellular morphogenesis during differentiation Cell growth 
central nervous system development Development 
chemotaxis signal transduction 
chemotaxis signal transduction 
cholesterol biosynthesis Metabolism 
cholesterol metabolism Metabolism 
cholesterol metabolism Metabolism 
chromatin assembly or disassembly Chromatin organisation 
chromatin assembly or disassembly Chromatin organisation 
chromatin modification Chromatin organisation 
chromatin remodeling Chromatin organisation 
chromosome organization and biogenesis (sensu Eukaryota) Chromatin organisation 
circadian rhythm Other 
complement activation Other 
cotranslational protein-membrane targeting Other 
creatine biosynthesis Metabolism 
cytokinesis Cell division 
cytokinesis Cell division 
cytoskeleton organization and biogenesis Cytoskelton 
cytoskeleton organization and biogenesis cytoskeleton 
D-amino acid catabolism Metabolism 
de novo pyilmidine base biosynthesis Nucleic acid metabolism 
defense response Other 




DNA damage checkpoint DNA processing 
DNA integration DNA processing 
DNA metabolism DNA processing 
DNA meth,lation DNA processing 
DNA packaging DNA processing 
DNA packaging DNA processing 
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DNA recombination DNA processing 
DNA repair DNA processing 
DNA repair DNA processing 
DNA replication DNA processing 
DNA replication DNA processing 
DNA replication and chromosome cycle DNA processing 
DNA topological change DNA processing 
DNA-dependent DNA replication DNA processing 
dopamine receptor signaling pathway signal transduction 
dTDP biosynthesis Metabolism 
electron transport Other 
electron transport Other 
embryonic development (sensu Mammalia) Development 
endocytosis Other 
endocytosis Other 
endoderm development Development 
endosome transport Transport 
epidermal growth factor receptor signaling pathway signal transduction 
epithelial to mesenchymal transition Other 
establishment and Other 
establishment of epithelial cell polarity Other 
exocytosis Transport 
eye morphogenesis Development 
eye photoreceptor cell differentiation Development 
Fast- biosynthesis Metabolism 
fatty acid biosynthesis Metabolism 
fatty acid biosynthesis Metabolism 
fatty acid elongation Metabolism 
fatty acid metabolism Metabolism 
fatty acid metabolism Metabolism 
fertilization (sensu Metazoa) Development 
fructose 2,6-bisphosphate metabolism Metabolism 
fucose metabolism Metabolism 
Gi Cell cycle 
gluconeogenesis Metabolism 
glucose catabolism Metabolism 
glucose metabolism Metabolism 
glucose metabolism Metabolism 
glutathione biosynthesis Metabolism 
glutathione metabolism Metabolism 
glycerol metabolism Metabolism 
glycerol-3-phosphate metabolism Metabolism 
glycine metabolism Metabolism 
glycine metabolism Metabolism 
glycogen biosynthesis Metabolism 
glycogen metabolism Metabolism 
glycolysis Metabolism 
glycolysis Metabolism 
glycosaminoglycan biosynthesis Metabolism 
G-protein coupled receptor protein signaling pathway Signal transduction 
G-protein coupled receptor protein signaling pathway Signal transduction 
G-protein signaling, coupled to cGMP nucleotide second messenger Signal transduction 
GTP biosynthesis Metabolism 
heme metabolism Metabolism 
hormone-mediated signaling Signal transduction 
1-kappaB kinase Signal transduction 
Immune response Other 
Immune response Other 
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imprinting Development 
Induction of apoptosis Apoptosis 
inflammatory response Other 
inhibition of caspase activation Other 
Insulin receptor signaling pathway Signal transduction 
lntegnn-mediated signaling pathway Signal transduction 
integrin-mediated signaling pathway Signal transduction 
intermediate filament cytoskeleton organization and biogenesis Cytoskeleton 
intracellular protein transport Transport 
intracellular protein transport Transport 
Intracellular signaling cascade Signal transduction 
intracellular signaling cascade Signal transduction 
Ion transport Transport 
Ion transport Transport 
iron ion transport Transport 
JAK-STAT cascade Signal transduction 
JNK cascade Signal transduction 
L-cysteine catabolism to taurine Metabolism 
L-glutamate transport Metabolism 
lipid catabolism Metabolism 
lipid catabolism Metabolism 
lipid metabolism Metabolism 
lipid transport Transport 
lipid transport Transport 
L-phenylalanine catabolism Metabolism 
L-serine biosynthesis Metabolism 
lymph gland development Development 
main pathways of carbohydrate metabolism Metabolism 
malate metabolism Metabolism 
MAPKKK cascade Signal transduction 
meiosis Cell division 
melanin biosynthesis from tyrosine Metabolism 
melanin biosynthesis from tyrosine Metabolism 
memory Other 
mesoderm formation Development 
metabolism Metabolism 
metabolism Metabolism 
metabotropic glutamate receptor signaling pathway Signal transduction 
metal ion homeostasis Other 
metal ion transport Other 
metanephros development Development 
methionine metabolism Metabolism 
methionyl-tRNA aminoacylation RNA processing 
microtubule bundle formation Cytoskeleton 
microtubule stabilization Cytoskeleton 
microtubule-based movement Cytoskeleton 
microtubule-based movement Cytoskeleton 
microtubule-based process Cytoskeleton 
microtubule-based process Cytoskeleton 
mitochondrial genome maintenance Other 
mitotic metaphase Cell division 
morphogenesis of an epithelial sheet Development 
mRNA processing RNA processing 
mRNA processing RNA processing 
mRNA splice site selection RNA processing 
muscle contraction Other 
muscle contraction Other 
muscle development Other 
myelination Development 
194 
myoblast differentiation Development 
myogenesis Development 
myo-inositol biosynthesis Metabolism 
N-acetglucosamine metabolism Metabolism 
negative regulation of apoptosis Apoptosis 
negative regulation of cell cycle Cell cycle 
negative regulation of mitotic cell cycle Cell cycle 
negative regulation of protein kinase activity Signal transduction 
negative regulation of protein kinase activity Signal transduction 
negative regulation of transcription Transcription 
negative regulation of transcription from P0111 promoter Transcription 
negative regulation of transcription from Pol II promoter Transcription 
negative regulation of transcription, DNA-dependent Transcription 
neural tube closure Development 
neurogenesis Development 
neurogenesis Development 
neuromuscular junction development Cell adhesion 
neuronal migration Development 
neuropeptide signaling pathway Signal transduction 
neuropeptide signaling pathway Signal transduction 
neurotransmitter transport Signal transduction 
nitrogen fixation Other 
nitrogen metabolism Other 
NOT cytoskeleton organization and biogenesis Cytoskeleton 
NOT regulation of cell cycle Cell cycle 
Notch signaling pathway Signal transduction 
Notch signaling pathway Signal transduction 
nuclear mRNA splicing, via spliceosome RNA processing 
nuclear mRNA splicing, via spliceosome RNA processing 
nudeobase, nucleoside, nucleotide and nucleic acid metabolism Nucleic acid metabolism 
nucleobase, nucleoside, nucleotide and nucleic acid metabolism Nucleic acid metabolism 
nucleocytoplasmic transport Transport 
nucleolus organization and biogenesis Transport 
nucleoside metabolism Nucleic acid metabolism 
nucleoside metabolism Nucleic acid metabolism 
nudeosome assembly Transcription 
nucleosome assembly Transcription 
nucleotide metabolism Nucleic acid metabolism 
nucleotide metabolism Nucleic acid metabolism 
0-linked glycosation Metabolism 
one-carbon compound metabolism Metabolism 




osteoblast differentiation Development 
ovarian follicle development Development 
pentose-phosphate shunt Metabolism 
peptide hormone processing Metabolism 
peptide metabolism Metabolism 
peptidyl-proline hydroxylation to 4-hydroxy-L-proline Metabolism 
peroxisome organization and biogenesis Metabolism 
peroxisome organization and biogenesis Metabolism 
phagocytosis, recognition Other 
phosphate transport Transport 
phosphate transport Transport 
phosphatidic acid biosynthesis Nucleic acid metabolism 
phosphatidyicholine biosynthesis Nucleic acid metabolism 
phosphoenolpyruvate-dependent sugar phosphotransferase system Nucleic add metabolism 
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phospholipid metabolism Metabolism 
phototransduction Other 
physiological process Other 
plasma membrane organization and biogenesis Other 
plasma membrane repair Other 
polyamine biosynthesis Other 
polysaccharide biosynthesis Metabolism 
porphyrin biosynthesis Metabolism 
positive regulation of cell proliferation Cell cycle 
posttranslational protein-membrane targeting Other 
potassium ion transport Transport 
potassium ion transport Transport 
prenylcysteine catabolism Metabolism 
proline biosynthesis Nucleic add metabolism 
proline biosynthesis Nucleic add metabolism 
prostaglandin biosynthesis Metabolism 
protein amino add ADP-ribosylation Protein modification 
protein amino add ADP-ribosylation Protein modification 
protein amino add dephosphorylation Protein modification 
protein amino add dephosphorylation Protein modification 
protein amino add glycosylation Protein modification 
protein amino acid phosphorylation Protein modification 
protein amino add phosphorylation Protein modification 
protein biosynthesis Protein modification 
protein biosynthesis Protein modification 
protein catabolism Protein modification 
protein catabolism Protein modification 
protein complex assembly Protein modification 
protein deubiquitination Protein modification 
protein folding Protein modification 
protein folding Protein modification 
protein kinase C activation Protein modification 
protein metabolism Protein modification 
protein modification Protein modification 
protein modification Protein modification 
protein prenylation Protein modification 
protein prenylation Protein modification 
protein repair Protein modification 
protein targeting Protein modification 
protein targeting Protein modification 
protein transport Transport 
protein transport Transport 
protein ubiquitination Protein modification 
protein ubiquitination Protein modification 
protein-Golgi targeting Transport 
protein-nucleus export Transport 
protein-nucleus Import Transport 
protein-nudeus import, docking Transport 
protein-nucleus import, translocation Transport 
proteolysis and peptidolysis Protein modification 
proteolysis and peptidolysis Protein modification 
proton transport Transport 
provirus integration Other 
purine nucleotide biosynthesis Nucleic acid metabolism 
punne nucleotide metabolism Nucleic acid metabolism 
purine ribonudeoside salvage Other 
pyrimidine base metabolism Nucleic acid metabolism 
pyilmidine nucleotide biosynthesis Nucleic acid metabolism 
Ras protein signal transduction Signal transduction 
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receptor mediated endocytosis Transport 
regulation of blood pressure Other 
regulation of cell cycle Cell cycle 
regulation of cell cycle Cell cycle 
regulation of cell growth Cell growth 
regulation of cell proliferation Cell cycle 
regulation of cell shape Cell growth 
regulation of cell shape Cell growth 
regulation of complement activation Other 
regulation of cydin dependent protein kinase activity Signal transduction 
regulation of G-protein coupled receptor protein signaling pathway Signal transduction 
regulation of JNK cascade Signal transduction 
regulation of muscle contraction Other 
regulation of muscle contraction Other 
regulation of pH Other 
regulation of protein biosynthesis Metabolism 
regulation of S phase of mitotic cell cycle Cell cycle 
regulation of smoothened receptor activity by patched Signal transduction 
regulation of transcription Transcription 
regulation of transcription from Pol II promoter Transcription 
regulation of transcription from P0111 promoter Transcription 
regulation of transcription, DNA-dependent Transcription 
regulation of transcription, DNA-dependent Transcription 
regulation of translation Transcription 
regulation of translational initiation Transcription 
release of cytochrome c from mitochondria Other 
response to add Other 
response to arsenate Other 
response to osmotic stress Other 
response to oxidative stress Other 
response to reactive oxygen species Other 
response to stress Other 
response to superoxide Other 
retinoid metabolism Metabolism 
retinoid metabolism Metabolism 
rhythmic behavior Other 
ribosome biogenesis Metabolism 
ribosome biogenesis Metabolism 
RNA catabolism RNA processing 
RNA elongation from Pd II promoter RNA processing 
RNA processing RNA processing 
RNA processing RNA processing 
rRNA processing RNA processing 
rRNA processing RNA processing 
S-adenoslmethionine biosynthesis Metabolism 
sensory organ development Development 
signal transduction Signal transduction 
signal transduction Signal transduction 
skeletal development Development 
small GTPase mediated signal transduction Signal transduction 
small GTPase mediated signal transduction Signal transduction 
smooth muscle contraction Other 




spermidine biosynthesis Metabolism 
spermidine catabolism to deoxyhypusine, using deoxyhypusine 
synthase Metabolism 
spermine biosynthesis Metabolism 
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spermine catabolism Metabolism 
sphingolipid metabolism Metabolism 
sphingolipid metabolism Metabolism 
stem cell division Cell cycle 
steroid biosynthesis Metabolism 
sulfate assimilation Other 
sulfate transport Transport 
sulfur metabolism Metabolism 
superoxide metabolism Metabolism 
synaptic transmission Signal transduction 
telomere maintenance Other 
tetrahydrobioptenn biosynthesis Metabolism 
transcription Transcription 
transcription Transcription 
transcription from Pol II promoter Transcription 
transcription, DNA-dependent Transcription 
transforming growth factor beta receptor signaling pathway Signal transduction 
translational initiation RNA processing 
transmembrane receptor protein tyrosine phosphatase signaling 
pathway Signal transduction 
transport Transport 
transport Transport 
tRNA aminoacylation for protein translation RNA processing 
tRNA aminoacylation for protein translation RNA processing 
two-component signal transduction system (phosphorelay) Signal transduction 
ubiquitin cycle Protein modification 
ubiquitin-dependent protein catabolism Protein modification 
ubiquitin-dependent protein catabolism Protein modification 
UDP-N-acetylgalactosamine metabolism Metabolism 
UDP-N-acetytglucosamine biosynthesis Metabolism 
ureteric bud development Development 
urogenital system development Development 
vacuolar protein processing or maturation Development 
vasculogenesis Development 
very-long-chain fatty acid metabolism Metabolism 
vitamin K biosynthesis Metabolism 
vitamin metabolism Metabolism 
Wnt receptor signaling pathway Signal transduction 
xenobiotic metabolism Metabolism 
xenobiotic metabolism Metabolism 
zinc ion homeostasis Metabolism 
zinc ion transport Metabolism 
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Mouse embryonic stem (ES) cells are competent for production 
of all fetal and adult cell types'. However, the utility of ES cells as 
a developmental model or as a source of defined cell populations 
for pharmaceutical screening or transplantation is compromised 
because their differentiation in vitro is poorly controlled 2 . 
Specification of primary lineages is not understood and conse-
quently differentiation protocols are empirical, yielding variable 
and heterogeneous outcomes. Here we report that neither multi-
cellular aggregation 34 nor coculturet is necessary for ES cells to 
commit efficiently to a neural fate. In adherent monoculture, elim-
ination of inductive signals for alternative fates is sufficient for ES 
cells to develop into neural precursors. This process is not a sim-
ple default pathway, however, but requires autocrine fibroblast 
growth factor (FGF). Using flow cytometry quantitation and 
recording of individual colonies, we establish that the bulk of ES 
cells undergo neural conversion. The neural precursors can be 
purified to homogeneity by fluorescence activated cell sorting 
(FACS) or drug selection. This system provides a platform for 
defining the molecular machinery of neural commitment and opti-
nizing the efficiency of neuronal and glial cell production from 
luripotent mammalian stem cells. 
irhe task of directing ES cell commitment represents a challenge to 
snderstanding of germ layer diversification in vertebrate embryos. 
Fhe mechanism of neuroectoderm formation from pluripotent 
$ounder cells is controversial. Studies in Xenopus laevis and chick 
mbryos have given rise both to a permissive, or default, model 6 and 
Ito an instructive model'. For ES cell differentiation it has been 
shown that neural fates emerge in the absence of serum or added 
growth factors in multicellular aggregates' or in suspension culture 
f single cells8 . However, in the latter case this occurs in only a small 
4raction (0.1-0.2%) of the cells'. Higher levels of neural differentia-
ion are achieved by treatment of aggregates with retinoic acid in 
the presence of serum 3 or by coculture with a particular stromal cell 
line, PA6 (ref. 5). The action of retinoic acid is pleiotropic and of 
indeterminate physiological relevance, whereas the effect of PA6 
cells is attributed to an undefined neural inducing activity, stromal 
cell—derived inducing activity (SDIA) 5 . 
We developed a green fluorescent protein (GFP) knock-in 
reporter ES cell line to examine the process by which ES cells acquire 
neural identity. The open reading frame of the Sax) gene was 
Institute for Stem Cell Research. University of Edinburgh, King's Buildings, West 
Mains Road, Edinburgh E1-19 31Q. United Kingdom. 'Corresponding author 
(ausmith@'e4.acuk). 'These authors contributed equally to this erk 
replaced with the coding sequence for GFP and an internal ribo-
some entry site (IRES)-linked puromycin resistance gene. Soxi is 
the earliest known specific marker of neuroectoderm in the mouse 
embryo9 . It is first expressed in the neural plate and subsequently 
maintained in neuroepitheial cells throughout the entire neuraxis, 
but is downregulated during neuronal and glial differentiation. This 
highly restricted expression was recapitulated by the GFP reporter 
following germline transmission (Fig. IA). Fidelity of the Sox]-GFP 
reporter is likewise maintained in vitro. GFP was not detectable in 
undifferentiated ES cells (Fig. 1 B) but becomes evident in a signifi-
cant proportion of cells after induction of neural differentiation by 
aggregation and treatment with retinoic acid". 
We used Soxl-GFP knock-in (46C) ES cells to investigate 
whether multicellular aggregation was necessary for activation of 
Soxi expression and neural determination. ES cells were plated on 
gelatin-coated tissue culture plastic, and differentiation was trig-
gered by withdrawal of leukemia inhibitory factor (LIF). In 
serum-containing medium, Soxl-GFP positive cells did not 
appear. In the absence of serum, however, withdrawal of LIF 
resulted in the emergence of GFP-positive cells in the rosette con-
formations typical of neuroepithelial cells (Fig. 1C). When 46C 
cells were plated on gelatin-coated plastic in a conventional 
serum-free culture medium with N2 and B27 supplements, more 
than 60% of cells expressed GFP by 4 days (Fig. ID, E). Plating 
efficiency in N2B27 medium was high (>50%), and the exponen-
tial increase in cell numbers throughout the culture period (Fig. 
IF) was evidence of high cell viability. Moreover, when the ES cells 
were plated on laminin or fibronectin, they produced large num-
bers of differentiated flattened cells that were Sox] -GFP negative, 
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Figure 1. Soxl.GFP reporter of neural specification. (A) GFP 
fluorescence restricted to the neural tissues of embryonic day 8.5 mouse 
embryo following germline transmission of Soxl°" allele. (B) Undiffer-
entiated 46C ES cells do not express GFP. (C) Expression of GFP in 
rosette of neural precursors derived from 46C ES cells plated in N2B27. 
(0) Flow cytometry profiles of Soxl-GFP activation in N2827. (E) Kinetics 
of Sax 1-GFP positive cell population during monolayer differentiation. 
Gates were set at 10 units of fluorescence, excluding 99% of the 
undifferentiated ES cell population. Data are means ± s.d. for triplicate 
determinations from two independent experiments. The decline in GFP 
positive cells after day 8 occurs because differentation into neurons and 
glia is accompanied by downregulation of Sox 1. (F) Plot of cell numbers 
during monolayer differentiation of 46C cells. Data are means from the 
same experimental series as shown In (E). Bar. 50 sm. 
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Igure 2. Neuronal and glial differentiation in monolayer culture. (A) Phase 
s,trast and type Ill -tubulln immunostained images of neurons gen- 
rated by monoculture of 46C ES cells In N2B27. (B) Phase contrast and 
FP expression from Tat, knock-in after monolayer differentiation of TK23 
S cells with replating on flbronectin in N21327. (C) Phase contrast and 
ABA immunostaining of neurons generated by monolayer differentiation 
ith replating on fibronectin in N21327. (0) DAPI and tyrosine hydroxylase 
nmunostaining after replatin9 of monolayer neural precursors and 
posure to FGF8 and SHH. (E) GFAP and CNPase lmmunostalning of 
strocytes and oligodendrocytes, respectively, generated 10-14 d after 
tplating monolayer precursors in N2B27 (plus 1% serum for 
ligodendrocytes). Bar, 50 pm. 
Cells with overt neuronal morphology and marker expression 
ecame apparent from 5 days after LIF withdrawal (Fig. 2A). To 
tonitor the production of neurons during monolayer differentia-
on, we engineered a second ES cell line, TK23, in which GFP is 
ttegrated into the Tau locus and is therefore expressed only in neu-
ms 1 . Tau-GFP-positive cells first appeared after 4 days of mono-
Lilture differentiation. When the cultures were dissociated between 
ay 6 and 8 and replated onto fibronectin-coated dishes, —60% of 
tlls developed into Tau-GFP-positive cells with extended neuronal 
rocesses (Fig. 2B). 
TK23 differentiation illustrates that the phenomenon of mono-
alture neural differentiation is not specific to the 46C ES cell 
[one. To date we have tested 15 different ES cell clones, derived 
'om 3 independent primary ES cell isolates, and all generated neu-
ns efficiently with this protocol. Many of the neurons formed in 
12B27 are immunopositive for y-aminobutyric acid (GABA) (Fig. 
C), with few tyrosine hydroxylase—positive cells. However, replat-
ig and addition of FGF8 and sonic hedgehogt 2 resulted in signifi-
tnt numbers of tyrosine hydroxylase—immunoreactive neurons 
Fig. 2D). Therefore, neural precursors generated by monolayer 
ifferentiation are malleable and can be directed into particular 
euronal fates. They can also produce both astrocytes and oligo-
endrocytes (Fig. 2E). 
The monolayer protocol facilitates visualization of the process of 
eural conversion. Figure 3A presents sequential images of a repre-
mtative colony of 46C cells during the transition from undifferen- 




Figure 3. Visualization of neural determination of ES cells. (A) Sequential 
images of a single colony during 46C monoculture differentiation Cells 
were plated at low density in ES cell medium containing serum and LIF 
and transferred to N2B27 without LIF after overnight incubation (Time 0). 
After 210 h cells were fixed and immunostained for nestle and class Ill 
-tubulin (TuJ 1). GFP fluorescence was captured at the Indicated times. 
(B) Oct4-GFP and nestin expression In Oct4GiP cells 24, 72, and 120 ft 
after plating in N2B27. There was no detectable nestin Immunoreactivity 
at 24 or 48 h. Immunostaining for Oct4 protein gave comparable results to 
the distribution of 0ct4-GFP. (C) Separation of Sox 1- and Oct4-expressing 
cells by FACS. RNAs were prepared from undifferentiated 46C ES cells or 
from GFP-positive (58.5%) and GFP-negative (17.5%) populations on day 
4 of monoculture differentiation and analyzed by RT-PCR. Bar, 50 pm. 
tiated ES cells to Soxl-GFP-positive neural precursors. It is evident 
that neural identity is acquired throughout the colony without sig-
nificant cell loss but also that the activation of SoxI-GFP is not syn-
chronous in all cells. 
We examined the profile of the ES cell transcriptional organizer 
Oct4 (ref. 13). lmmunostainmg for Oct4 protein and GFP fluores-
cence from an Oct4-GIP transgen& 4 gave comparable results. 
Figure 313 shows the time course of downregulation of Oct4-GFP 
coincident with upregulation of the neuroepithelial marker nestin. 
GFP expression is evident uniformly in all cells 24 hours after plat-
ing. Oct4 began to be lost from the population only after 48 hours, 
coincident with the emergence of nestin-positive cells. The loss of 
Oct4 was also asynchronous within the culture. Furthermore, some 
clusters of cells escaped differentiation and retained Oct4 expres-
sion indefinitely. 
We used FACS purification to verify that Sox]-GFP-expressing 
46C cells are distinct from ES cells and constitute neural precursors. 
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l'-PCR analysis of sorted GFP-positive and GFP-negative popula-
sns confirmed that the former expressed Soxi mRNA as expected 
A lacked detectable levels of Oct4 transcript (Fig. 3C). Conversely, 
,e GFP negative population had very low levels of Soxi mRNA and 
ipreciable Oct4 mRNA, indicating persistence of undifferentiated 
cells. We next plated the sorted cells in the presence of serum and 
F to test for ES cells. ES cell colonies were readily generated from 
FP-negative cells but arose only at very low frequency (<0.1%) 
sm the GFP-positive population. Contamination of the FACS 
uld account for the latter result, although it is also possible that 
ry primitive neural cells may retain the capacity to regenerate 
uripotent cells 8 . 
We replaced the N213127 supplements in a stepwise fashion (see 
ipplementary Table online). Removal of B27 did not reduce the 
tquency of conversion to GFP-positive cells, indicating that the 
rious components of this supplement do not have specific 
ductive activity. Furthermore, although plating efficiency and 
ability were reduced on removal of albumin and insulin, Sox] -
FP cells could be generated in fully defined medium in which 
ansferrin was the sole protein component. We conclude that 
ogenous inductive stimuli are not essential for neural specifica-
)fl of ES cells. 
In Xenopus laevis, bone morphogenetic protein (BMP) antago-
ats such as noggin promote neural development 6 . However, we 
d not detect any effect of noggin on neural conversion of ES cells 
ig. 4A). The addition of BMP4, in contrast, suppressed the devel-
ment of neural precursors and neurons and induced the appear-
cc of non-neural differentiated cells (Fig. 411). These large, fiat-
ied cells resembled the predominant cell types generated in the 
esence of serum or in N2B27 on laminin or fibronectin. They 
re viable in N21527 medium, confirming that this medium is not 
trinsically inhibitory to non-neural cell types. We conclude that 
hough BMPs act as potent stimulators of alternative differentia-
in, endogenous EMP activity does not limit neural determina-
in in ES cell cultures. This may be explained, at least in part, by 
pression in the cultures of the BMP antagonists noggin and fol-
tatin (Fig. 4C). 
Addition of LIF increased the proportion of undifferentiated ES 
Is and consequently reduced the production of Soxi-GFP cells 
ig. 4A). This contrasts with a suggestion that LIF promotes the 
rseration of primitive neural precursors from ES cells 8 , but is con-
tent with the well-established role of gp 130 cytokines in promot-
self-renewal of undifferentiated ES cells 2 . Interestingly, LIF 
pears rather less effective at blocking ES cell differentiation into 
ural derivatives in defined medium than at inhibiting develop-
tnt of non-neural cell types in serum-containing medium'. 
Studies in planariall and in frog 16 and avian"-" embryos have 
gested a primary requirement for FGF signaling in neural speci-
ation. ES cells express appreciable amounts of FGF4 (ref. 13; Fig. 
). We therefore plated cells at low densities under which an 
tocrine factor might become limiting. Under these conditions, 
dition of FGF4 modestly but reproducibly increased the initial 
quency of Soxi-GFP-positive 46C cells on day 3 (Fig. 4D). This 
ect is unlikely to be attributable to selective amplification of 
ural precursors because FGF4 was withdrawn on day 2, at which 
mt very few Soxi-GFP positive cells had emerged (Fig. lE). 
rthermore, FGF2 had no stimulatory effect in this assay, although 
s a potent nutogen for Sox 1-positive cells. 
We used a pharmacological inhibitor of FGF receptor tyrosine 
iases, SU5402 (ref. 19), to test whether autocrine FGF signaling is 
obligate requirement for neural specification of ES cells. SU5402 
tM) virtually eliminated the development of Soxi-GFP-positive 
C cells without observable effect on cell viability or proliferation 
g. 4E). Notably, SU5402 prevented the initial formation of Soxi - 
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Figure 4. Effects of growth factors and antagonists on neural 
determination. (A) Effect of BMP4, noggin, and LIF. 46C cells were cultured 
in N2/B27 medium with recombinant proteins: 10 ng/ml BMP-4, 0.1 ag/ml 
nogglnlFc chimera (all from R&D Systems), or 100 U/mI LIF, as indicated. 
Data are means ± s.d. of triplicate determinations from two or three 
independent experiments, normalized relative to the frequency of GFP 
positive cells obtained in N2B27 alone. (B) Non-neural differentiation 
induced by exposure of 46C ES cells to BMP4 in N212127. (C) RT-PCR 
analyses of mRNA expression during monoculture differentiation. 
(D) FGF4 increases the frequency of Soxl-GFP positive cells emerging on 
day 3. For each condition, data are from a total of 17 wells In four 
independent pairwise experiments. The Increased frequency of GFP. 
positive cells after FGF4 treatment is significant, P < 0.001 (ANOVA). In 
parallel assays, addition of FGF2 produced no significant difference from 
N2B27 only. (E) Effect of FGF receptor inhibitor SU5402 (5 tM). Assays 
performed as In (A). (F, G) Suppression of neural development from ES 
cells expressing DN.FGFR. Cells transfected with control vector (F) or 
DN-FGFR expression vector (C) were plated in N212127, allowed to 
differentiate for 6 d, then immunostalned for nestln and the neuronal 
marker class Ill -tubulin. Bar, 50 pm. 
GFP-positive cells on day 3, indicating that it acts directly on 
pluripotent cells. This action was not reversed by addition of noggin 
at levels that completely block the action of 50 rig/ml BMP4 (Fig. 
4A, E), and is therefore unlikely to be mediated via derepression of 
BMP expression as reported in the chick". Independent evidence 
that FGF signaling is necessary for neural specification was obtained 
by expression of dominant-negative FGF receptor (DN-FGFR) 20 . 
Under ES cell maintenance conditions, DN-FGFR transfectants 
showed viability and growth rate comparable to those of parental 
cells or cells transfected with a control plasmid. However, on with-
drawal of UF and serum from N2B27, ES cells expressing the DN-
FGFR remained viable but specifically failed to generate appreciable 
numbers of either nestin-positive neural precursors or type III - 
tubulin (TuJ)-positive neurons (Fig. 4F, G). 
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Elsewhere we have provided evidence that Writ signaling directs 
cells into non-neural lineages' 0, and here we show that serum, 
vlPs, and extracdllular matrix components also induce non-neur -
differentiation. Thus, suppression of neural determination by 
duction of alternative fates appears to be a principle conserved 
tween the differentiation of pluripotent cells in embryos 6 and of 
cells. However, the critical requirement for FGF signaling in ES 
lls indicates that this is not a simple default process. Previous 
udies have provided evidence for a role for FGFs in neural induc-
rn in planaria' 5 , frogs ' 6, and chicks' 7 ' 8 . Whether FGFs are required 
r neural specification in mammalian epiblast is not known 
cause both Fgf4 (ref. 21) and Fgfr2 (ref. 22) knockouts result in 
e-gastrulation lethality. Germ layer commitment in embryos and 
i cells may follow the same rules. However, the culture setting of 
cells may also confer distinct responses compared with epiblast 
us in vivo. For example, the action of LIF in sustaining self-renew-
is particular to cultured ES cells, as this pathway serves a purely 
cultative function in the early embry0 23 . 
An intriguing feature of the monoculture system, also evident in 
6 cocultures 5 , is that not all cells behave identically. The onset of 
,xl-GFP expression is not synchronous throughout the cultures 
ig 3A). Furthermore, a minority of cells differentiate into non-
!ural cell types and 10-15% persist as clusters of undifferentiated 
cells. The latter are fully competent for differentiation if 
ypsinized and replated. These observations might indicate that 
ere is a stochastic component, a community effect, or both in lin-
ge commitment. The Soxl-GFP-expressing neural precursors can 
adily be purified from other cells, however, by FACS or by tran-
nt selection with puromycin. 
Understanding how to generate appropriate cell types robustly 
id under defined conditions from ES cells will be essential for 
.nctional applications including the development of cell replace-
ent therapies. The present findings provide a simple, rational sys- 
m for conversion of ES cells into neuroepithelial precursors and 
,ence into neurons and glia. Furthermore, the elimination of mul-
:ellular aggregation, coculture, or conditioned medium extracts 
ovides for direct assay of lineage determination factors and a 
undation for truly directed differentiation of ES cells. 
cperimental protocol 
nbryonic stem cell culture. ES cells were routinely propagated without 
rders in LIF-supplemented medium 2. Cell lines were CGR8 or El4Tg2a.IV 
4 derivatives thereof, or Oct4GiP, derived from strain 12901a mice carry-
g an Oct4-GFPiresPac transgene' 4. 46C ES cells were generated by gene tar-
ting in E14Tg2a.IV ES cells, The open reading frame of the Soxi gene was 
placed by GFPiresPac, with excision of the hytk selection cassette being 
complished via transient expression of Crc recombinase. 
ifferentiation protocol. For monoculture differentiation, undifferentiated 
cells were dissociated and plated onto 0.1% gelatin-coated tissue culture 
astic at a density of 0.5-1.5 x 10 41cm2 in N2B27 medium. Medium was 
newed every 2 d. N2B27 is a 1:1 mixture of DMEM/F12 (Gibco, Paisley, 
K) supplemented with modified N2 (25 sg/ml insulin, 100 jig/ml apo-
snsferrin, 6 ng/ml progesterone, 16 j.cg/ml putrescine, 30 n.M sodium 
lenite and 50 jug/ml bovine serum albumin fraction V ( Gibco)) and 
turobasal medium supplemented with 827 (both from Gibco). Tyrosine 
'droxytase-positive neurons were induced with FGF2 (20 ngfml), Sonic 
rdgehog (400 ng/ml). and FGF8 (100 ng/ml)". For assay of FGF effects on 
riergence of neural precursors, cells were plated at 2.6 x 10' cells/cm 2 and 
iltured for 24 h in N2827 plus LIE. Cells were then transferred to N2B27 
sac or containing FGF2 or FGF4 (2 ag/mI). After 48 h medium was 
placed with non-supplemented N2B27 for a further 24 h prior to FACS 
alysis. The dominant-negative FGF receptor construct encodes a truncat-
version of murine FGFR2 Ilic lacking the cytoplasmic domain 20. This 
nstruct was inserted into the pPyCAGiP episomal expression vector and 
troduced by supertransfection into E14IT ES cells harboring polyoma 
rge T protein". 
Immunostaining and RT-PCR. Details of antibodies are given in the 
Supplementary Experimental protocol online. For RT-PCR analyses, I jig 
total RNA was reverse transcribed using random hexamer primers and PCR 
performed on 1/20 of the final cDNA volume. Primers and PCR details are 
available in Supplementary Experimental protocol online. 
Note: Supplementary information is available on the Nature Biotechnology 
website. 
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